US20020084196A1 - Small volume in vitro analyte sensor and methods - Google Patents

Small volume in vitro analyte sensor and methods Download PDF

Info

Publication number
US20020084196A1
US20020084196A1 US10/033,506 US3350601A US2002084196A1 US 20020084196 A1 US20020084196 A1 US 20020084196A1 US 3350601 A US3350601 A US 3350601A US 2002084196 A1 US2002084196 A1 US 2002084196A1
Authority
US
United States
Prior art keywords
sensor
substrate
analyte
major surface
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US10/033,506
Other versions
US20020157948A2 (en
US6942518B2 (en
Inventor
Charles Liamos
Benjamin Feldman
Jeffery Funderburk
Rajesh Krishnan
Phillip Plante
Joseph Vivolo
Robert Jin
Michael Cloud
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Therasense Inc
Original Assignee
Therasense Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therasense Inc filed Critical Therasense Inc
Priority to US10/033,506 priority Critical patent/US6942518B2/en
Publication of US20020084196A1 publication Critical patent/US20020084196A1/en
Publication of US20020157948A2 publication Critical patent/US20020157948A2/en
Application granted granted Critical
Publication of US6942518B2 publication Critical patent/US6942518B2/en
Adjusted expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28Electrolytic cell components
    • G01N27/30Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • G01N27/3271Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
    • G01N27/3272Test elements therefor, i.e. disposable laminated substrates with electrodes, reagent and channels
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S439/00Electrical connectors
    • Y10S439/909Medical use or attached to human body

Definitions

  • This invention relates to analytical sensors for the detection of bioanalytes in a small volume sample, and methods of making and using the sensors.
  • Analytical sensors are useful in chemistry and medicine to determine the presence and concentration of a biological analyte. Such sensors are needed, for example, to monitor glucose in diabetic patients and lactate during critical care events.
  • the sensors of the present invention provide a method for the detection and quantification of an analyte in submicroliter samples.
  • the invention includes a method and sensor for analysis of an analyte in a small volume of sample by, for example, coulometry, amperometry and/or potentiometry.
  • a sensor of the invention preferably utilizes a non-leachable or diffusible redox mediator.
  • the sensor also includes a sample chamber to hold the sample in electrolytic contact with the working electrode. In many instances, the sensor also contains a non-leachable or diffusible second electron transfer agent.
  • the working electrode faces a counter electrode, forming a measurement zone within the sample chamber, between the two electrodes, that is sized to contain no more than about 1 ⁇ L of sample, preferably no more than about 0.5 ⁇ L, more preferably no more than about 0.32 ⁇ L, still more preferably no more than about 0.25 ⁇ L, and most preferably no more than about 0.1 ⁇ L of sample.
  • a sensor configured for insertion into an electronic meter, is provided with a working electrode and a counter electrode, and a conductive insertion monitor which provides electrical contact with the electronic meter if the sensor is properly inserted into the meter.
  • the conductive insertion monitor is configured and arranged to close an electrical circuit when the sensor is properly inserted into the electronic connector.
  • a sensor is provided with a plurality of contacts, each contact having a contact pad, which is a region for connection with an electronic meter.
  • the plurality of contacts and contact pads are disposed on a substrate having a length and a width, and each contact pad has a contact pad width taken parallel to the width of the substrate. The sum of the contact pad widths is greater than the width of the substrate.
  • six electrical connections are made with six contact pads on the sensor but in a width that is approximately the width of four contact pads.
  • a working electrode, three counter electrodes (e.g., one counter electrode and two indicator electrodes), and two insertion trace connections each have a contact pad; connection can be made to each of these six contact pads in the same width of the contact pads of the working electrode and three counter electrodes.
  • the present invention also includes an electrical connector, for providing electrical contact between a sensor and an electrical meter or other device.
  • the electrical connector has a plurality of contact structures, each which has a proximal contact end for electrical connection to a sensor contact, and a distal end for electrical connection to the electrical device.
  • a plurality of first contact structures extend longitudinally parallel from the distal to the proximal end.
  • one or more second contract structures extend longitudinally next to the first contact structures, from the distal end past the proximal end of the first contact structures, and angle toward a longitudinal center line of the connector. Contact to the sensor is then made via the proximal contact ends.
  • the electrical connector has at least two second contact structures extending longitudinally past the proximal end of the first contact structures and angling toward the longitudinal center line of the connector.
  • the proximal contact ends of the second contact structures make electrical contact with a single conductive surface of a sensor, such as a conductive insertion monitor.
  • the first contact structures can be configured and arranged to contact one or more working and/or counter electrodes of a sensor, and the second contact structures are configured and arranged to contact one or more conductive insertion monitors.
  • the sensors of the present invention can be configured for side-filling or tip-filling.
  • the sensor may be part of an integrated sample acquisition and analyte measurement device.
  • the integrated sample acquisition and analyte measurement device can include the sensor and a skin piercing member, so that the device can be used to pierce the skin of a user to cause flow of a fluid sample, such as blood, that can then be collected by the sensor.
  • the fluid sample can be collected without moving the integrated sample acquisition and analyte measurement device.
  • the senor is connected with an electrical device, to provide a processor coupled to the sensor.
  • the processor is configured and arranged to determine, during electrolysis of a sample in the sample chamber, a series of current values.
  • the processor determines a peak current value from the series of current values. After the current values decrease below a threshold fraction of the peak current values, slope values are determined from the current values and represent a linear function of the logarithm of current values over time.
  • the processor determines, from the slope values, an extrapolation slope. From the extrapolated slope and the measured current values, the processor determines an amount of charge needed to electrolyze the sample and, from that amount of charge, the concentration of the analyte in the sample.
  • One method of forming a sensor includes forming at least one working electrode on a first substrate and forming at least one counter or counter/reference electrode on a second substrate.
  • a spacer layer is disposed on either the first or second substrates.
  • the spacer layer defines a chamber into which a sample can be drawn and held when the sensor is completed.
  • a redox mediator and/or second electron transfer agent can be disposed on the first or second substrate in a region that will be exposed within the sample chamber when the sensor is completed.
  • the first and second substrates are then brought together and spaced apart by the spacer layer with the sample chamber providing access to the at least one working electrode and the at least one counter or counter/reference electrode.
  • the first and second substrates are portions of a single sheet or continuous web of material. The invention includes particularly efficient and reliable methods for the manufacture of these sensors.
  • One such efficient and reliable method includes providing an adhesive having first and second surfaces covered with first and second release liners and then making detailed cuts through the first release liner and the adhesive but not through the second release liner. These cuts define one or more sample chamber regions. A portion of the first release liner is removed to expose a portion of the first adhesive surface, which leaves a remaining portion of the first release liner over the sample chamber regions. This exposed first adhesive surface is applied to a first substrate having one or more conductive traces disposed thereon. The second release liner is removed together with the adhesive and the first release liner of the sample chamber regions in order to expose the second adhesive surface. The second adhesive surface is then applied to a second substrate having one or more conductive traces disposed thereon. This method forms a sensor having a sample chamber corresponding to one of the sample chamber regions.
  • FIG. 1 is a schematic view of a first embodiment of an electrochemical sensor in accordance with the present invention having a working electrode and a counter electrode facing each other and having a sample chamber;
  • FIG. 2 is an exploded view of the sensor shown in FIG. 1, the layers illustrated individually;
  • FIG. 3 is a schematic view of a second embodiment of an electrochemical sensor in accordance with the principles of the present invention having a working electrode and a counter electrode facing each other and having an extended sample chamber;
  • FIG. 4 is a top view of a third embodiment of an electrochemical sensor in accordance with the principles of the present invention, this sensor includes multiple working electrodes;
  • FIG. 5A illustrates a top view of a first substrate with a working electrode for use in a fourth embodiment of a sensor according to the invention
  • FIG. 5B illustrates a bottom view of a second substrate (inverted with respect to FIG. 5A) with counter electrodes placement over and opposite the substrate of FIG. 5A;
  • FIG. 5C illustrates a top view of a spacer for placement between the first substrate of FIG. 5A and the second substrate of FIG. 5B;
  • FIG. 6A illustrates a top view of a first film with a working electrode for use in a fifth embodiment of a sensor according to the invention
  • FIG. 6B illustrates a top view of a spacer for placement on the first film of FIG. 6A
  • FIG. 6C illustrates a bottom view of a second film (inverted with respect to FIGS. 6A and 6B) with counter electrodes placement over the spacer of FIG. 6B and first film of FIG. 6A;
  • FIG. 7A illustrates a top view of a first film with a working electrode for use in a sixth embodiment of a sensor according to the invention
  • FIG. 7B illustrates a top view of a spacer for placement on the first film of FIG. 7A
  • FIG. 7C illustrates a bottom view of a second film (inverted with respect to FIGS. 7A and 7B) with counter electrodes placement over the spacer of FIG. 7B and first film of FIG. 7A;
  • FIG. 8A illustrates a top view of a first film with a working electrode for use in a seventh embodiment of a sensor according to the invention
  • FIG. 8B illustrates a top view of a spacer for placement on the first film of FIG. 8A
  • FIG. 8C illustrates a bottom view of a second film (inverted with respect to FIGS. 8A and 8B) with counter electrodes placement over the spacer of FIG. 8B and first film of FIG. 8A;
  • FIG. 9A illustrates a top view of a first film with a working electrode for use in a eighth embodiment of a sensor according to the invention
  • FIG. 9B illustrates a top view of a spacer for placement on the first film of FIG. 9A
  • FIG. 9C illustrates a bottom view of a second film (inverted with respect to FIGS. 9A and 9B) with counter electrodes placement over the spacer of FIG. 9B and first film of FIG. 9A;
  • FIG. 10A illustrates a top view of a first film with a working electrode for use in a ninth embodiment of a sensor according to the invention
  • FIG. 10B illustrates a top view of a spacer for placement on the first film of FIG. 10A
  • FIG. 10C illustrates a bottom view of a second film (inverted with respect to FIGS. 10A and 10B) with counter electrodes placement over the spacer of FIG. 10B and first film of FIG. 10A;
  • FIG. 11A illustrates a top view of a first film with a working electrode for use in a tenth embodiment of a sensor according to the invention
  • FIG. 11B illustrates a top view of a spacer for placement on the first film of FIG. 11A
  • FIG. 11C illustrates a bottom view of a second film (inverted with respect to FIGS. 11A and 11B) with counter electrodes placement over the spacer of FIG. 11B and first film of FIG. 11A;
  • FIG. 12A illustrates a top view of a first film with a working electrode for use in a eleventh embodiment of a sensor according to the invention
  • FIG. 12B illustrates a top view of a spacer for placement on the first film of FIG. 12A
  • FIG. 12C illustrates a bottom view of a second film (inverted with respect to FIGS. 12A and 12B) with counter electrodes placement over the spacer of FIG. 12B and first film of FIG. 12A;
  • FIG. 13A illustrates a top view of one embodiment of a sheet of sensor components, according to the invention.
  • FIG. 13B illustrates a top view of another embodiment of a sheet of sensor components, according to the invention.
  • FIGS. 14A through 14F illustrate cross sectional views of a sequential process of providing a sample chamber in a spacer layer
  • FIG. 14G is a bottom view of FIG. 14B;
  • FIG. 15A is a graphical representation of the current over time used to calculate the concentration of an analyte
  • FIG. 15B is a graphical representation of the log of current over time used to calculate the concentration of an analyte
  • FIG. 16A is a top perspective view of a sensor positioned for insertion within an electrical connector device in accordance with the present invention
  • FIG. 16B is an exploded view of the electrical connector device of FIG. 16A;
  • FIG. 17A is a top perspective view of a sensor fully positioned within the electrical connector device of FIG. 16A;
  • FIG. 17B is an exploded view of the electrical connector device of FIG. 17A;
  • FIG. 18A is a bottom perspective view of the electrical connector device of FIGS. 16A and 16B;
  • FIG. 18B is a bottom perspective view of the electrical connector device of FIGS. 17A and 17B;
  • FIGS. 19A through 19L illustrate examples of suitable conductive pathways between contact pads
  • FIG. 20 illustrates a cross-sectional view looking from inside a connector to a sensor of the invention disposed within the connector
  • FIG. 21 illustrates a perspective view of a ring for use with a lancet device.
  • An “air-oxidizable mediator” is a redox mediator that is oxidized by air, preferably so that at least 90% of the mediator is in an oxidized state upon storage in air either as a solid or as a liquid during a period of time, for example, one month or less, and, preferably, one week or less, and, more preferably, one day or less.
  • Amperometry includes steady-state amperometry, chronoamperometry, and Cottrell-type measurements.
  • a “biological fluid” is any body fluid in which the analyte can be measured, for example, blood (which includes whole blood and its cell-free components, such as, plasma and serum), interstitial fluid, dermal fluid, sweat, tears, urine and saliva.
  • Coulometry is the determination of charge passed or projected to pass during complete or nearly complete electrolysis of the analyte, either directly on the electrode or through one or more electron transfer agents.
  • the charge is determined by measurement of charge passed during partial or nearly complete electrolysis of the analyte or, more often, by multiple measurements during the electrolysis of a decaying current and elapsed time.
  • the decaying current results from the decline in the concentration of the electrolyzed species caused by the electrolysis.
  • a “counter electrode” refers to one or more electrodes paired with the working electrode, through which passes an electrochemical current equal in magnitude and opposite in sign to the current passed through the working electrode.
  • the term “counter electrode” is meant to include counter electrodes which also function as reference electrodes (i.e. a counter/reference electrode) unless the description provides that a “counter electrode” excludes a reference or counter/reference electrode.
  • an “effective diffusion coefficient” is the diffusion coefficient characterizing transport of a substance, for example, an analyte, an enzyme, or a redox mediator, in the volume between the electrodes of the electrochemical cell.
  • the cell volume may be occupied by more than one medium (e.g., the sample fluid and a polymer film). Diffusion of a substance through each medium may occur at a different rate.
  • the effective diffusion coefficient corresponds to a diffusion rate through this multiple-media volume and is typically different than the diffusion coefficient for the substance in a cell filled solely with sample fluid.
  • An “electrochemical sensor” is a device configured to detect the presence of and/or measure the concentration of an analyte via electrochemical oxidation and reduction reactions. These reactions are transduced to an electrical signal that can be correlated to an amount or concentration of analyte.
  • Electrolysis is the electrooxidation or electroreduction of a compound either directly at an electrode or via one or more electron transfer agents (e.g., redox mediators and/or enzymes).
  • electron transfer agents e.g., redox mediators and/or enzymes.
  • facing electrodes refers to a configuration of the working and counter electrodes in which the working surface of the working electrode is disposed in approximate opposition to a surface of the counter electrode. In at least some instances, the distance between the working and counter electrodes is less than the width of the working surface of the working electrode.
  • a compound is “immobilized” on a surface when it is entrapped on or chemically bound to the surface.
  • An “indicator electrode” is an electrode that detects partial or complete filling of a sample chamber and/or measurement zone.
  • a “layer” is one or more layers.
  • the “measurement zone” is defined herein as a region of the sample chamber sized to contain only that portion of the sample that is to be interrogated during an analyte assay.
  • a “non-diffusible,” “non-leachable,” or “non-releasable” compound is a compound which does not substantially diffuse away from the working surface of the working electrode for the duration of the analyte assay.
  • the “potential of the counter/reference electrode” is the half cell potential of the reference electrode or counter/reference electrode of the cell when the solution in the cell is 0.1 M NaCl solution at pH7.
  • a “redox mediator” is an electron transfer agent for carrying electrons between the analyte and the working electrode, either directly, or via a second electron transfer agent.
  • a “reference electrode” includes a reference electrode that also functions as a counter electrode (i.e., a counter/reference electrode) unless the description provides that a “reference electrode” excludes a counter/reference electrode.
  • a “second electron transfer agent” is a molecule that carries electrons between a redox mediator and the analyte.
  • a “surface in the sample chamber” is a surface of a working electrode, counter electrode, counter/reference electrode, reference electrode, indicator electrode, a spacer, or any other surface bounding the sample chamber.
  • a “working electrode” is an electrode at which analyte is electrooxidized or electroreduced with or without the agency of a redox mediator.
  • a “working surface” is the portion of a working electrode that is covered with non-leachable redox mediator and exposed to the sample, or, if the redox mediator is diffusible, a “working surface” is the portion of the working electrode that is exposed to the sample.
  • the small volume, in vitro analyte sensors of the present invention are designed to measure the concentration of an analyte in a portion of a sample having a volume no more than about 1 ⁇ L, preferably no more than about 0.5 ⁇ L, more preferably no more than about 0.32 ⁇ L, still more preferably no more than about 0.25 ⁇ L, and most preferably no more than about 0.1 ⁇ L of sample.
  • the analyte of interest is typically provided in a solution or biological fluid, such as blood or serum.
  • a small volume, in vitro electrochemical sensor 20 of the invention generally includes a working electrode 22 on a first substrate 32 , a counter (or counter/reference) electrode 24 on a second substrate 34 , and a sample chamber 26 .
  • the sample chamber 26 is configured so that when a sample is provided in the chamber, the sample is in electrolytic contact with both the working electrode 22 , the counter electrode 24 and any reference electrodes or indicator electrodes that may be present. This allows electrical current to flow between the electrodes to effect the electrolysis (electrooxidation or electroreduction) of the analyte.
  • a spacer 33 is positioned between first substrate 32 and second substrate 34 to provide a spacing between electrodes 22 , 24 and to provide sample chamber 26 in which the sample to be evaluated is housed.
  • the working electrode 22 may be formed from a molded carbon fiber composite or it may include an inert non-conducting base material, such as polyester, upon which a suitable conducting layer is deposited.
  • the conducting layer typically has relatively low electrical resistance and is typically electrochemically inert over the potential range of the sensor during operation.
  • Suitable conducting layers include gold, carbon, platinum, ruthenium dioxide, palladium, and conductive epoxies, such as, for example, ECCOCOAT CT5079-3 Carbon-Filled Conductive Epoxy Coating (available from W. R. Grace Company, Woburn, Mass.), as well as other non-corroding materials known to those skilled in the art.
  • the electrode e.g., the conducting layer
  • the electrode is printed onto the base material.
  • the inert non-conducting base material is also referred to as a substrate, base, or the like.
  • This base material is typically an electrically non-conducting material, e.g., any insulating material, that is not capable of carrying electric charge or current.
  • materials usable as the base material for sensors of the present invention include polyesters, polyethylene (both high density and low density), polyethylene terephthalate, polycarbonate, vinyls, and the like.
  • the base material can be treated with a primer or other such coating to improve the adhesion of the electrodes thereon.
  • a tab 23 ′ can be provided on the end of the working electrode 22 for easy connection of the electrode to external electronics (not shown) such as a voltage source or current measuring equipment.
  • External electronics such as a voltage source or current measuring equipment.
  • Contact pad 23 which is connected to working electrode 22 , such as an extension from the working electrode, can be positioned on tab 23 ′.
  • a dielectric or other insulating material can be deposited on the electrode over, under, or surrounding the region with the redox mediator.
  • Suitable dielectric materials include waxes and non-conducting organic polymers, such as polyethylene.
  • the dielectric material can also cover a portion of the redox mediator on the electrode. The covered portion of the redox mediator will not contact the sample, and, therefore, will not be a part of the electrode's working surface.
  • sensing chemistry materials are provided in the sample chamber 26 for the analysis of the analyte.
  • This sensing chemistry preferably includes a redox mediator and a second electron transfer mediator, although in some instances, one or the other may be used alone.
  • the redox mediator and second electron transfer agent can be independently diffusible or non-leachable (i.e., non-diffusible) such that either or both may be diffusible or non-leachable.
  • Placement of sensor chemistry components can depend on whether they are diffusible or non-leachable. For example, non-leachable and/or diffusible component(s) typically form a sensing layer on the working electrode.
  • one or more diffusible components can be disposed on any surface in the sample chamber prior to the introduction of the sample.
  • one or more diffusible component(s) are placed in the sample prior to introduction of the sample into the sensor.
  • the non-leachable redox mediator is typically disposed on the working electrode 22 as a sensing layer.
  • the redox mediator and second electron transfer agent are both non-leachable, then both of the non-leachable components are disposed on the working electrode 22 as a sensing layer.
  • the second electron transfer agent is diffusible and the redox mediator is non-leachable, then at least the redox mediator is disposed on the working electrode 22 as a sensing layer.
  • the diffusible second electron transfer agent need not be disposed on a sensing layer of the working electrode, but can be disposed on any surface of the sample chamber, including within the redox mediator sensing layer, or can be placed in the sample. If the redox mediator is diffusible, then the redox mediator can be disposed on any surface of the sample chamber or can be placed in the sample.
  • the diffusible components can be independently or jointly disposed on any surface of the sample chamber and/or placed in the sample (i.e., each diffusible component need not be disposed on the same surface of the sample chamber or placed in the sample).
  • the redox mediator whether it is diffusible or non-leachable, mediates a current between the working electrode 22 and the analyte and enables the electrochemical analysis of molecules which may not be suited for direct electrochemical reaction on an electrode.
  • the mediator functions as an electron transfer agent between the electrode and the analyte.
  • Analytes that can be interrogated include, for example, glucose, acetyl choline, amylase, bilirubin, cholesterol, chorionic gonadotropin, creatine kinase (e.g., CK-MB), creatine, DNA, fructosamine, glucose, glutamine, growth hormones, hormones, ketones, lactate, peroxide, prostate-specific antigen, prothrombin, RNA, thyroid stimulating hormone, and troponin.
  • creatine kinase e.g., CK-MB
  • the concentration of analytes such as drugs or medication, such as, for example, antibiotics (e.g., gentamicin, vancomycin, and the like), digitoxin, digoxin, drugs of abuse, theophylline, and warfarin, can also be determined.
  • antibiotics e.g., gentamicin, vancomycin,
  • redox mediator any organic or organometallic redox species can be used as a redox mediator
  • one type of suitable redox mediator is a transition metal compound or complex.
  • suitable transition metal compounds or complexes include osmium, ruthenium, iron, and cobalt compounds or complexes.
  • the transition metal is coordinatively bound to one or more ligands.
  • the ligands are typically mono-, di-, tri-, or tetradentate.
  • the most preferred ligands are heterocyclic nitrogen compounds, such as, for example, pyridine and/or imidazole derivatives.
  • Multidentate ligands may include multiple pyridine and/or imidazole rings.
  • metallocene derivatives such as, for example, ferrocene
  • metallocene derivatives such as, for example, ferrocene
  • An example of one mediator is [Os(4-(N-(6-aminohexyl)aminobipyridine)(1,1′-dimethyl-2,2′-biimidazole) 2 ]Cl 3 .
  • the redox mediators can be diffusible redox mediators or non-leachable redox mediators, such as non-leachable redox polymers.
  • non-leachable redox mediators such as non-leachable redox polymers.
  • the senor includes a redox mediator and a second electron transfer agent which is capable of transferring electrons to or from the redox mediator and the analyte.
  • the second electron transfer agent can be diffusible or can be non-leachable (e.g., entrapped in or coordinatively, covalently, or ionically bound to a redox polymer).
  • a suitable second electron transfer agent is an enzyme which catalyzes a reaction of the analyte.
  • a glucose oxidase or glucose dehydrogenase such as pyrroloquinoline quinone glucose dehydrogenase (PQQ)
  • PQQ pyrroloquinoline quinone glucose dehydrogenase
  • a lactate oxidase fills this role when the analyte is lactate.
  • Other enzymes can be used for other analytes.
  • Counter electrode 24 can be constructed in a manner similar to working electrode 22 .
  • Counter electrode 24 may also be a counter/reference electrode.
  • a separate reference electrode may be provided in contact with the sample chamber.
  • Suitable materials for the counter/reference or reference electrode include, for example, Ag/AgCl or Ag/AgBr printed on a non-conducting base material or silver chloride on a silver metal base. The same materials and methods may be used to make the counter electrode as are available for constructing the working electrode 22 , although different materials and methods may also be used.
  • the counter or counter/reference electrode is printed on an insulating base material.
  • a tab 25 ′, on which contact pad 25 is disposed, can be provided for making convenient connection to the external electronics (not shown), such as a coulometer, potentiostat, or other measuring device.
  • a non-conductive filler material such as a non-conductive ink
  • a non-conductive filler material can be formed adjacent a counter electrode, or between multiple counter electrodes to provide a planar surface along the path of travel of the sample fluid in the sample chamber.
  • the non-conductive filler material preferably creates a smooth surface to facilitate filling of the sample chamber by capillary action and/or for reducing the likelihood that air bubbles will become entrapped near the counter electrodes.
  • This non-conductive material can be colored or colorless and may be formed on the substrate by printing or other techniques.
  • the non-conductive material may be deposited prior to or subsequent to the formation of the counter electrode.
  • a non-conductive ink is used to fill in the area between multiple 12.3 micrometer (0.5 mil) thick counter electrodes.
  • a non-conductive ink is used to fill the area between multiple 6.4 micrometer (0.25 mil) thick counter electrodes.
  • no filler ink is needed for thickness less about 6.4 micrometers, and in some sensor designs, no filler ink is needed for 6.4 micrometer thick counter electrodes.
  • working electrode 22 and counter electrode 24 are disposed opposite to and facing each other to form a facing electrode pair as depicted in FIGS. 1 and 2.
  • the sample chamber 26 is typically disposed between the two electrodes.
  • the electrodes are separated by a distance of no more than about 0.2 mm (e.g., at least one portion of the working electrode is separated from one portion of the counter electrode by no more than 200 ⁇ m), preferably no more than 100 ⁇ m, and most preferably no more than 50 ⁇ m.
  • the electrodes need not be directly opposing each other; they may be slightly offset. Furthermore, the two electrodes need not be the same size.
  • the working electrode 22 extends the width of sensor 20 and counter electrode 24 is a portion or all of that width.
  • Either of working electrode 22 or counter electrode 24 may include more than one electrode, such as shown in FIG. 4 (as counter electrodes 324 , 344 ) and in FIG. 5B (as counter electrodes 424 , 441 , 442 ).
  • Counter electrode 24 can also be formed with tines in a comb shape. Other configurations of both the counter electrode and working electrode are within the scope of the invention. However, for this particular embodiment, the separation distance between at least one portion of the working electrode and some portion of the counter electrode preferably does not exceed the limits specified hereinabove.
  • the working and counter electrodes are coplanar.
  • the sample chamber is in contact with both electrodes and is bounded on the side opposite the electrodes by a non-conducting inert base or substrate.
  • Suitable materials for the inert base include non-conducting materials such as polyester.
  • the two electrodes can be formed on surfaces that make an angle to each other.
  • One such configuration would have the electrodes on surfaces that form a right angle.
  • Another possible configuration has the electrodes on a curved surface such as the interior of a tube.
  • the working and counter electrodes can be arranged so that they face each other from opposite sides of the tube. This is another example of a facing electrode pair.
  • the electrodes can be placed near each other on the tube wall (e.g., one on top of the other or side-by-side).
  • the two electrodes must be configured so that they do not make direct electrical contact with each other, to prevent shorting of the electrochemical sensor.
  • each trace provides a contact pad 23 , 25 for providing electrical connection to a meter or other device to allow for data and measurement collection, as will be described later.
  • each contact pad 23 , 25 is positioned on a tab 23 ′, 25 ′ that extends from each non-conducting base substrate 32 , 34 .
  • a tab has more than one contact pad positioned thereon.
  • a single contact pad is used to provide a connection to one or more electrodes; that is, multiple electrodes are coupled together and are connected via one contact pad.
  • a spacer 33 can be used to keep the electrodes apart when the electrodes face each other as depicted in FIGS. 1 and 2; spacer 33 is clearly seen in FIG. 2.
  • the spacer is typically constructed from an inert non-conducting material such as pressure-sensitive adhesive, polyester, MylarTM, KevlarTM or any other strong, thin polymer film, or, alternatively, a thin polymer film such as a TeflonTM film, chosen for its chemical inertness.
  • the spacer 33 can function as a portion of the boundary for the sample chamber 26 .
  • Other spacers include layers of adhesive and double-sided adhesive tape (e.g., a carrier film with adhesive on opposing sides of the film). Adhesive may be applied, for example by coating, onto a polymeric material to provide spacer 33 .
  • the sample chamber 26 is typically defined by a combination of the electrodes 22 , 24 , the substrates 32 , 34 , and a spacer 33 as shown in FIGS. 1 and 2.
  • a measurement zone is contained within this sample chamber and is the region of the sample chamber that contains only that portion of the sample that is interrogated during the analyte assay.
  • sample chamber 26 is the space between the two electrodes 22 , 24 and their non-conductive base substrates 32 , 34 , bounded by spacer 33 .
  • the sample chamber has a volume that is preferably no more than about 1 ⁇ L, more preferably no more than about 0.32 ⁇ L, and still more preferably no more than about 0.25 ⁇ L.
  • the measurement zone has a volume that is approximately equal to the volume of the sample chamber.
  • the measurement zone includes 80% of the sample chamber, 90% in a more preferred embodiment, and about 100% in a most preferred embodiment.
  • sensor 220 has a working electrode 222 on non-conducting substrate base 232 , a counter electrode 224 on non-conducting substrate base 234 , and a spacer 233 therebetween.
  • a contact pad 223 extends from working electrode 222 , and likewise, a contact pad 225 extends from counter electrode 224 .
  • Sample chamber 226 (defined by base 232 , 234 and spacer 233 ) extends the length of sensor 220 and includes much more space than the region proximate electrodes 222 , 224 .
  • the measurement zone corresponding to the region containing the portion of the sample which will be interrogated, is the portion of sample chamber 226 bounded by the working surface of the working electrode 222 and counter electrode 224 .
  • the measurement zone has a volume that is preferably no more than about 1 ⁇ L, more preferably no more than about 0.32 ⁇ L, still more preferably no more than about 0.25 ⁇ L, and most preferably no more than about 0.1 ⁇ L of sample.
  • the thickness of the sample chamber and of the measurement zone correspond typically to the thickness of spacer 33 , 233 (e.g., the distance between the electrodes in FIGS. 2 and 3, or the distance between the electrodes and the inert base in an embodiment where the electrodes are co-planar).
  • the spacer can be, for example, an adhesive or double-sided adhesive tape or film.
  • useable adhesives include urethanes, acrylates, acrylics, latexes, rubbers, and other known adhesive materials.
  • this thickness is small to promote rapid electrolysis of the analyte, as more of the sample will be in contact with the electrode surface for a given sample volume.
  • a thin sample chamber helps to reduce errors from diffusion of analyte into the measurement zone from other portions of the sample chamber during the analyte assay, because diffusion time is long relative to the measurement time.
  • the thickness of the sample chamber is between about 50 and about 200 micrometers.
  • the sample chamber can be empty before the sample is placed in the chamber, or, in some embodiments, the sample chamber can include a sorbent material (shown in FIG. 3 as sorbent 50 ) to sorb and hold a fluid sample during the measurement process.
  • sorbent materials include polyester, nylon, cellulose, and cellulose derivatives such as nitrocellulose.
  • the sorbent material facilitates the uptake of small volume samples by a wicking action which can complement or, preferably, replace any capillary action of the sample chamber.
  • a portion or the entirety of the wall of the sample chamber may be coated by a surfactant, which is intended to lower the surface tension of the fluid sample and improve fluid flow within the sample chamber.
  • a surfactant is available under the tradename “Zonyl FSO” from Dupont of Wilmington, Del.
  • Methods other than the wicking action of a sorbent can be used to transport the sample into the sample chamber or measurement zone.
  • methods for transport include the application of pressure on a sample to push it into the sample chamber, the creation of a vacuum by a pump or other vacuum-producing method in the sample chamber to pull the sample into the chamber, capillary action due to interfacial tension of the sample with the walls of a thin sample chamber, as well as the wicking action of a sorbent material.
  • the entire sensor assembly is held firmly together to ensure that the sample remains in contact with the electrodes and that the sample chamber and measurement zone maintain the same volume. This is an important consideration in the coulometric analysis of a sample, where measurement of a defined sample volume is needed.
  • FIGS. 4 through 12 illustrate alternative sensor designs, both tip-filling and side-filling.
  • a sensor 320 has a working electrode 322 , a counter electrode 324 , a second counter electrode 344 (which may provide a fill indicator function, as described below), and a sample chamber 326 extending along at least a portion of the length of sensor 320 and optionally including a sorbent 350 .
  • FIGS. 5A through 5C illustrate three layers that when assembled, provide a preferred embodiment of a sensor.
  • FIG. 5A has a working electrode 422 on substrate 432 .
  • Working electrode 422 has a trace 453 extending from sample chamber 426 to tab 423 ′ on which is contact pad 423 ; contact pad 423 connects the sensor to a meter or other measurement equipment.
  • FIG. 5B (inverted with respect to FIG. 5A to show the electrode side up), has a counter electrode 424 on substrate 434 , and also includes a first indicator electrode 441 and a second indicator electrode 442 .
  • Counter electrode 424 has a trace 454
  • first indicator electrode 441 has trace 451
  • second indicator electrode 442 has trace 452 , that end at contact pads 425 , 443 , 444 , respectively, on tab 425 ′.
  • Spacer 433 in FIG. 5C defines sample chamber 426 and provides spacing between the electrodes when the two substrates 432 , 434 are positioned opposite and facing one another.
  • FIGS. 6A through 6C also illustrate three layers that, when assembled, provide a sensor.
  • a working electrode 502 is formed on first substrate 500 .
  • the working electrode 502 includes a contact pad 503 for connection with external electronics; this contact pad 503 is connected to working electrode 502 by trace 552 .
  • a spacer 504 shown in FIG. 6B, such as a layer of adhesive or a double-sided tape defines a channel 506 to produce a sample chamber for the sensor.
  • Two counter (or counter/reference) electrodes 510 , 512 are formed on a second substrate 508 , as shown in FIG. 6C (inverted with respect to FIG. 6A to show the electrode side up).
  • This multiple counter electrode arrangement can provide a fill indicator function, using counter electrode 512 , as described below.
  • Each counter electrode 510 , 512 has a contact region or pad 511 , 513 for connection with external electronics; these contact pads 511 , 513 are connected to counter electrodes 510 , 512 by traces 551 , 553 .
  • the second substrate 508 is inverted and placed over the first substrate 500 , with the spacer 504 between, so that the working electrode 502 and the two counter electrodes 510 , 512 are facing in the region of the channel 506 .
  • the counter electrode 510 nearest an entrance 514 (FIG. 6B) of the channel 506 has a surface area within the sample chamber that is at least two times larger than the other counter electrode 512 , and may be at least five or ten times larger.
  • the non-leachable or diffusible redox mediator and/or second electron transfer agent can be provided on either the first or second substrates 500 , 508 in a region corresponding to the channel 506 , as described above.
  • the working electrode and counter electrodes can be formed to cover the entire channel region (except for a small space between the two counter electrodes).
  • the sample chamber and measurement zone are effectively the same and have the same volume.
  • the measurement zone has, for example, 80% or 90% of the volume of the sample chamber. It will be understood that similar sensors could be made using one counter electrode or three or more counter electrodes. It will also be understood that multiple working electrodes may also be provided on the sensor.
  • FIGS. 7A, 7B and 7 C illustrate a side-filling sensor arrangement.
  • FIG. 7A shows a first substrate 520 with a working electrode 522 .
  • FIG. 7B illustrates a spacer 524 defining a channel 526 .
  • FIG. 7C (inverted with respect to FIG. 7A and 7B) illustrate a second substrate 528 with three counter (or counter/reference) electrodes 530 , 532 , 534 .
  • This multiple counter electrode arrangement can provide a fill indicator function, as described below.
  • An indentation 536 , 538 or recessed or indented portion can be formed at either edge of the opening to channel 526 to facilitate the drawing of fluid into the sensor.
  • This configuration can aid in wicking or capillary filling of the channel (i.e., sample chamber). This configuration can also reduce the likelihood that the user will inadvertently block the channel during collection of the sample, which could occur by pressing the tip of the sensor edgewise against the skin.
  • FIGS. 8A, 8B, and 8 C illustrate another example of a side-filling sensor arrangement.
  • FIG. 8A illustrates a first substrate 540 with a working electrode 542 .
  • FIG. 8B illustrates a spacer 544 defining a channel 546 .
  • FIG. 8C (inverted with respect to FIGS. 8A and 8B) illustrates a second substrate 548 with three counter (or counter/reference) electrodes 550 , 552 , 554 .
  • FIGS. 9A, 9B, and 9 C illustrate another example of a tip-filling sensor arrangement.
  • FIG. 9A illustrates a first substrate 560 with a working electrode 562 .
  • FIG. 9B illustrates a spacer 564 defining a channel 566 .
  • FIG. 9C (inverted with respect to FIGS. 9A and 9B) illustrates a second thin film substrate 568 with two counter (or counter/reference) electrodes 570 , 572 .
  • This multiple counter electrode arrangement can provide a fill indicator function, as described below.
  • a vent hole 574 (indicated as a shaded region in FIG. 9C) is provided through the second substrate.
  • this vent hole 574 is made through only the substrate 568 that carries the counter electrode(s) and, optionally, the spacer 564 .
  • the vent hole can be formed by, for example, die cutting a portion of the substrate. This die cut can remove a portion of at least one counter electrode, but a sufficient amount of the counter electrode should remain for contact with the sample in the channel and for electrical connection to a contact at the other end of the sensor.
  • the vent hole 574 can be made through all of the layers or through the first substrate and not the second substrate.
  • FIGS. 10A, 10B, and 10 C Another embodiment is illustrated in FIGS. 10A, 10B, and 10 C, with a different shape.
  • This sensor includes a first substrate 579 with at least one working electrode 580 , as illustrated in FIG. 10A.
  • the sensor also includes a spacer 581 with a channel 582 formed in the spacer 581 , as shown in FIG. 10B.
  • the sensor further includes a second substrate 583 with two counter electrodes 584 , 585 , as shown in FIG. 10C (inverted with respect to FIGS. 10A and 10B).
  • a venting aperture 586 is cut typically through all of the layers and extends from a side of the sensor.
  • the venting aperture and the front portion 587 of the sensor are simultaneously cut with a reproducible distance between the venting aperture and the front portion 587 of the sensor to provide a reproducible length for the channel 582 and the working electrode 580 .
  • This tip-filling sensor arrangement optionally includes an indentation 588 or recessed or indented portion that can be formed at the filling opening of the channel 582 to facilitate the drawing of fluid into the sensor.
  • FIGS. 11A, 11B, and 11 C illustrate another example of a side-filling sensor arrangement.
  • FIG. 11A illustrates a first substrate 640 with a working electrode 642 .
  • FIG. 11B illustrates a spacer 644 defining a channel 646 .
  • FIG. 11C (inverted with respect to FIGS. 11A and 11B) illustrates a second substrate 648 with three counter (or counter/reference) electrodes 650 , 652 , 654 .
  • This multiple counter electrode arrangement can provide a fill indicator function, as described below.
  • the length of the channel 646 is typically defined by the two parallel cuts along the sides 656 , 658 of the sensors.
  • these sensors can be manufactured adjacent to one another, as illustrated in FIG. 13A. Such positioning during manufacture produces less waste material.
  • Another optional processing advantage of the adjacent sensor manufacturing process is that the redox mediator and/or second electron transfer agent can be readily disposed in the channel by striping a continuous stream of these components along a row or column of adjacent sensors. This can result in better efficiency and less waste of expensive reagents such as the redox mediator and/or second electron transfer agent, as compared to other techniques, such as individually placing these components within the individual channels.
  • FIGS. 12A, 12B, and 12 C illustrate another sensor configuration.
  • This sensor includes a first substrate 600 with at least one working electrode 602 , as illustrated in FIG. 12A.
  • the sensor also includes a spacer 604 with a channel 606 formed in the spacer 604 , as shown in FIG. 12B.
  • the sensor further includes a second substrate 608 with two counter electrodes 610 , 612 , as shown in FIG. 12C (inverted with respect to FIGS. 12A and 12B).
  • This multiple counter electrode arrangement may provide a fill indicator function, as described below.
  • the sensor can also include, for example, an indicator, such as a slot 614 or an extension 616 from the body of the sensor that indicates to the user which side of the sensor should be placed adjacent to the sample. Surface printing can also or alternatively be applied to the sensor to act as an indicator. Some indication mechanism can be particularly important where the sensor reading is only correct when the sample enters from a particular side.
  • multiple electrode sensors can be used for a variety of reasons. For example, multiple electrodes can be used to test a variety of analytes using a single sample.
  • One embodiment with multiple electrodes has one or more sample chambers, each of which contains one or more working electrodes, with each working electrode defining a different measurement zone. If the redox mediator is non-leachable, one or more of the working electrodes can have the appropriate chemical reagents, for example, an appropriate enzyme, to test a first analyte and one or more of the remaining working electrodes can have the appropriate chemical reagents to test a second analyte, and so on.
  • a multiple electrode sensor might include a working electrode having glucose oxidase disposed thereon to determine glucose concentration and another working electrode can have lactate oxidase disposed thereon to determine lactate concentration.
  • Multiple electrodes could also be used to improve the precision of the resulting readings.
  • the measurements from each of the working electrodes can be averaged or otherwise combined together to obtain a more precise or reliable reading.
  • measurements could be rejected if the difference between the value and the average exceeds a threshold limit.
  • This threshold limit could be, for example, determined based on a statistical parameter, such as the standard deviation of the averaged measurements. The average could then be recalculated while omitting the rejected values.
  • multiple measurements could be made at each electrode and averaged together to increase precision. This technique could also be used with a single electrode sensor to increase precision.
  • one of the working electrodes is prepared with a non-leachable redox mediator and a non-leachable second electron transfer agent (e.g., an enzyme).
  • Another working electrode includes non-leachable redox mediator, but no second electron transfer agent on the electrode.
  • An optional third working electrode has no redox mediator and no second electron transfer agent bound to the electrode.
  • a similar configuration can be constructed using diffusible redox mediator and/or diffusible second electron transfer agent although diffusible components are not limited to being disposed on the working electrode.
  • the distance between the working electrodes is sufficient that redox mediator and/or enzyme do not substantially diffuse between electrodes within the measurement period (e.g., in the time period from introduction of the same sample into the sample chamber to the end of the measurement).
  • the sensor error caused by the redox mediator being in a non-uniform oxidation state prior to the introduction of the sample can be measured by concurrently electrolyzing the sample in the measurement zones that are proximate working and counter electrodes.
  • the analyte is electrolyzed to provide the sample signal.
  • the analyte is not electrolyzed because of the absence of the second electron transfer agent (assuming that a second electron transfer agent is necessary).
  • a charge will pass (and a current will flow) due to the electrolysis of the redox mediator that was in a mixed oxidation state (i.e., some redox centers in the reduced state and some in the oxidized state) prior to the introduction of the sample and/or the shuttling of a diffusible redox mediator between the working electrode and the counter electrode.
  • the small charge passed using this second working electrode can be subtracted from the charge passed using the first electrode pair to substantially remove the error due to the oxidation state of the redox mediator and/or to remove the background current caused by a diffusible redox mediator.
  • This procedure also reduces the error associated with other electrolyzed interferents, such as ascorbate, urate, and acetaminophen, as well as errors associated with capacitive charging and faradaic currents.
  • the thickness of the sample chamber can be determined by measuring the capacitance, preferably in the absence of any fluid, between an electrode and its corresponding counter electrode.
  • the capacitance of an electrode pair depends on the surface area of the electrodes, the interelectrode spacing, and the dielectric constant of the material between the plates.
  • the dielectric constant of air is unity which typically means that the capacitance of this electrode configuration is a few picofarads (or about 100-1000 picofarads if there is fluid between the electrode and counter electrode given that the dielectric constant for most biological fluids is approximately 75).
  • measurement of the capacitance of the electrode pair allows for the determination of the thickness of the measurement zone to within about 1-5%.
  • Electrodes configurations can also use these techniques (i.e., capacitance measurements and coulometric measurements in the absence of a critical component) to reduce background noise and error due to interferents and imprecise knowledge of the volume of the interrogated sample. Protocols involving one or more working electrode(s) and counter electrode(s) and one or more of the measurements described above can be developed and are within the scope of the invention. For example, only one electrode pair is needed for the capacitance measurements, however, additional electrodes can be used for convenience.
  • FIGS. 6A through 6C illustrate a sensor having a fill indicator structure.
  • FIG. 6A illustrates a first substrate 500 upon which a working electrode 502 is printed.
  • a spacer 504 (FIG. 6B), such as, for example, a layer of adhesive or a double-sided tape, is formed over the first substrate 500 and working electrode 502 with a channel 506 formed in the layer to provide a sample chamber.
  • a second substrate 508 is printed with two counter electrodes 510 , 512 , as shown in FIG. 6C (inverted with respect to FIGS. 6A and 6B to show the electrode side up).
  • the counter electrode 510 nearest an entrance 514 of the channel 506 has a surface area within the sample chamber that is at least two times larger than the other counter electrode 512 , and preferably at least five or ten times larger.
  • the sensor can be indicated as filled, or substantially filled, by observing a signal between the second counter electrode 512 and the working electrode 502 as the sensor fills with fluid. When fluid reaches the second counter electrode 512 , the signal from that counter electrode will change. Suitable signals for observing include, for example, voltage, current, resistance, impedance, or capacitance between the second counter electrode 512 and the working electrode 502 . Alternatively, the sensor can be observed after filling to determine if a value of the signal (e.g., voltage, current, resistance, impedance, or capacitance) has been reached indicating that the sample chamber is filled.
  • a value of the signal e.g., voltage, current, resistance, impedance, or capacitance
  • the counter electrode or working electrode can be divided into two or more parts and the signals from the respective parts observed to determine whether the sensor has been filled.
  • the working electrode is in a facing relationship with the counter electrode and the indicator electrode.
  • the counter electrode, working electrode, and indicator electrode are not in a facing relationship, but are, for example, side-by-side.
  • the indicator electrode is further downstream from a sample inlet port than the working electrode and counter electrode.
  • an indicator electrode can be disposed on each side of the primary counter electrode. This permits the user to fill the sample chamber from either the left or right side with an indicator electrode disposed further upstream. This three-electrode configuration is not necessary. Side-fill sensors can also have a single indicator electrode and, preferably, some indication as to which side should be placed in contact with the sample fluid.
  • two indicator electrodes used in combination with one counter/reference electrode, detect when the sample chamber begins to fill and when the sample chamber has been filled to prevent partial filling of the sample chamber.
  • the two indicator electrodes are optionally held at a different potential than the counter/reference electrode. The start and completion of filling of the sample chamber is indicated by the flow of current between the indicator and counter/reference electrodes.
  • the potential of each of the counter/reference electrodes may be the same.
  • the fluid allows for electrical current flowt between a working electrode and the first counter/reference electrode, causing a current at the first counter/reference electrode due to the reaction of the analyte with the enzyme and the mediator.
  • the fluid reaches the third counter/reference electrode, another current may be measured similar to the first counter/reference electrode indicating that the measurement zone is full.
  • the three counter/reference electrodes are optionally shorted together or their signals can be added or otherwise combined.
  • the indicator electrode can also be used to improve the precision of the analyte measurements.
  • the indicator electrode may operate as a working electrode or as a counter electrode or counter/reference electrode.
  • the indicator electrode 512 can act as a second counter or counter/reference electrode with respect to the working electrode 502 . Measurements from the indicator electrode/working electrode can be combined (for example, added or averaged) with those from the first counter/reference electrode/working electrode to obtain more accurate measurements.
  • the indicator electrode operates as a second working electrode with the counter electrode or counter/reference electrode.
  • the indicator electrode operates as a second working electrode with a second counter electrode or counter/reference electrode.
  • the indicator electrode operates as a second counter electrode or counter/reference electrode with a second working electrode.
  • the sensor or a sensor reader can include a sign (e.g., a visual sign or auditory signal) that is activated in response to the indicator electrode to alert the user that the measurement zone has been filled.
  • the sensor or a sensor reader can be configured to initiate a reading when the indicator electrode indicates that the measurement zone has been filled with or without alerting the user. The reading can be initiated, for example, by applying a potential between the working electrode and the counter electrode and beginning to monitor the signals generated at the working electrode.
  • FIGS. 13A and 13B one example of a method for making thin film sensors is described with respect to the sensor arrangement displayed in FIGS. 5 A through SC, although this method can be used to make a variety of other sensor arrangements, including those described before.
  • a sensor 420 is formed.
  • a substrate 1000 such as a plastic substrate, is moving in the direction indicated by the arrow.
  • the substrate 1000 can be an individual sheet or a continuous roll on a web.
  • Multiple sensors 420 can be formed on a substrate 1000 as sections 1022 that have working electrodes 422 (FIG. 5A) thereon and sections 1024 that have counter electrode 424 and indicator electrodes 441 , 442 (FIG. 5B). These working, counter and indicator electrodes are electrically connected to their corresponding traces and contact pads.
  • working electrode sections 1022 are produced on one half of substrate 1000 and counter electrode sections 1024 are produce on the other half of substrate 1000 .
  • the substrate 1000 can be scored and folded to bring the sections 1022 , 1024 together to form the sensor.
  • the individual working electrode sections 1022 can be formed next to or adjacent each other on the substrate 1000 , to reduce waste material.
  • individual counter electrode sections 1024 can be formed next to or adjacent each other.
  • the individual working electrode sections 1022 (and, similarly, the counter electrode sections 1024 ) can be spaced apart, as illustrated in FIG. 13B. The remainder of the process is described for the manufacture of multiple sensors, but can be readily modified to form individual sensors.
  • Carbon or other electrode material (e.g., metal, such as gold or platinum) is formed on the substrate 1000 to provide a working electrode 422 for each sensor.
  • the carbon or other electrode material can be deposited by a variety of methods including printing a carbon or metal ink, vapor deposition, and other methods. The printing may be done by screen printing, gravure roll printing, transfer printing, and other known printing methods. Trace 453 and contact pad 423 are preferably applied together with working electrode 422 , but may be applied in a subsequent step.
  • the counter electrode(s) 424 , 441 , 442 are formed on the substrate 1000 .
  • the counter electrodes are formed by providing carbon or other conductive electrode material onto the substrate.
  • the material used for the counter electrode(s) is a Ag/AgCl ink.
  • the material of the counter electrode(s) may be deposited by a variety of methods including printing or vapor deposition. The printing may be done by screen printing, gravure roll printing, transfer printing, and other known printing methods.
  • Traces 454 , 451 , 452 and contact pads 425 , 443 , 444 are preferably applied together with counter electrodes 424 , 441 , 442 , but may be applied in a subsequent step.
  • multiple sensors 420 are manufactured simultaneously; that is, the working electrodes, including their traces and contact pads, for a plurality of sensors are produced (e.g., printed) on a polymer sheet or web, and simultaneously or subsequently, the counter electrodes, and their traces and contact pads, for a plurality of sensors are produced (e.g., printed).
  • the working electrode(s) and counter electrode(s) can be formed on separate substrates that are later positioned opposite one another so that the electrodes face each other.
  • the working electrodes can be formed on a first half of a substrate sheet of web and the counter electrodes are formed on a second half of the substrate sheet or web so that the sheet or web can be folded to superimpose the working and counter electrodes in a facing arrangement.
  • a spacer 433 is formed over at least one of the substrate/working electrode and substrate/counter electrode(s).
  • the spacer 433 is preferably an adhesive spacer, such as a single layer of adhesive or a double-sided adhesive tape (e.g., a polymer carrier film with adhesive disposed on opposing surfaces).
  • Suitable spacer materials include adhesives such as urethanes, acrylates, acrylics, latexes, rubbers and the like.
  • a channel which will result in the sample chamber, is provided in the spacer 433 , either by cutting out a portion of the adhesive spacer or placing two adhesive pieces in close proximity but having a gap therebetween.
  • the adhesive can be printed or otherwise disposed on the substrate according to a pattern which defines the channel region.
  • the adhesive spacer can be optionally provided with one or more release liners prior to its incorporation into the sensor.
  • the adhesive can be cut (e.g., die-cut or slit) to remove the portion of the adhesive corresponding to the channel prior to disposing the spacer on the substrate.
  • the adhesive includes a first and a second release liner.
  • the adhesive Prior to applying the adhesive to a first substrate/working electrode or substrate/counter electrode(s), the adhesive is “kiss-cut” through the first release liner and at least a portion of the underlying adhesive, preferably the entire adhesive but not through the second release liner, to form one or more sections, one of which will eventually result in a sample chamber.
  • the first release liner is removed from the adhesive over its length but is retained over the sample chamber section.
  • the exposed adhesive is then applied to the first substrate/working electrode or substrate/counter electrode(s).
  • the adhesive positioned within the sample chamber sections is also removed, leaving a channel or opening in the adhesive spacer.
  • the second substrate/working electrode or substrate/counter electrode(s) is then applied to the adhesive to form the layered sensor structure.
  • FIGS. 14A through 14G describe in detail the processing of an adhesive layer by a “kiss-cut”.
  • An adhesive layer that will eventually become spacer 433 is preferably obtained from an adhesive structure including an adhesive layer 1030 between a first release liner 1020 and a second release liner 1040 .
  • a blade e.g., a knife or die blade
  • sample chamber region The space occupied by 1030 b is the area that will result in the sample chamber of the sensor and can be referred to as “sample chamber region”.
  • a cut configuration such as shown in FIG. 14G allows removal of one release liner section 1030 a, leaving behind release liner section 1030 b.
  • the liner could be cut to provide individual strips extending the entire length of the liner; this would then need removal of each individual liner strip.
  • the release liner section 1030 a is removed to provide the adhesive configuration shown in FIGS. 14C.
  • the exposed adhesive is positioned over and securely adhered to the substrate 1050 , as illustrated in FIG. 14D.
  • the adhesive sections 1030 a without the release liner will adhere to the substrate 1050 .
  • the second release liner 1040 is removed, pulling the cut and non-adhered section of adhesive 1030 b and the first liner 1020 b with it; this results in adhesive areas 1030 a providing spacer layer sections 433 a, 433 b, with sample chamber 426 therebetween, as illustrated in FIG. 14F.
  • the second substrate is then positioned over the adhesive layer and laminated to the first substrate via the spacer 433 .
  • the thickness of the spacer 433 typically determines the spacing between the working and counter electrodes, and thus impacts the volume of the sample chamber 426 .
  • the thickness does not vary more than ⁇ 5% over the individual sensor and/or among individual sensors in a batch.
  • Use of the “kiss-cut” method for manufacturing the layered sensor structure preserves the integrity of the sample chamber walls during manufacturing, thereby providing for more reliable and reproducible sample chamber volumes.
  • the non-leachable or diffusible redox mediator and/or second electron transfer agent are disposed onto the substrate in at least the sample chamber regions. If either or both of these components is non-leachable, that component or components is preferably disposed on the working electrode. If either or both of these components is diffusible, that component or components can be disposed on any surface of the substrate in the channel region.
  • the redox mediator and/or second electrode transfer agent can be disposed independently or together on the substrate prior to or after disposition of the spacer.
  • the redox mediator and/or second electrode transfer agent may be disposed by a variety of methods including, for example, screen printing, ink jet printing, spraying, painting, striping along a row or column of aligned and/or adjacent electrodes, and the like.
  • Other components can be deposited separately or together with the redox mediator and/or second electrode transfer agent; these components can include, for example, surfactants, polymers, polymer films, preservatives, binders, buffers, and cross-linkers.
  • the first and second substrates (having the working and counter electrodes thereon) are positioned opposite each other to form the sensor.
  • the faces of the substrate are joined by the adhesive of the spacer.
  • individual sensors are cut out from the web of sensors using a variety of methods including, for example, die cutting, slitting, or otherwise cutting away the excess substrate material and separating the individual sensors. In some embodiments, a combination of cutting or slitting methods is used.
  • the individual sensor components can first be cut out of the substrates and then brought together to form the sensor by adhesively joining the two components, such as by using the spacer adhesive.
  • the sides of the sensor can be straight to allow the sensor to be cut out from the remainder of the substrate and/or from other sensors by slitting the substrate in parallel directions using, for example, a gang arbor blade system.
  • the edges of the sensor can define edges of the sample chamber and/or measurement zone.
  • the assembled sensor of FIGS. 5A through 5C (as will be referred to as sensor 1420 ) is typically coupled to a meter or other electrical device by electrical connector 1500 which is configured to couple with and contact the end of the sensor 1420 at contact pads 423 , 425 , 443 , 444 .
  • the sensor meter typically includes a potentiostat or other component to provide a potential and/or current for the electrodes of the sensor.
  • the sensor reader also typically includes a processor (e.g., a microprocessor or hardware) for determining analyte concentration from the sensor signals.
  • the sensor meter also includes a display or a port for coupling a display to the sensor.
  • the display displays the sensor signals and/or results determined from the sensor signals including, for example, analyte concentration, rate of change of analyte concentration, and/or the exceeding of a threshold analyte concentration (indicating, for example, hypo- or hyperglycemia).
  • Connector 1500 (which is used to connect a sensor to a meter or other electrical device) is generally a two part structure, having top portion 1510 and bottom portion 1520 (see FIG. 16B). Positioned between and secured by top portion 1510 and bottom portion 1520 are contact leads 1423 , 1425 , 1443 , 1444 that provide electrical connection between the sensor 1420 and a meter. These leads 1423 , 1425 , 1443 , 1444 have proximal ends to physically contact pads 423 , 425 , 443 , 444 (in FIGS.
  • the end of the sensor 1420 which has the contact pads can be slid into or mated with the connector 1500 by placing the sensor 1420 into slide area 1530 , which provides a support for and retains sensor 1420 . It is typically important that the contact structures of the connector 1500 make electrical contact with the correct pads of the sensor so that the working electrode and counter electrode(s) are correctly coupled to the meter.
  • FIGS. 16A and 16B are top views of the sensor prior to insertion into connector 1500 .
  • This conductive insertion monitor is positioned on the non-conductive base substrate and has a contact pad for electrical contact with a connector.
  • the insertion monitor is configured and arranged to close an electrical circuit between two contact structures 1451 and 1452 when the sensor is properly inserted into the connector.
  • Proper insertion into the connector 1500 means that the sensor strip 1420 is inserted right side up, that the correct end of the strip is inserted into the connector, and that the strip is inserted far enough into the connector that reliable electrical connections are made between the electrodes' contact pads on the strip and the corresponding contact structures of the connector.
  • the insertion monitor may have shapes other than a stripe across the width of the sensor; for example, other designs include an individual dot, a grid pattern, or may include stylistic features, such as words or letters.
  • the width of the contact pads 443 , 425 , 444 , 423 is defined as the width on which a lead could be placed that would result in an electrical connection; typically, the contact width is the width of the exposed contact area.
  • six contact lead structures on the connector i.e., 1451 , 1443 , 1425 , 1444 , 1423 , 1452
  • leads 1443 , 1425 , 1444 , 1423 make contact with contact pads 443 , 425 , 444 , 423 . If each lead and/or contact pad is one millimeter wide, a sensor of at least 4 mm wide is needed to make contact. Additional leads, such as those for insertion monitor 1450 (i.e., contact leads 1451 , 1452 ), can make contact by having leads 1451 , 1452 extend along the side of leads 1443 and 1423 and then angle in toward the center of the strip 1420 after the point where leads 1443 , 1425 , 1444 , 1423 contact strip 1420 . The insertion monitor stripe leads 1451 , 1452 cross side edges of sensor 1420 to make contact with the sensor, thus not requiring additional sensor width.
  • the contact structures are parallel and non-overlapping and they run longitudinally from the distal end to the proximal end.
  • the lead structures 1443 , 1425 , 1444 , 1423 terminate at their proximal end, but lead structures 1451 , 1452 continue longitudinally past the proximal end of lead structures 1443 , 1425 , 1444 , 1423 . Once past the proximal end, lead structures 1452 , 1452 angle in toward the center of the sensor strip.
  • the insertion monitor can also be used to encode information on a test strip.
  • the encoded information can be, for example, calibration information for that manufacturing lot or for that specific strip. Such calibration information may relate to the sensitivity of the strip or to the y-intercept of its calibration curve.
  • the insertion monitor comprises two or more contact pads for connection to a meter. The two or more contact pads are connected to each other by a conductive material, such as a conductive ink. The resistance of conductive path between the two or more contact pads is related to the encoded information.
  • resistance values in a given range can correspond to one calibration setting
  • resistance values in a different range can correspond to a different calibration setting.
  • the calibration setting may be a continuous function of the resistance. Examples of suitable conductive pathways between contact pads are shown in FIGS. 19A through 19L.
  • FIGS. 19 A- 19 F multiple conductive pathways with different resistances are printed on the strip.
  • the resistance of the pathway is varied by cutting or scoring some or all of the conductive pathways so that they do not carry charge.
  • FIGS. 19 G- 19 L the resistance is controlled by the width or length of the conductive path. While it is preferred to provide this encoded information on the insertion monitor, it should be recognized that the insertion monitor function and the encoding of information can also be implemented separately using separate conductive traces on the strip.
  • the meter may include a raised area or bump that prevents or hinders the insertion of the sensor in an improper direction, as shown in FIG. 20.
  • the connector 1110 may include a raised area 1140 that prevents or hinders the insertion of the sensor in an improper direction.
  • the width, w 2 , of the contact region of the second substrate 1130 may be wider than the width, w 1 , of the contact region of the first substrate 1120 .
  • the raised area 1140 is positioned to allow sensor 1100 to be slid into the connector so that the first substrate 1120 is next to the surface 1150 from which the raised area 1140 protrudes, but would prevent or hinder having the second substrate 1130 next to the surface 1150 from which the raised area 1140 protrudes.
  • Objects other than a raised area can also be used to guide the user in correct introduction of the sensor into the meter.
  • An analyte measurement device constructed according to the principles of the present invention typically includes a sensor, as described hereinabove, combined with a sample acquisition apparatus to provide an integrated sampling and measurement device.
  • the sample acquisition apparatus typically includes, for example, a skin piercing member, such as a lancet, that can be injected into a patient's skin to cause blood flow.
  • the integrated sample acquisition and analyte measurement device comprises a lancing instrument that holds a lancet and measurement strip.
  • the lancing instrument preferably requires active cocking. By requiring the user to cock the device prior to use, the risk of inadvertently triggering the lancet is minimized.
  • the lancing instrument will also permit the user to adjust the depth of penetration of the lancet into the skin.
  • Such devices are already commercially available from companies such as Boehringer Mannheim and Palco. This feature allows users to adjust the lancing device for differences in skin thickness, skin durability, and pain sensitivity across different sites on the body and across different users.
  • a larger sample of body fluid such as blood or interstitial fluid is expressed when pressure is applied around a site where a hole has been created the skin.
  • a sample acquisition device having a protruding ring such as illustrated in FIG. 21, may be used.
  • Ring 1200 circumferentially surrounds the lancing site to create increased pressure and extract a larger sample out of the wound.
  • a lancet would protrude from the center 1220 of ring 1200 .
  • Ring 1200 has a surface area 1210 that presses against the skin, thus increasing the tension on the skin and often providing a bump of skin. Skin that is more taught, and even extended, provides a large volume of fluid from the wound.
  • the increased surface area 1210 and tighter skin provided by ring 1200 decreases the amount of pain experienced by the patient during the lancing. Further, the tendency to bruise is typically decreased.
  • the lancing instrument and the meter are integrated into a single device.
  • the user need only insert a disposable cartridge containing a measurement sensor and lancing device into the integrated device, cock the lancing instrument, press it against the skin to activate it, and read the result of the measurement.
  • a disposable cartridge containing a measurement sensor and lancing device into the integrated device, cock the lancing instrument, press it against the skin to activate it, and read the result of the measurement.
  • Such an integrated lancing instrument and test reader simplifies the testing procedure for the user and minimizes the handling of body fluids.
  • An electrochemical sensor of the invention can be operated with or without applying a potential across the electrodes.
  • the electrochemical reaction occurs spontaneously and a potential need not be applied between the working and counter electrodes.
  • a potential which may or may not remain constant, is applied between the working and counter electrodes. The magnitude of the required potential depends on the redox mediator used.
  • the potential at which the electrode poises itself, or where it is poised by applying an external bias, and where the analyte is electrolyzed is typically such that the electrochemical reaction is driven to or near completion, but it is, preferably, not oxidizing enough to result in significant electrochemical reaction of interferents, such as urate, ascorbate, and acetaminophen, that can affect the signal measured.
  • the potential is typically between about ⁇ 350 mV and about +400 mV versus the standard calemel electrode (SCE).
  • the potential of the redox mediator is more negative than +100 mV, more preferably the potential is more negative than 0 mV, and most preferably the potential is about ⁇ 150 mV versus SCE.
  • an external potential When an external potential is applied, it can be applied either before or after the sample has been placed in the sample chamber. If the measurement zone includes only a portion of the sample chamber then the potential is preferably applied after the sample has come to rest in the sample chamber to prevent electrolysis of sample passing through the measurement zone as the sample chamber is filling. Alternatively, in the case where the measurement zone includes most or all of the sample chamber, the potential can be applied before or during the filling of the sample chamber without affecting the accuracy of the assay. When the potential is applied and the sample is in the measurement zone, an electrical current will flow between the working electrode and the counter electrode. The current is a result, at least in part, of the electrolysis of the analyte in the sample.
  • Biochemical B is oxidized to C by redox mediator A in the presence of an appropriate enzyme. Then the redox mediator A is oxidized at the electrode. Electrons are collected by the electrode and the resulting current is measured. The measured current may also include a background current resulting in a measured background charge, due, at least in part, to the shuttling of a diffusible redox mediator between the working electrode and the counter electrode. This background current can be minimized or accounted for, as described in PCT Application PCT/US99/23425, incorporated herein by reference.
  • a variety of techniques can be used to determine the concentration of an analyte in a sample. These techniques include, for example, coulometry, amperometry, and potentiometry.
  • concentration of analyte e.g., glucose
  • the charge passing or projected to pass between the working electrode(s) and counter electrode(s) during electrolysis of the analyte is determined.
  • Knowledge of the charge and the volume of the sample chamber permit the calculation of the concentration of the electrolyzed analyte in the sample. This charge can be determined by several methods.
  • the charge can be measured directly. This can be accomplished using a coulometer and known coulometric techniques. Typically, the charge is measured during the complete or nearly complete electrolysis of the analyte.
  • the charge can be determined from measurements of the electrolysis current, it, over time, t.
  • a series of currents (i x , i x+1 , i x+2 , . . . ) is measured for a series of times (t x , t x+1 , t x+2 , . . . ).
  • the current can then be integrated (e.g., numerically integrated using known numerical methods) to give the charge.
  • current can be measured during the entire electrolysis.
  • current can be extrapolated after a period of time and the charge determined using a combination of the measured currents and extrapolated currents.
  • Extrapolation of current utilizes a projected relationship between current and time during at least a portion of the electrolysis.
  • the natural logarithm of the current is linearly related to the time. This typically occurs after a period of time during which the sensor “equilibrates”.
  • FIG. 15A is an example of a graph of current versus time for electrolysis of an analyte, such as glucose, in one of the previously described sensors;
  • FIG. 15B is a graph of the natural logarithm of current versus time for the same data. After the sample completely fills the sample chamber, the current increases to a peak current value, designated as “P” in FIGS. 15A and 15B, during which time the sensor is equilibrating.
  • the peak current typically occurs during a period of time in which the system is kinetically, rather than diffusionally, limited. Typically, the current then begins to decrease, although, in some instances, further increases may occur before the current becomes diffusion limited. Eventually, the current values enter a region, designated as “L” in FIG. 15B, where there is a linear relationship between the natural logarithm of current and time.
  • the remaining current needed to electrolyze a remaining portion of the analyte can then be extrapolated using estimation methods, such as nonlinear or, preferably, linear estimation methods (e.g., linear least squares techniques).
  • the region where extrapolation occurs is designated as “E” in FIG. 15B and the extrapolation is indicated as a solid line.
  • the current values being referred to are the absolute value of the actual current, thus, the sign of the current measurement is ignored.
  • the peak current is the largest deviation from zero current, whether positive or negative.
  • the threshold value is chosen based on the characteristics of the sensor so that one has a high degree of confidence that the system will be diffusion limited at this time.
  • This procedure can reduce the effect of random noise in the system.
  • the consistency of multiple slope values e.g., three or five or ten slope values
  • the system can look for ten monotonically decreasing slope values before accepting the slope value for use in the estimation.
  • the determined slope value is used to extrapolate the charge required to completely electrolyze the analyte remaining in the sample. That is, the current is extrapolated to zero current.
  • Known extrapolation techniques e.g., linear extrapolation techniques
  • the total charge required to electrolyze the analyte is determined by adding the measured charge and extrapolated charge.
  • Current values can also be used to monitor the operation of the sensor and meter. For example, ratios of current values can be checked to determine if there has been some failure of the measurement (e.g., the sensor has been pulled out of the measuring device, etc.).
  • the acceptable ratio range will typically depend on the type and components of the sensor, the rate at which measurements are made, and the acceptable noise level. As an example, an acceptable ratio range could be, for example, 2:1 to 1:2 for immediately adjacent measurements.
  • the extrapolation of current measurements and the determination of charge passed or projected to pass, as well as the concentration of the analyte, and other functions can be performed by a processor with or without a storage medium, in which the desired procedures are performed by software, hardware, or a combination thereof. According to another embodiment, these same procedures are accomplished using discrete or semi-programmable hardware configured, for example, using a hardware descriptive language, such as Verilog. In yet another embodiment, the procedures are performed using a processor having at least one look-up table arrangement with data stored therein to represent the complete result or partial results of the above equations based on a given set of input data.
  • Current measurements can be made by a variety of methods.
  • the current measurements can be made by measuring the current directly using any known techniques and devices.
  • Another method of measuring current includes discharging a known amount of charge into the sample (by electrolysis of the analyte) and measuring the time required for the discharge. Current is then calculated as the quotient of charge and discharge time.
  • a capacitor can be charged by circuitry in the meter and then coupled to the working or counter electrode(s) to discharge by electrolysis of the analyte.
  • the time to discharge to a threshold level can be measured using, for example, a clock circuit that is part of the processing circuitry of the meter.
  • the use of a clock circuit permits very accurate measurements of time. This can be advantageous over designs that directly measure current or charge and must convert these analog measurements to processible digital representations using the more expensive A/D (analog-to-digital) converters.
  • the accuracy of the charge and time measurement which provides the current values, affects the accuracy of the final analyte concentration measurement.
  • the capacitor used to store the charge can be a high-quality, expensive capacitor that has a precisely known capacitance.
  • an accurate charge measurement can be obtained by using a calibrating resistor in parallel with the capacitor. During a calibration period, the capacitor discharges through the resistor and the current through the resistor or the time constant of the discharge can be determined. This can then be used to determine the charge stored in the capacitor.
  • a high-quality, very accurate resistor is typically less expensive than a similarly accurate capacitor, and will provide the same amount of accuracy to the charge measurement.
  • n is the number of electron equivalents required to electrolyze the analyte
  • F is Faraday's constant (approximately 96,500 coulombs per equivalent)
  • V is the volume of sample in the measurement zone.
  • Q tot is the total charge transferred during the measurement and Q back is the amount of charge transferred that was not due to the analyte, e.g., charge transferred by the shuttling of the diffusible mediator between the working electrode and the counter electrode.
  • the sensor is constructed so that the background charge is at most 5 times the size of the charge generated by electrolysis of an amount of analyte.
  • the background signal is at most 200%, 100%, 50%, 25%, 10%, or 5% of the charge generated by electrolysis of the analyte.
  • the charge of the analyte when the analyte is electrooxidized to about 90% completion in the measurement period, may be represented by the following formula:
  • C G is 5 mM (or 5 ⁇ 10 ⁇ 6 moles/cm 3 )
  • t is 60 seconds
  • n G is 2
  • n M is 1
  • the ratio of charge from the redox mediator to the charge from electrooxidation of the analyte may be represented by the following formula:
  • a sensor may be configured to have the desired ratio by choosing D M , C M , and d accordingly.
  • the ratio can be affected, for example, by reducing the concentration of the redox mediator (i.e., C M may be reduced). Alternatively, or additionally, the diffusion of the redox mediator may be reduced.
  • Other sensor configurations are also suitable for controlling the ratio of background signal to signal generated by the analyte and will be described below.
  • Q back can be accounted for in a variety of ways.
  • Q back can be made small, for example, by using only limited amounts of diffusible redox mediator; by providing a membrane over the counter electrode that limits diffusion of the redox mediator to the counter electrode; or by having a relatively small potential difference between the working electrode and the counter electrode.
  • Other examples of sensor configurations and methods suitable for reducing Q back include having a redox mediator reaction rate at the working electrode that is significantly faster than that at the counter electrode; immobilizing the redox mediator on the working electrode; having the redox mediator become immobilized on the counter or counter/reference electrode upon its reaction at the counter or counter/reference electrode; or slowing the diffusion of the redox mediator.
  • At least 20% of the analyte is electrolyzed, preferably at least 50%, more preferably at least 80%, and even more preferably at least 90% of the analyte is electrolyzed.
  • the analyte is completely or nearly completely electrolyzed.
  • the charge can then be calculated from current measurements made during the electrochemical reaction, and the concentration of the analyte is determined using equation (3a) or (3b).
  • the completion of the electrochemical reaction is typically signaled when the current reaches a steady-state value. This indicates that all or nearly all of the analyte has been electrolyzed.
  • At least 90% of the analyte is typically electrolyzed, preferably, at least 95% of the analyte is electrolyzed and, more preferably, at least 99% of the analyte is electrolyzed.
  • the analyte be electrolyzed quickly.
  • the speed of the electrochemical reaction depends on several factors, including the potential that is applied between the electrodes and the kinetics of reactions (1) and (2). Other significant factors include the size of the measurement zone. In general, the larger the potential, the larger the current through the cell and therefore, the faster the reaction will typically occur. However, if the potential is too large, other electrochemical reactions may introduce significant error in the measurement.
  • the potential between the electrodes as well as the specific redox mediator and optional second electron transfer agent are chosen so that the analyte will be almost completely electrolyzed in less than 5 minutes, based on the expected concentration of the analyte in the sample. Preferably, the analyte will be almost completely electrolyzed within about 2 minutes and, more preferably, within about 1 minute.
  • coulometry has the disadvantage of requiring the volume of the measured sample be known
  • coulometry is a preferred technique for the analysis of the small sample because it has the advantages of, for example, no temperature dependence for the measurement, no enzyme activity dependence for the measurement, no redox-mediator activity dependence for the measurement, and no error in the measurement from depletion of analyte in the sample.
  • coulometry is a method for determining the amount of charge passed or projected to pass during complete or nearly complete electrolysis of the analyte.
  • One coulometric technique involves electrolyzing the analyte on a working electrode and measuring the resulting current between the working electrode and a counter electrode at two or more times during the electrolysis.
  • the electrolysis is complete when the current reaches a steady state.
  • the charge used to electrolyze the sample is then calculated by integrating the measured currents over time and accounting for any background signal. Because the charge is directly related to the amount of analyte in the sample there is no temperature dependence of the measurement.
  • the activity of the enzyme does not affect the value of the measurement, but only the time required to obtain the measurement (i.e., less active enzyme requires a longer time to achieve complete electrolysis of the sample) so that decay of the enzyme over time will not render the analyte concentration determination inaccurate.
  • the depletion of the analyte in the sample by electrolysis is not a source of error, but rather the objective of the technique. (However, the analyte need not be completely electrolyzed if the electrolysis curve is extrapolated from the partial electrolysis curve based on well-known electrochemical principles.)
  • non-coulometric assays such as amperometric or potentiometric measurement techniques.
  • Amperometry and “chronopotentiometry” refer to taking a potentiometric measurement at one or more points in time. These measurement techniques are useful when the volume of the measured sample is unknown; the volume of the sample in the measurement zone of a small volume sensor (i.e., no more than one microliter) may be difficult to accurately reproduce if the manufacturing tolerances of one or more dimensions of the measurement zone have significant variances.
  • non-coulometric measuring such as amperometric and potentiometric techniques, see, for example, U.S. application Ser. No. 09/295,962, filed Apr. 21, 1999, incorporated herein by reference in its entirety.
  • the sample can be heated to increase the rate of diffusion, oxidation, or reduction of the analyte.
  • This heating can be accomplished by a variety of techniques including placing the sensor in a heated environment or applying a heating unit to the sensor.
  • Another technique includes providing a thermal heating element, such as, for example, a wire or an ink that is capable of converting electrical energy into heat energy, on the sensor.
  • This wire or ink can be applied, for example, on the opposite side of a base material, such as a polymer film, from one or more of the working, counter, reference, or counter/reference electrodes, or applied around the periphery of the working, counter, reference, or counter/reference electrodes.
  • the sample is heated up to 5 to 20° C. above an initial temperature. In other instances, the temperature of the sample may not be known but a constant amount of power or current is applied to the wire or ink.
  • FIGS. 5A through 5C One method for manufacturing the sensor shown in FIGS. 5A through 5C, having a working electrode, multiple counter/reference electrodes, and a side filled sample chamber, is described below. According to the method described herein, a plurality of sensors are produced and then separated.
  • a first non-conducting substrate preferably polyester
  • a conductive carbon ink such as that available from Ercon of Wareham, Mass. under the trade designation “Graphite #G4491”
  • Graphite #G4491 is screen printed onto a first half of the first polymeric substrate in the pattern shown in FIG. 5A and dried, to provide the working electrode 422 , trace 453 and contact pad 423 .
  • each working electrode 422 will extend across the width of the sensor and have a trace 453 that extends to the far end of the sensor.
  • a sensor can be made with a width of about 6.1 mm (0.240 inch). Typical sensor widths are about 2 mm to 20 mm, preferably about 4 mm to 10 mm, but wider or narrower sensors can be used as desired.
  • a sensing layer as described in U.S. patent application Ser. No. 09/295,962, comprising a diffusible mediator and diffusible glucose dehydrogenase enzyme, is applied to the working electrode in a sample chamber region.
  • the sensing layer can be provided on the electrode prior to or subsequent to providing the sample chamber.
  • a conductive silver/silver chloride ink such as that commercially available from Ercon under the trade designation “Silver/Silver Chloride #R414”, is screen printed onto a second half of the first polymeric substrate in the pattern shown in FIG. 5B and dried.
  • FIG. 1 conductive silver/silver chloride ink
  • the Ag/AgCl ink provides a first indicator or reference electrode 441 , a counter electrode 424 , and a second indicator electrode 442 .
  • Counter electrode may extend across the entire sensor surface, or may extend only a portion thereof.
  • the width of a counter electrode is about 1 mm to 20 mm, preferably about 2 to 10 mm.
  • the counter electrode 424 has a width of about 3.71 mm (0.146 inch).
  • the indicator electrodes can have a width, for example, of about 0.1 mm to 5 mm, preferably about 0.25 mm to about 1 mm.
  • working electrode such as working electrode 422 shown in FIG. 5A
  • a counter electrode such as counter electrode 424
  • Indicator electrodes each can have a width of about 0.51 mm (0.020 inch).
  • a spacing of 0.30 mm (0.012 inch) is present between these indicator electrodes and the counter electrode.
  • the indicator electrodes may be each set back from the eventual side edge of the sensor strip, for example, by approximately 0.38 mm (0.015 inch), so that the electrodes 441 , 442 are not damaged, for example, smeared, streaked, chipped or the like, by the process of slitting the substrate into individual sensors.

Abstract

A small volume sensor, and methods of making, for determining the concentration of an analyte, such as glucose or lactate, in a biological fluid, such as blood or serum, using techniques such as coulometry, amperometry, and potentiometry. The sensor includes a working electrode and a counter electrode, and can include an insertion monitoring trace to determine correct positioning of the sensor in a connector. In one embodiment, the sensor determines the concentration of the analyte by discharging an amount of charge into the sample, determining the time needed to discharge the charge, and determining the current used to electrolyze a portion of the analyte using the amount of charge and the amount of time.

Description

    FIELD OF THE INVENTION
  • This invention relates to analytical sensors for the detection of bioanalytes in a small volume sample, and methods of making and using the sensors. [0001]
  • BACKGROUND
  • Analytical sensors are useful in chemistry and medicine to determine the presence and concentration of a biological analyte. Such sensors are needed, for example, to monitor glucose in diabetic patients and lactate during critical care events. [0002]
  • Currently available technology measures bioanalytes in relatively large sample volumes, e.g., generally requiring 3 microliters or more of blood or other biological fluid. These fluid samples are obtained from a patient, for example, using a needle and syringe, or by lancing a portion of the skin such as the fingertip and “milking” the area to obtain a useful sample volume. These procedures are inconvenient for the patient, and often painful, particularly when frequent samples are required. Less painful methods for obtaining a sample are known such as lancing the arm or thigh, which have a lower nerve ending density. However, lancing the body in the preferred regions typically produces submicroliter samples of blood, because these regions are not heavily supplied with near-surface capillary vessels. [0003]
  • It would therefore be desirable and very useful to develop a relatively painless, easy to use blood analyte sensor, capable of performing an accurate and sensitive analysis of the concentration of analytes in a small volume of sample. [0004]
  • It would also be desirable to develop methods for manufacturing small volume electrochemical sensors capable of decreasing the errors that arise from the size of the sensor and the sample. [0005]
  • SUMMARY OF THE INVENTION
  • The sensors of the present invention provide a method for the detection and quantification of an analyte in submicroliter samples. In general, the invention includes a method and sensor for analysis of an analyte in a small volume of sample by, for example, coulometry, amperometry and/or potentiometry. A sensor of the invention preferably utilizes a non-leachable or diffusible redox mediator. The sensor also includes a sample chamber to hold the sample in electrolytic contact with the working electrode. In many instances, the sensor also contains a non-leachable or diffusible second electron transfer agent. [0006]
  • In a preferred embodiment, the working electrode faces a counter electrode, forming a measurement zone within the sample chamber, between the two electrodes, that is sized to contain no more than about 1 μL of sample, preferably no more than about 0.5 μL, more preferably no more than about 0.32 μL, still more preferably no more than about 0.25 μL, and most preferably no more than about 0.1 μL of sample. [0007]
  • In one embodiment of the invention, a sensor, configured for insertion into an electronic meter, is provided with a working electrode and a counter electrode, and a conductive insertion monitor which provides electrical contact with the electronic meter if the sensor is properly inserted into the meter. The conductive insertion monitor is configured and arranged to close an electrical circuit when the sensor is properly inserted into the electronic connector. [0008]
  • In another embodiment of the invention, a sensor is provided with a plurality of contacts, each contact having a contact pad, which is a region for connection with an electronic meter. The plurality of contacts and contact pads are disposed on a substrate having a length and a width, and each contact pad has a contact pad width taken parallel to the width of the substrate. The sum of the contact pad widths is greater than the width of the substrate. In a preferred embodiment, six electrical connections are made with six contact pads on the sensor but in a width that is approximately the width of four contact pads. For example, a working electrode, three counter electrodes (e.g., one counter electrode and two indicator electrodes), and two insertion trace connections each have a contact pad; connection can be made to each of these six contact pads in the same width of the contact pads of the working electrode and three counter electrodes. [0009]
  • The present invention also includes an electrical connector, for providing electrical contact between a sensor and an electrical meter or other device. The electrical connector has a plurality of contact structures, each which has a proximal contact end for electrical connection to a sensor contact, and a distal end for electrical connection to the electrical device. In one embodiment, a plurality of first contact structures extend longitudinally parallel from the distal to the proximal end. Additionally, one or more second contract structures extend longitudinally next to the first contact structures, from the distal end past the proximal end of the first contact structures, and angle toward a longitudinal center line of the connector. Contact to the sensor is then made via the proximal contact ends. [0010]
  • Preferably, the electrical connector has at least two second contact structures extending longitudinally past the proximal end of the first contact structures and angling toward the longitudinal center line of the connector. After the angled or bent portion, the proximal contact ends of the second contact structures of one embodiment make electrical contact with a single conductive surface of a sensor, such as a conductive insertion monitor. In another aspect, the first contact structures can be configured and arranged to contact one or more working and/or counter electrodes of a sensor, and the second contact structures are configured and arranged to contact one or more conductive insertion monitors. [0011]
  • The sensors of the present invention can be configured for side-filling or tip-filling. In addition, in some embodiments, the sensor may be part of an integrated sample acquisition and analyte measurement device. The integrated sample acquisition and analyte measurement device can include the sensor and a skin piercing member, so that the device can be used to pierce the skin of a user to cause flow of a fluid sample, such as blood, that can then be collected by the sensor. In at least some embodiments, the fluid sample can be collected without moving the integrated sample acquisition and analyte measurement device. [0012]
  • In one embodiment, the sensor is connected with an electrical device, to provide a processor coupled to the sensor. The processor is configured and arranged to determine, during electrolysis of a sample in the sample chamber, a series of current values. The processor determines a peak current value from the series of current values. After the current values decrease below a threshold fraction of the peak current values, slope values are determined from the current values and represent a linear function of the logarithm of current values over time. The processor determines, from the slope values, an extrapolation slope. From the extrapolated slope and the measured current values, the processor determines an amount of charge needed to electrolyze the sample and, from that amount of charge, the concentration of the analyte in the sample. [0013]
  • One method of forming a sensor, as described above, includes forming at least one working electrode on a first substrate and forming at least one counter or counter/reference electrode on a second substrate. A spacer layer is disposed on either the first or second substrates. The spacer layer defines a chamber into which a sample can be drawn and held when the sensor is completed. A redox mediator and/or second electron transfer agent can be disposed on the first or second substrate in a region that will be exposed within the sample chamber when the sensor is completed. The first and second substrates are then brought together and spaced apart by the spacer layer with the sample chamber providing access to the at least one working electrode and the at least one counter or counter/reference electrode. In some embodiments, the first and second substrates are portions of a single sheet or continuous web of material. The invention includes particularly efficient and reliable methods for the manufacture of these sensors. [0014]
  • One such efficient and reliable method includes providing an adhesive having first and second surfaces covered with first and second release liners and then making detailed cuts through the first release liner and the adhesive but not through the second release liner. These cuts define one or more sample chamber regions. A portion of the first release liner is removed to expose a portion of the first adhesive surface, which leaves a remaining portion of the first release liner over the sample chamber regions. This exposed first adhesive surface is applied to a first substrate having one or more conductive traces disposed thereon. The second release liner is removed together with the adhesive and the first release liner of the sample chamber regions in order to expose the second adhesive surface. The second adhesive surface is then applied to a second substrate having one or more conductive traces disposed thereon. This method forms a sensor having a sample chamber corresponding to one of the sample chamber regions. [0015]
  • These and various other features which characterize the invention are pointed out with particularity in the attached claims. For a better understanding of the invention, its advantages, and objectives obtained by its use, reference should be made to the drawings and to the accompanying description, in which there is illustrated and described preferred embodiments of the invention.[0016]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • Referring now to the drawings, wherein like reference numerals and letters indicate corresponding structure throughout the several views: [0017]
  • FIG. 1 is a schematic view of a first embodiment of an electrochemical sensor in accordance with the present invention having a working electrode and a counter electrode facing each other and having a sample chamber; [0018]
  • FIG. 2 is an exploded view of the sensor shown in FIG. 1, the layers illustrated individually; [0019]
  • FIG. 3 is a schematic view of a second embodiment of an electrochemical sensor in accordance with the principles of the present invention having a working electrode and a counter electrode facing each other and having an extended sample chamber; [0020]
  • FIG. 4 is a top view of a third embodiment of an electrochemical sensor in accordance with the principles of the present invention, this sensor includes multiple working electrodes; [0021]
  • FIG. 5A illustrates a top view of a first substrate with a working electrode for use in a fourth embodiment of a sensor according to the invention; [0022]
  • FIG. 5B illustrates a bottom view of a second substrate (inverted with respect to FIG. 5A) with counter electrodes placement over and opposite the substrate of FIG. 5A; [0023]
  • FIG. 5C illustrates a top view of a spacer for placement between the first substrate of FIG. 5A and the second substrate of FIG. 5B; [0024]
  • FIG. 6A illustrates a top view of a first film with a working electrode for use in a fifth embodiment of a sensor according to the invention; [0025]
  • FIG. 6B illustrates a top view of a spacer for placement on the first film of FIG. 6A; [0026]
  • FIG. 6C illustrates a bottom view of a second film (inverted with respect to FIGS. 6A and 6B) with counter electrodes placement over the spacer of FIG. 6B and first film of FIG. 6A; [0027]
  • FIG. 7A illustrates a top view of a first film with a working electrode for use in a sixth embodiment of a sensor according to the invention; [0028]
  • FIG. 7B illustrates a top view of a spacer for placement on the first film of FIG. 7A; [0029]
  • FIG. 7C illustrates a bottom view of a second film (inverted with respect to FIGS. 7A and 7B) with counter electrodes placement over the spacer of FIG. 7B and first film of FIG. 7A; [0030]
  • FIG. 8A illustrates a top view of a first film with a working electrode for use in a seventh embodiment of a sensor according to the invention; [0031]
  • FIG. 8B illustrates a top view of a spacer for placement on the first film of FIG. 8A; [0032]
  • FIG. 8C illustrates a bottom view of a second film (inverted with respect to FIGS. 8A and 8B) with counter electrodes placement over the spacer of FIG. 8B and first film of FIG. 8A; [0033]
  • FIG. 9A illustrates a top view of a first film with a working electrode for use in a eighth embodiment of a sensor according to the invention; [0034]
  • FIG. 9B illustrates a top view of a spacer for placement on the first film of FIG. 9A; [0035]
  • FIG. 9C illustrates a bottom view of a second film (inverted with respect to FIGS. 9A and 9B) with counter electrodes placement over the spacer of FIG. 9B and first film of FIG. 9A; [0036]
  • FIG. 10A illustrates a top view of a first film with a working electrode for use in a ninth embodiment of a sensor according to the invention; [0037]
  • FIG. 10B illustrates a top view of a spacer for placement on the first film of FIG. 10A; [0038]
  • FIG. 10C illustrates a bottom view of a second film (inverted with respect to FIGS. 10A and 10B) with counter electrodes placement over the spacer of FIG. 10B and first film of FIG. 10A; [0039]
  • FIG. 11A illustrates a top view of a first film with a working electrode for use in a tenth embodiment of a sensor according to the invention; [0040]
  • FIG. 11B illustrates a top view of a spacer for placement on the first film of FIG. 11A; [0041]
  • FIG. 11C illustrates a bottom view of a second film (inverted with respect to FIGS. 11A and 11B) with counter electrodes placement over the spacer of FIG. 11B and first film of FIG. 11A; [0042]
  • FIG. 12A illustrates a top view of a first film with a working electrode for use in a eleventh embodiment of a sensor according to the invention; [0043]
  • FIG. 12B illustrates a top view of a spacer for placement on the first film of FIG. 12A; [0044]
  • FIG. 12C illustrates a bottom view of a second film (inverted with respect to FIGS. 12A and 12B) with counter electrodes placement over the spacer of FIG. 12B and first film of FIG. 12A; [0045]
  • FIG. 13A illustrates a top view of one embodiment of a sheet of sensor components, according to the invention; [0046]
  • FIG. 13B illustrates a top view of another embodiment of a sheet of sensor components, according to the invention; [0047]
  • FIGS. 14A through 14F illustrate cross sectional views of a sequential process of providing a sample chamber in a spacer layer; [0048]
  • FIG. 14G is a bottom view of FIG. 14B; [0049]
  • FIG. 15A is a graphical representation of the current over time used to calculate the concentration of an analyte; [0050]
  • FIG. 15B is a graphical representation of the log of current over time used to calculate the concentration of an analyte; [0051]
  • FIG. 16A is a top perspective view of a sensor positioned for insertion within an electrical connector device in accordance with the present invention; [0052]
  • FIG. 16B is an exploded view of the electrical connector device of FIG. 16A; [0053]
  • FIG. 17A is a top perspective view of a sensor fully positioned within the electrical connector device of FIG. 16A; [0054]
  • FIG. 17B is an exploded view of the electrical connector device of FIG. 17A; [0055]
  • FIG. 18A is a bottom perspective view of the electrical connector device of FIGS. 16A and 16B; [0056]
  • FIG. 18B is a bottom perspective view of the electrical connector device of FIGS. 17A and 17B; [0057]
  • FIGS. 19A through 19L illustrate examples of suitable conductive pathways between contact pads; [0058]
  • FIG. 20 illustrates a cross-sectional view looking from inside a connector to a sensor of the invention disposed within the connector; and [0059]
  • FIG. 21 illustrates a perspective view of a ring for use with a lancet device. [0060]
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
  • As used herein, the following definitions define the stated term: [0061]
  • An “air-oxidizable mediator” is a redox mediator that is oxidized by air, preferably so that at least 90% of the mediator is in an oxidized state upon storage in air either as a solid or as a liquid during a period of time, for example, one month or less, and, preferably, one week or less, and, more preferably, one day or less. [0062]
  • “Amperometry” includes steady-state amperometry, chronoamperometry, and Cottrell-type measurements. [0063]
  • A “biological fluid” is any body fluid in which the analyte can be measured, for example, blood (which includes whole blood and its cell-free components, such as, plasma and serum), interstitial fluid, dermal fluid, sweat, tears, urine and saliva. [0064]
  • “Coulometry” is the determination of charge passed or projected to pass during complete or nearly complete electrolysis of the analyte, either directly on the electrode or through one or more electron transfer agents. The charge is determined by measurement of charge passed during partial or nearly complete electrolysis of the analyte or, more often, by multiple measurements during the electrolysis of a decaying current and elapsed time. The decaying current results from the decline in the concentration of the electrolyzed species caused by the electrolysis. [0065]
  • A “counter electrode” refers to one or more electrodes paired with the working electrode, through which passes an electrochemical current equal in magnitude and opposite in sign to the current passed through the working electrode. The term “counter electrode” is meant to include counter electrodes which also function as reference electrodes (i.e. a counter/reference electrode) unless the description provides that a “counter electrode” excludes a reference or counter/reference electrode. [0066]
  • An “effective diffusion coefficient” is the diffusion coefficient characterizing transport of a substance, for example, an analyte, an enzyme, or a redox mediator, in the volume between the electrodes of the electrochemical cell. In at least some instances, the cell volume may be occupied by more than one medium (e.g., the sample fluid and a polymer film). Diffusion of a substance through each medium may occur at a different rate. The effective diffusion coefficient corresponds to a diffusion rate through this multiple-media volume and is typically different than the diffusion coefficient for the substance in a cell filled solely with sample fluid. [0067]
  • An “electrochemical sensor” is a device configured to detect the presence of and/or measure the concentration of an analyte via electrochemical oxidation and reduction reactions. These reactions are transduced to an electrical signal that can be correlated to an amount or concentration of analyte. [0068]
  • “Electrolysis” is the electrooxidation or electroreduction of a compound either directly at an electrode or via one or more electron transfer agents (e.g., redox mediators and/or enzymes). [0069]
  • The term “facing electrodes” refers to a configuration of the working and counter electrodes in which the working surface of the working electrode is disposed in approximate opposition to a surface of the counter electrode. In at least some instances, the distance between the working and counter electrodes is less than the width of the working surface of the working electrode. [0070]
  • A compound is “immobilized” on a surface when it is entrapped on or chemically bound to the surface. [0071]
  • An “indicator electrode” is an electrode that detects partial or complete filling of a sample chamber and/or measurement zone. [0072]
  • A “layer” is one or more layers. [0073]
  • The “measurement zone” is defined herein as a region of the sample chamber sized to contain only that portion of the sample that is to be interrogated during an analyte assay. [0074]
  • A “non-diffusible,” “non-leachable,” or “non-releasable” compound is a compound which does not substantially diffuse away from the working surface of the working electrode for the duration of the analyte assay. [0075]
  • The “potential of the counter/reference electrode” is the half cell potential of the reference electrode or counter/reference electrode of the cell when the solution in the cell is 0.1 M NaCl solution at pH7. [0076]
  • A “redox mediator” is an electron transfer agent for carrying electrons between the analyte and the working electrode, either directly, or via a second electron transfer agent. [0077]
  • A “reference electrode” includes a reference electrode that also functions as a counter electrode (i.e., a counter/reference electrode) unless the description provides that a “reference electrode” excludes a counter/reference electrode. [0078]
  • A “second electron transfer agent” is a molecule that carries electrons between a redox mediator and the analyte. [0079]
  • A “surface in the sample chamber” is a surface of a working electrode, counter electrode, counter/reference electrode, reference electrode, indicator electrode, a spacer, or any other surface bounding the sample chamber. [0080]
  • A “working electrode” is an electrode at which analyte is electrooxidized or electroreduced with or without the agency of a redox mediator. [0081]
  • A “working surface” is the portion of a working electrode that is covered with non-leachable redox mediator and exposed to the sample, or, if the redox mediator is diffusible, a “working surface” is the portion of the working electrode that is exposed to the sample. [0082]
  • The small volume, in vitro analyte sensors of the present invention are designed to measure the concentration of an analyte in a portion of a sample having a volume no more than about 1 μL, preferably no more than about 0.5 μL, more preferably no more than about 0.32 μL, still more preferably no more than about 0.25 μL, and most preferably no more than about 0.1 μL of sample. [0083]
  • The analyte of interest is typically provided in a solution or biological fluid, such as blood or serum. [0084]
  • Referring to the Drawings in general, and in particular FIGS. 1 and 2, a small volume, in vitro [0085] electrochemical sensor 20 of the invention generally includes a working electrode 22 on a first substrate 32, a counter (or counter/reference) electrode 24 on a second substrate 34, and a sample chamber 26. The sample chamber 26 is configured so that when a sample is provided in the chamber, the sample is in electrolytic contact with both the working electrode 22, the counter electrode 24 and any reference electrodes or indicator electrodes that may be present. This allows electrical current to flow between the electrodes to effect the electrolysis (electrooxidation or electroreduction) of the analyte. A spacer 33 is positioned between first substrate 32 and second substrate 34 to provide a spacing between electrodes 22, 24 and to provide sample chamber 26 in which the sample to be evaluated is housed.
  • Working Electrode [0086]
  • The working [0087] electrode 22 may be formed from a molded carbon fiber composite or it may include an inert non-conducting base material, such as polyester, upon which a suitable conducting layer is deposited. The conducting layer typically has relatively low electrical resistance and is typically electrochemically inert over the potential range of the sensor during operation. Suitable conducting layers include gold, carbon, platinum, ruthenium dioxide, palladium, and conductive epoxies, such as, for example, ECCOCOAT CT5079-3 Carbon-Filled Conductive Epoxy Coating (available from W. R. Grace Company, Woburn, Mass.), as well as other non-corroding materials known to those skilled in the art. The electrode (e.g., the conducting layer) is deposited on the surface of the inert material by methods such as vapor deposition or printing. Preferably, the electrode is printed onto the base material.
  • The inert non-conducting base material, is also referred to as a substrate, base, or the like. This base material is typically an electrically non-conducting material, e.g., any insulating material, that is not capable of carrying electric charge or current. Examples of materials usable as the base material for sensors of the present invention include polyesters, polyethylene (both high density and low density), polyethylene terephthalate, polycarbonate, vinyls, and the like. The base material can be treated with a primer or other such coating to improve the adhesion of the electrodes thereon. [0088]
  • A [0089] tab 23′ can be provided on the end of the working electrode 22 for easy connection of the electrode to external electronics (not shown) such as a voltage source or current measuring equipment. Contact pad 23, which is connected to working electrode 22, such as an extension from the working electrode, can be positioned on tab 23′.
  • To prevent electrochemical reactions from occurring on portions of the working electrode not coated by the mediator, when a non-leachable mediator is used, a dielectric or other insulating material can be deposited on the electrode over, under, or surrounding the region with the redox mediator. Suitable dielectric materials include waxes and non-conducting organic polymers, such as polyethylene. The dielectric material can also cover a portion of the redox mediator on the electrode. The covered portion of the redox mediator will not contact the sample, and, therefore, will not be a part of the electrode's working surface. [0090]
  • Sensing Chemistry [0091]
  • In addition to the working [0092] electrode 22, sensing chemistry materials are provided in the sample chamber 26 for the analysis of the analyte. This sensing chemistry preferably includes a redox mediator and a second electron transfer mediator, although in some instances, one or the other may be used alone. The redox mediator and second electron transfer agent can be independently diffusible or non-leachable (i.e., non-diffusible) such that either or both may be diffusible or non-leachable. Placement of sensor chemistry components can depend on whether they are diffusible or non-leachable. For example, non-leachable and/or diffusible component(s) typically form a sensing layer on the working electrode. Alternatively, one or more diffusible components can be disposed on any surface in the sample chamber prior to the introduction of the sample. As another example, one or more diffusible component(s) are placed in the sample prior to introduction of the sample into the sensor.
  • If the redox mediator is non-leachable, then the non-leachable redox mediator is typically disposed on the working [0093] electrode 22 as a sensing layer. In an embodiment having a redox mediator and a second electron transfer agent, if the redox mediator and second electron transfer agent are both non-leachable, then both of the non-leachable components are disposed on the working electrode 22 as a sensing layer.
  • If, for example, the second electron transfer agent is diffusible and the redox mediator is non-leachable, then at least the redox mediator is disposed on the working [0094] electrode 22 as a sensing layer. The diffusible second electron transfer agent need not be disposed on a sensing layer of the working electrode, but can be disposed on any surface of the sample chamber, including within the redox mediator sensing layer, or can be placed in the sample. If the redox mediator is diffusible, then the redox mediator can be disposed on any surface of the sample chamber or can be placed in the sample. If both the redox mediator and second electron transfer agent are diffusible, then the diffusible components can be independently or jointly disposed on any surface of the sample chamber and/or placed in the sample (i.e., each diffusible component need not be disposed on the same surface of the sample chamber or placed in the sample).
  • The redox mediator, whether it is diffusible or non-leachable, mediates a current between the working [0095] electrode 22 and the analyte and enables the electrochemical analysis of molecules which may not be suited for direct electrochemical reaction on an electrode. The mediator functions as an electron transfer agent between the electrode and the analyte.
  • Analytes that can be interrogated include, for example, glucose, acetyl choline, amylase, bilirubin, cholesterol, chorionic gonadotropin, creatine kinase (e.g., CK-MB), creatine, DNA, fructosamine, glucose, glutamine, growth hormones, hormones, ketones, lactate, peroxide, prostate-specific antigen, prothrombin, RNA, thyroid stimulating hormone, and troponin. The concentration of analytes such as drugs or medication, such as, for example, antibiotics (e.g., gentamicin, vancomycin, and the like), digitoxin, digoxin, drugs of abuse, theophylline, and warfarin, can also be determined. Assays suitable for determining the concentration of DNA and/or RNA are disclosed in U.S. patent applications Ser. Nos. 09/138,888 and 09/145,776 and described in PCT Application PCT/US99/14460, all which are incorporated herein by reference. [0096]
  • Redox Mediators
  • Although any organic or organometallic redox species can be used as a redox mediator, one type of suitable redox mediator is a transition metal compound or complex. Examples of suitable transition metal compounds or complexes include osmium, ruthenium, iron, and cobalt compounds or complexes. In these complexes, the transition metal is coordinatively bound to one or more ligands. The ligands are typically mono-, di-, tri-, or tetradentate. The most preferred ligands are heterocyclic nitrogen compounds, such as, for example, pyridine and/or imidazole derivatives. Multidentate ligands may include multiple pyridine and/or imidazole rings. Alternatively, metallocene derivatives, such as, for example, ferrocene, can be used. An example of one mediator is [Os(4-(N-(6-aminohexyl)aminobipyridine)(1,1′-dimethyl-2,2′-biimidazole)[0097] 2]Cl3.
  • The redox mediators can be diffusible redox mediators or non-leachable redox mediators, such as non-leachable redox polymers. For additional information on redox mediators, see, for example, U.S. patent application Ser. No. 09/295,962, filed Apr. 21, 1999, and PCT published application WO 98/35225, both which are incorporated herein by reference. [0098]
  • Second Electron Transfer Agent
  • In a preferred embodiment of the invention, the sensor includes a redox mediator and a second electron transfer agent which is capable of transferring electrons to or from the redox mediator and the analyte. The second electron transfer agent can be diffusible or can be non-leachable (e.g., entrapped in or coordinatively, covalently, or ionically bound to a redox polymer). One example of a suitable second electron transfer agent is an enzyme which catalyzes a reaction of the analyte. For example, a glucose oxidase or glucose dehydrogenase, such as pyrroloquinoline quinone glucose dehydrogenase (PQQ), is used when the analyte is glucose. A lactate oxidase fills this role when the analyte is lactate. Other enzymes can be used for other analytes. [0099]
  • Counter Electrode [0100]
  • [0101] Counter electrode 24, as illustrated in FIGS. 1 and 2, can be constructed in a manner similar to working electrode 22. Counter electrode 24 may also be a counter/reference electrode. Alternatively, a separate reference electrode may be provided in contact with the sample chamber. Suitable materials for the counter/reference or reference electrode include, for example, Ag/AgCl or Ag/AgBr printed on a non-conducting base material or silver chloride on a silver metal base. The same materials and methods may be used to make the counter electrode as are available for constructing the working electrode 22, although different materials and methods may also be used. Preferably, the counter or counter/reference electrode is printed on an insulating base material. A tab 25′, on which contact pad 25 is disposed, can be provided for making convenient connection to the external electronics (not shown), such as a coulometer, potentiostat, or other measuring device.
  • Optionally, a non-conductive filler material, such as a non-conductive ink, can be formed adjacent a counter electrode, or between multiple counter electrodes to provide a planar surface along the path of travel of the sample fluid in the sample chamber. The non-conductive filler material preferably creates a smooth surface to facilitate filling of the sample chamber by capillary action and/or for reducing the likelihood that air bubbles will become entrapped near the counter electrodes. This non-conductive material can be colored or colorless and may be formed on the substrate by printing or other techniques. The non-conductive material may be deposited prior to or subsequent to the formation of the counter electrode. In one embodiment, a non-conductive ink is used to fill in the area between multiple 12.3 micrometer (0.5 mil) thick counter electrodes. In another embodiment, a non-conductive ink is used to fill the area between multiple 6.4 micrometer (0.25 mil) thick counter electrodes. Generally, no filler ink is needed for thickness less about 6.4 micrometers, and in some sensor designs, no filler ink is needed for 6.4 micrometer thick counter electrodes. [0102]
  • Electrode Configuration [0103]
  • In one embodiment of the invention, working [0104] electrode 22 and counter electrode 24 are disposed opposite to and facing each other to form a facing electrode pair as depicted in FIGS. 1 and 2. In this preferred configuration, the sample chamber 26 is typically disposed between the two electrodes. For this facing electrode configuration, it is preferred that the electrodes are separated by a distance of no more than about 0.2 mm (e.g., at least one portion of the working electrode is separated from one portion of the counter electrode by no more than 200 μm), preferably no more than 100 μm, and most preferably no more than 50 μm.
  • The electrodes need not be directly opposing each other; they may be slightly offset. Furthermore, the two electrodes need not be the same size. Preferably, the working [0105] electrode 22 extends the width of sensor 20 and counter electrode 24 is a portion or all of that width. Either of working electrode 22 or counter electrode 24 may include more than one electrode, such as shown in FIG. 4 (as counter electrodes 324, 344) and in FIG. 5B (as counter electrodes 424, 441, 442). Counter electrode 24 can also be formed with tines in a comb shape. Other configurations of both the counter electrode and working electrode are within the scope of the invention. However, for this particular embodiment, the separation distance between at least one portion of the working electrode and some portion of the counter electrode preferably does not exceed the limits specified hereinabove.
  • In another embodiment of the invention, the working and counter electrodes are coplanar. In this case, the sample chamber is in contact with both electrodes and is bounded on the side opposite the electrodes by a non-conducting inert base or substrate. Suitable materials for the inert base include non-conducting materials such as polyester. [0106]
  • Other configurations of the inventive sensors are also possible. For example, the two electrodes can be formed on surfaces that make an angle to each other. One such configuration would have the electrodes on surfaces that form a right angle. Another possible configuration has the electrodes on a curved surface such as the interior of a tube. For example, the working and counter electrodes can be arranged so that they face each other from opposite sides of the tube. This is another example of a facing electrode pair. Alternatively, the electrodes can be placed near each other on the tube wall (e.g., one on top of the other or side-by-side). In any configuration, the two electrodes must be configured so that they do not make direct electrical contact with each other, to prevent shorting of the electrochemical sensor. [0107]
  • Referring again to FIGS. 1 and 2, the [0108] electrodes 22, 24 extend from the sample chamber 26 to the other end of the sensor 20 as electrode extensions called “traces”. Each trace provides a contact pad 23, 25 for providing electrical connection to a meter or other device to allow for data and measurement collection, as will be described later. Preferably, each contact pad 23, 25 is positioned on a tab 23′, 25′ that extends from each non-conducting base substrate 32, 34. In one embodiment, a tab has more than one contact pad positioned thereon. In a second embodiment, a single contact pad is used to provide a connection to one or more electrodes; that is, multiple electrodes are coupled together and are connected via one contact pad.
  • A [0109] spacer 33 can be used to keep the electrodes apart when the electrodes face each other as depicted in FIGS. 1 and 2; spacer 33 is clearly seen in FIG. 2. The spacer is typically constructed from an inert non-conducting material such as pressure-sensitive adhesive, polyester, Mylar™, Kevlar™ or any other strong, thin polymer film, or, alternatively, a thin polymer film such as a Teflon™ film, chosen for its chemical inertness. In addition to preventing contact between the electrodes, the spacer 33 can function as a portion of the boundary for the sample chamber 26. Other spacers include layers of adhesive and double-sided adhesive tape (e.g., a carrier film with adhesive on opposing sides of the film). Adhesive may be applied, for example by coating, onto a polymeric material to provide spacer 33.
  • Sample Chamber [0110]
  • The [0111] sample chamber 26 is typically defined by a combination of the electrodes 22, 24, the substrates 32, 34, and a spacer 33 as shown in FIGS. 1 and 2. A measurement zone is contained within this sample chamber and is the region of the sample chamber that contains only that portion of the sample that is interrogated during the analyte assay. In the embodiment of the invention illustrated in FIGS. 1 and 2, sample chamber 26 is the space between the two electrodes 22, 24 and their non-conductive base substrates 32, 34, bounded by spacer 33. In this embodiment, the sample chamber has a volume that is preferably no more than about 1 μL, more preferably no more than about 0.32 μL, and still more preferably no more than about 0.25 μL.
  • In the embodiment of the invention depicted in FIGS. 1 and 2, the measurement zone has a volume that is approximately equal to the volume of the sample chamber. In a preferred embodiment the measurement zone includes 80% of the sample chamber, 90% in a more preferred embodiment, and about 100% in a most preferred embodiment. [0112]
  • In another embodiment of the invention, shown in FIG. 3, [0113] sensor 220 has a working electrode 222 on non-conducting substrate base 232, a counter electrode 224 on non-conducting substrate base 234, and a spacer 233 therebetween. A contact pad 223 extends from working electrode 222, and likewise, a contact pad 225 extends from counter electrode 224. Sample chamber 226 (defined by base 232, 234 and spacer 233) extends the length of sensor 220 and includes much more space than the region proximate electrodes 222, 224. In this embodiment, the measurement zone, corresponding to the region containing the portion of the sample which will be interrogated, is the portion of sample chamber 226 bounded by the working surface of the working electrode 222 and counter electrode 224. In this embodiment, the measurement zone has a volume that is preferably no more than about 1 μL, more preferably no more than about 0.32 μL, still more preferably no more than about 0.25 μL, and most preferably no more than about 0.1 μL of sample.
  • In both of the embodiments discussed above, the thickness of the sample chamber and of the measurement zone correspond typically to the thickness of [0114] spacer 33, 233 (e.g., the distance between the electrodes in FIGS. 2 and 3, or the distance between the electrodes and the inert base in an embodiment where the electrodes are co-planar). The spacer can be, for example, an adhesive or double-sided adhesive tape or film. Examples of useable adhesives include urethanes, acrylates, acrylics, latexes, rubbers, and other known adhesive materials. Preferably, this thickness is small to promote rapid electrolysis of the analyte, as more of the sample will be in contact with the electrode surface for a given sample volume. In addition, a thin sample chamber helps to reduce errors from diffusion of analyte into the measurement zone from other portions of the sample chamber during the analyte assay, because diffusion time is long relative to the measurement time. Typically, the thickness of the sample chamber is between about 50 and about 200 micrometers.
  • Sorbent Material [0115]
  • The sample chamber can be empty before the sample is placed in the chamber, or, in some embodiments, the sample chamber can include a sorbent material (shown in FIG. 3 as sorbent [0116] 50) to sorb and hold a fluid sample during the measurement process. Suitable sorbent materials include polyester, nylon, cellulose, and cellulose derivatives such as nitrocellulose. The sorbent material facilitates the uptake of small volume samples by a wicking action which can complement or, preferably, replace any capillary action of the sample chamber. In addition to or alternatively, a portion or the entirety of the wall of the sample chamber may be coated by a surfactant, which is intended to lower the surface tension of the fluid sample and improve fluid flow within the sample chamber. An example of a useable surfactant is available under the tradename “Zonyl FSO” from Dupont of Wilmington, Del.
  • Methods other than the wicking action of a sorbent can be used to transport the sample into the sample chamber or measurement zone. Examples of such methods for transport include the application of pressure on a sample to push it into the sample chamber, the creation of a vacuum by a pump or other vacuum-producing method in the sample chamber to pull the sample into the chamber, capillary action due to interfacial tension of the sample with the walls of a thin sample chamber, as well as the wicking action of a sorbent material. [0117]
  • The entire sensor assembly is held firmly together to ensure that the sample remains in contact with the electrodes and that the sample chamber and measurement zone maintain the same volume. This is an important consideration in the coulometric analysis of a sample, where measurement of a defined sample volume is needed. [0118]
  • Alternative Sensor Designs [0119]
  • FIGS. 4 through 12 illustrate alternative sensor designs, both tip-filling and side-filling. Referring to FIG. 4, a [0120] sensor 320 has a working electrode 322, a counter electrode 324, a second counter electrode 344 (which may provide a fill indicator function, as described below), and a sample chamber 326 extending along at least a portion of the length of sensor 320 and optionally including a sorbent 350.
  • FIGS. 5A through 5C illustrate three layers that when assembled, provide a preferred embodiment of a sensor. FIG. 5A has a working [0121] electrode 422 on substrate 432. Working electrode 422 has a trace 453 extending from sample chamber 426 to tab 423′ on which is contact pad 423; contact pad 423 connects the sensor to a meter or other measurement equipment. FIG. 5B, (inverted with respect to FIG. 5A to show the electrode side up), has a counter electrode 424 on substrate 434, and also includes a first indicator electrode 441 and a second indicator electrode 442. Counter electrode 424 has a trace 454, first indicator electrode 441 has trace 451, and second indicator electrode 442 has trace 452, that end at contact pads 425, 443, 444, respectively, on tab 425′. Spacer 433 in FIG. 5C defines sample chamber 426 and provides spacing between the electrodes when the two substrates 432, 434 are positioned opposite and facing one another.
  • FIGS. 6A through 6C also illustrate three layers that, when assembled, provide a sensor. In FIG. 6A, a working [0122] electrode 502 is formed on first substrate 500. The working electrode 502 includes a contact pad 503 for connection with external electronics; this contact pad 503 is connected to working electrode 502 by trace 552. A spacer 504, shown in FIG. 6B, such as a layer of adhesive or a double-sided tape defines a channel 506 to produce a sample chamber for the sensor. Two counter (or counter/reference) electrodes 510, 512 are formed on a second substrate 508, as shown in FIG. 6C (inverted with respect to FIG. 6A to show the electrode side up). This multiple counter electrode arrangement can provide a fill indicator function, using counter electrode 512, as described below. Each counter electrode 510, 512 has a contact region or pad 511, 513 for connection with external electronics; these contact pads 511, 513 are connected to counter electrodes 510, 512 by traces 551, 553. The second substrate 508 is inverted and placed over the first substrate 500, with the spacer 504 between, so that the working electrode 502 and the two counter electrodes 510, 512 are facing in the region of the channel 506.
  • In some instances, the [0123] counter electrode 510 nearest an entrance 514 (FIG. 6B) of the channel 506 has a surface area within the sample chamber that is at least two times larger than the other counter electrode 512, and may be at least five or ten times larger. The non-leachable or diffusible redox mediator and/or second electron transfer agent can be provided on either the first or second substrates 500, 508 in a region corresponding to the channel 506, as described above.
  • The working electrode and counter electrodes can be formed to cover the entire channel region (except for a small space between the two counter electrodes). In this embodiment, the sample chamber and measurement zone are effectively the same and have the same volume. In other embodiments, the measurement zone has, for example, 80% or 90% of the volume of the sample chamber. It will be understood that similar sensors could be made using one counter electrode or three or more counter electrodes. It will also be understood that multiple working electrodes may also be provided on the sensor. [0124]
  • FIGS. 7A, 7B and [0125] 7C illustrate a side-filling sensor arrangement. FIG. 7A shows a first substrate 520 with a working electrode 522. FIG. 7B illustrates a spacer 524 defining a channel 526. FIG. 7C (inverted with respect to FIG. 7A and 7B) illustrate a second substrate 528 with three counter (or counter/reference) electrodes 530, 532, 534. This multiple counter electrode arrangement can provide a fill indicator function, as described below. An indentation 536, 538 or recessed or indented portion can be formed at either edge of the opening to channel 526 to facilitate the drawing of fluid into the sensor. This configuration can aid in wicking or capillary filling of the channel (i.e., sample chamber). This configuration can also reduce the likelihood that the user will inadvertently block the channel during collection of the sample, which could occur by pressing the tip of the sensor edgewise against the skin.
  • FIGS. 8A, 8B, and [0126] 8C illustrate another example of a side-filling sensor arrangement. FIG. 8A illustrates a first substrate 540 with a working electrode 542. FIG. 8B illustrates a spacer 544 defining a channel 546. FIG. 8C (inverted with respect to FIGS. 8A and 8B) illustrates a second substrate 548 with three counter (or counter/reference) electrodes 550, 552, 554.
  • FIGS. 9A, 9B, and [0127] 9C illustrate another example of a tip-filling sensor arrangement. FIG. 9A illustrates a first substrate 560 with a working electrode 562. FIG. 9B illustrates a spacer 564 defining a channel 566. FIG. 9C (inverted with respect to FIGS. 9A and 9B) illustrates a second thin film substrate 568 with two counter (or counter/reference) electrodes 570, 572. This multiple counter electrode arrangement can provide a fill indicator function, as described below. A vent hole 574 (indicated as a shaded region in FIG. 9C) is provided through the second substrate. In the illustrated embodiment, this vent hole 574 is made through only the substrate 568 that carries the counter electrode(s) and, optionally, the spacer 564. In this embodiment, the vent hole can be formed by, for example, die cutting a portion of the substrate. This die cut can remove a portion of at least one counter electrode, but a sufficient amount of the counter electrode should remain for contact with the sample in the channel and for electrical connection to a contact at the other end of the sensor. In another embodiment, the vent hole 574 can be made through all of the layers or through the first substrate and not the second substrate.
  • Another embodiment is illustrated in FIGS. 10A, 10B, and [0128] 10C, with a different shape. This sensor includes a first substrate 579 with at least one working electrode 580, as illustrated in FIG. 10A. The sensor also includes a spacer 581 with a channel 582 formed in the spacer 581, as shown in FIG. 10B. The sensor further includes a second substrate 583 with two counter electrodes 584, 585, as shown in FIG. 10C (inverted with respect to FIGS. 10A and 10B). A venting aperture 586 is cut typically through all of the layers and extends from a side of the sensor. In some embodiments, the venting aperture and the front portion 587 of the sensor are simultaneously cut with a reproducible distance between the venting aperture and the front portion 587 of the sensor to provide a reproducible length for the channel 582 and the working electrode 580. This tip-filling sensor arrangement optionally includes an indentation 588 or recessed or indented portion that can be formed at the filling opening of the channel 582 to facilitate the drawing of fluid into the sensor.
  • FIGS. 11A, 11B, and [0129] 11C illustrate another example of a side-filling sensor arrangement. FIG. 11A illustrates a first substrate 640 with a working electrode 642. FIG. 11B illustrates a spacer 644 defining a channel 646. FIG. 11C (inverted with respect to FIGS. 11A and 11B) illustrates a second substrate 648 with three counter (or counter/reference) electrodes 650, 652, 654. This multiple counter electrode arrangement can provide a fill indicator function, as described below. The length of the channel 646 is typically defined by the two parallel cuts along the sides 656, 658 of the sensors.
  • Because of the straight sides, these sensors (and also those shown in FIGS. 1, 2 and [0130] 5) can be manufactured adjacent to one another, as illustrated in FIG. 13A. Such positioning during manufacture produces less waste material. Another optional processing advantage of the adjacent sensor manufacturing process is that the redox mediator and/or second electron transfer agent can be readily disposed in the channel by striping a continuous stream of these components along a row or column of adjacent sensors. This can result in better efficiency and less waste of expensive reagents such as the redox mediator and/or second electron transfer agent, as compared to other techniques, such as individually placing these components within the individual channels.
  • FIGS. 12A, 12B, and [0131] 12C illustrate another sensor configuration. This sensor includes a first substrate 600 with at least one working electrode 602, as illustrated in FIG. 12A. The sensor also includes a spacer 604 with a channel 606 formed in the spacer 604, as shown in FIG. 12B. The sensor further includes a second substrate 608 with two counter electrodes 610, 612, as shown in FIG. 12C (inverted with respect to FIGS. 12A and 12B). This multiple counter electrode arrangement may provide a fill indicator function, as described below. The sensor can also include, for example, an indicator, such as a slot 614 or an extension 616 from the body of the sensor that indicates to the user which side of the sensor should be placed adjacent to the sample. Surface printing can also or alternatively be applied to the sensor to act as an indicator. Some indication mechanism can be particularly important where the sensor reading is only correct when the sample enters from a particular side.
  • Multiple Electrode Sensors and Calibration Thereof [0132]
  • Multiple electrode sensors can be used for a variety of reasons. For example, multiple electrodes can be used to test a variety of analytes using a single sample. One embodiment with multiple electrodes has one or more sample chambers, each of which contains one or more working electrodes, with each working electrode defining a different measurement zone. If the redox mediator is non-leachable, one or more of the working electrodes can have the appropriate chemical reagents, for example, an appropriate enzyme, to test a first analyte and one or more of the remaining working electrodes can have the appropriate chemical reagents to test a second analyte, and so on. For example, a multiple electrode sensor might include a working electrode having glucose oxidase disposed thereon to determine glucose concentration and another working electrode can have lactate oxidase disposed thereon to determine lactate concentration. [0133]
  • Multiple electrodes could also be used to improve the precision of the resulting readings. The measurements from each of the working electrodes (all of which are detecting the same analyte) can be averaged or otherwise combined together to obtain a more precise or reliable reading. In some cases, measurements could be rejected if the difference between the value and the average exceeds a threshold limit. This threshold limit could be, for example, determined based on a statistical parameter, such as the standard deviation of the averaged measurements. The average could then be recalculated while omitting the rejected values. In addition to using multiple electrode sensors to increase precision, multiple measurements could be made at each electrode and averaged together to increase precision. This technique could also be used with a single electrode sensor to increase precision. [0134]
  • One example of a multiple electrode sensor that can be used to accurately determine the volume of the measurement zones of the electrode pairs and that is also useful in reducing noise is presented herein. In this example, one of the working electrodes is prepared with a non-leachable redox mediator and a non-leachable second electron transfer agent (e.g., an enzyme). Another working electrode includes non-leachable redox mediator, but no second electron transfer agent on the electrode. An optional third working electrode has no redox mediator and no second electron transfer agent bound to the electrode. A similar configuration can be constructed using diffusible redox mediator and/or diffusible second electron transfer agent although diffusible components are not limited to being disposed on the working electrode. Preferably, the distance between the working electrodes is sufficient that redox mediator and/or enzyme do not substantially diffuse between electrodes within the measurement period (e.g., in the time period from introduction of the same sample into the sample chamber to the end of the measurement). [0135]
  • The sensor error caused by the redox mediator being in a non-uniform oxidation state prior to the introduction of the sample can be measured by concurrently electrolyzing the sample in the measurement zones that are proximate working and counter electrodes. At the first working electrode, the analyte is electrolyzed to provide the sample signal. At the second working electrode, the analyte is not electrolyzed because of the absence of the second electron transfer agent (assuming that a second electron transfer agent is necessary). However, a charge will pass (and a current will flow) due to the electrolysis of the redox mediator that was in a mixed oxidation state (i.e., some redox centers in the reduced state and some in the oxidized state) prior to the introduction of the sample and/or the shuttling of a diffusible redox mediator between the working electrode and the counter electrode. The small charge passed using this second working electrode can be subtracted from the charge passed using the first electrode pair to substantially remove the error due to the oxidation state of the redox mediator and/or to remove the background current caused by a diffusible redox mediator. This procedure also reduces the error associated with other electrolyzed interferents, such as ascorbate, urate, and acetaminophen, as well as errors associated with capacitive charging and faradaic currents. [0136]
  • The thickness of the sample chamber can be determined by measuring the capacitance, preferably in the absence of any fluid, between an electrode and its corresponding counter electrode. The capacitance of an electrode pair depends on the surface area of the electrodes, the interelectrode spacing, and the dielectric constant of the material between the plates. The dielectric constant of air is unity which typically means that the capacitance of this electrode configuration is a few picofarads (or about 100-1000 picofarads if there is fluid between the electrode and counter electrode given that the dielectric constant for most biological fluids is approximately 75). Thus, since the surface area of the electrodes are known, measurement of the capacitance of the electrode pair allows for the determination of the thickness of the measurement zone to within about 1-5%. [0137]
  • Other electrode configurations can also use these techniques (i.e., capacitance measurements and coulometric measurements in the absence of a critical component) to reduce background noise and error due to interferents and imprecise knowledge of the volume of the interrogated sample. Protocols involving one or more working electrode(s) and counter electrode(s) and one or more of the measurements described above can be developed and are within the scope of the invention. For example, only one electrode pair is needed for the capacitance measurements, however, additional electrodes can be used for convenience. [0138]
  • Fill Indicator [0139]
  • When using a sample chamber that is filled with 1 μL or less of fluid, it is often desirable to be able to determine when the sample chamber is filled. FIGS. 6A through 6C illustrate a sensor having a fill indicator structure. In particular, FIG. 6A illustrates a [0140] first substrate 500 upon which a working electrode 502 is printed. A spacer 504 (FIG. 6B), such as, for example, a layer of adhesive or a double-sided tape, is formed over the first substrate 500 and working electrode 502 with a channel 506 formed in the layer to provide a sample chamber. A second substrate 508 is printed with two counter electrodes 510, 512, as shown in FIG. 6C (inverted with respect to FIGS. 6A and 6B to show the electrode side up). Preferably, the counter electrode 510 nearest an entrance 514 of the channel 506 has a surface area within the sample chamber that is at least two times larger than the other counter electrode 512, and preferably at least five or ten times larger.
  • The sensor can be indicated as filled, or substantially filled, by observing a signal between the [0141] second counter electrode 512 and the working electrode 502 as the sensor fills with fluid. When fluid reaches the second counter electrode 512, the signal from that counter electrode will change. Suitable signals for observing include, for example, voltage, current, resistance, impedance, or capacitance between the second counter electrode 512 and the working electrode 502. Alternatively, the sensor can be observed after filling to determine if a value of the signal (e.g., voltage, current, resistance, impedance, or capacitance) has been reached indicating that the sample chamber is filled.
  • In alternative embodiments, the counter electrode or working electrode can be divided into two or more parts and the signals from the respective parts observed to determine whether the sensor has been filled. In one example, the working electrode is in a facing relationship with the counter electrode and the indicator electrode. In another example, the counter electrode, working electrode, and indicator electrode are not in a facing relationship, but are, for example, side-by-side. Typically, the indicator electrode is further downstream from a sample inlet port than the working electrode and counter electrode. [0142]
  • For side-fill sensors, such as those illustrated in FIGS. 5, 7, [0143] 8 and 11, an indicator electrode can be disposed on each side of the primary counter electrode. This permits the user to fill the sample chamber from either the left or right side with an indicator electrode disposed further upstream. This three-electrode configuration is not necessary. Side-fill sensors can also have a single indicator electrode and, preferably, some indication as to which side should be placed in contact with the sample fluid.
  • Alternately or additionally, two indicator electrodes, used in combination with one counter/reference electrode, detect when the sample chamber begins to fill and when the sample chamber has been filled to prevent partial filling of the sample chamber. The two indicator electrodes are optionally held at a different potential than the counter/reference electrode. The start and completion of filling of the sample chamber is indicated by the flow of current between the indicator and counter/reference electrodes. [0144]
  • In other instances, the potential of each of the counter/reference electrodes may be the same. When the potential at all three counter/reference electrodes is the same, for example, 0 volts, then as the measurement zone begins to fill, the fluid allows for electrical current flowt between a working electrode and the first counter/reference electrode, causing a current at the first counter/reference electrode due to the reaction of the analyte with the enzyme and the mediator. When the fluid reaches the third counter/reference electrode, another current may be measured similar to the first counter/reference electrode indicating that the measurement zone is full. When the measurement zone is full, the three counter/reference electrodes are optionally shorted together or their signals can be added or otherwise combined. [0145]
  • The indicator electrode can also be used to improve the precision of the analyte measurements. The indicator electrode may operate as a working electrode or as a counter electrode or counter/reference electrode. In the embodiment of FIGS. 6A through 6C, the [0146] indicator electrode 512 can act as a second counter or counter/reference electrode with respect to the working electrode 502. Measurements from the indicator electrode/working electrode can be combined (for example, added or averaged) with those from the first counter/reference electrode/working electrode to obtain more accurate measurements. In one embodiment, the indicator electrode operates as a second working electrode with the counter electrode or counter/reference electrode. In another embodiment, the indicator electrode operates as a second working electrode with a second counter electrode or counter/reference electrode. In still another embodiment, the indicator electrode operates as a second counter electrode or counter/reference electrode with a second working electrode.
  • The sensor or a sensor reader can include a sign (e.g., a visual sign or auditory signal) that is activated in response to the indicator electrode to alert the user that the measurement zone has been filled. The sensor or a sensor reader can be configured to initiate a reading when the indicator electrode indicates that the measurement zone has been filled with or without alerting the user. The reading can be initiated, for example, by applying a potential between the working electrode and the counter electrode and beginning to monitor the signals generated at the working electrode. [0147]
  • General Method for Manufacturing Sensors [0148]
  • Referring now to FIGS. 13A and 13B, one example of a method for making thin film sensors is described with respect to the sensor arrangement displayed in FIGS. [0149] 5A through SC, although this method can be used to make a variety of other sensor arrangements, including those described before. When the three layers of FIGS. 5A through 5C are assembled, a sensor 420 is formed.
  • In FIGS. 13A and 13B, a [0150] substrate 1000, such as a plastic substrate, is moving in the direction indicated by the arrow. The substrate 1000 can be an individual sheet or a continuous roll on a web. Multiple sensors 420 can be formed on a substrate 1000 as sections 1022 that have working electrodes 422 (FIG. 5A) thereon and sections 1024 that have counter electrode 424 and indicator electrodes 441, 442 (FIG. 5B). These working, counter and indicator electrodes are electrically connected to their corresponding traces and contact pads. Typically, working electrode sections 1022 are produced on one half of substrate 1000 and counter electrode sections 1024 are produce on the other half of substrate 1000. In some embodiments, the substrate 1000 can be scored and folded to bring the sections 1022, 1024 together to form the sensor. In some embodiments, as illustrated in FIG. 13A, the individual working electrode sections 1022 can be formed next to or adjacent each other on the substrate 1000, to reduce waste material. Similarly, individual counter electrode sections 1024 can be formed next to or adjacent each other. In other embodiments, the individual working electrode sections 1022 (and, similarly, the counter electrode sections 1024) can be spaced apart, as illustrated in FIG. 13B. The remainder of the process is described for the manufacture of multiple sensors, but can be readily modified to form individual sensors.
  • Carbon or other electrode material (e.g., metal, such as gold or platinum) is formed on the [0151] substrate 1000 to provide a working electrode 422 for each sensor. The carbon or other electrode material can be deposited by a variety of methods including printing a carbon or metal ink, vapor deposition, and other methods. The printing may be done by screen printing, gravure roll printing, transfer printing, and other known printing methods. Trace 453 and contact pad 423 are preferably applied together with working electrode 422, but may be applied in a subsequent step.
  • Similar to the working [0152] electrode 422, the counter electrode(s) 424, 441, 442 (shown in FIG. 5B) are formed on the substrate 1000. The counter electrodes are formed by providing carbon or other conductive electrode material onto the substrate. In one embodiment, the material used for the counter electrode(s) is a Ag/AgCl ink. The material of the counter electrode(s) may be deposited by a variety of methods including printing or vapor deposition. The printing may be done by screen printing, gravure roll printing, transfer printing, and other known printing methods. Traces 454, 451, 452 and contact pads 425, 443, 444 are preferably applied together with counter electrodes 424, 441, 442, but may be applied in a subsequent step.
  • Preferably, multiple sensors [0153] 420 are manufactured simultaneously; that is, the working electrodes, including their traces and contact pads, for a plurality of sensors are produced (e.g., printed) on a polymer sheet or web, and simultaneously or subsequently, the counter electrodes, and their traces and contact pads, for a plurality of sensors are produced (e.g., printed). The working electrode(s) and counter electrode(s) can be formed on separate substrates that are later positioned opposite one another so that the electrodes face each other. Alternately, to simplify registration of the substrates, the working electrodes can be formed on a first half of a substrate sheet of web and the counter electrodes are formed on a second half of the substrate sheet or web so that the sheet or web can be folded to superimpose the working and counter electrodes in a facing arrangement.
  • To provide a [0154] sample chamber 426, a spacer 433 is formed over at least one of the substrate/working electrode and substrate/counter electrode(s). The spacer 433 is preferably an adhesive spacer, such as a single layer of adhesive or a double-sided adhesive tape (e.g., a polymer carrier film with adhesive disposed on opposing surfaces). Suitable spacer materials include adhesives such as urethanes, acrylates, acrylics, latexes, rubbers and the like.
  • A channel, which will result in the sample chamber, is provided in the [0155] spacer 433, either by cutting out a portion of the adhesive spacer or placing two adhesive pieces in close proximity but having a gap therebetween. The adhesive can be printed or otherwise disposed on the substrate according to a pattern which defines the channel region. The adhesive spacer can be optionally provided with one or more release liners prior to its incorporation into the sensor. The adhesive can be cut (e.g., die-cut or slit) to remove the portion of the adhesive corresponding to the channel prior to disposing the spacer on the substrate.
  • In one method of the invention, illustrated in FIGS. 14A through 14G, the adhesive includes a first and a second release liner. Prior to applying the adhesive to a first substrate/working electrode or substrate/counter electrode(s), the adhesive is “kiss-cut” through the first release liner and at least a portion of the underlying adhesive, preferably the entire adhesive but not through the second release liner, to form one or more sections, one of which will eventually result in a sample chamber. The first release liner is removed from the adhesive over its length but is retained over the sample chamber section. The exposed adhesive is then applied to the first substrate/working electrode or substrate/counter electrode(s). On removal of the second release liner, the adhesive positioned within the sample chamber sections is also removed, leaving a channel or opening in the adhesive spacer. The second substrate/working electrode or substrate/counter electrode(s) is then applied to the adhesive to form the layered sensor structure. [0156]
  • FIGS. 14A through 14G describe in detail the processing of an adhesive layer by a “kiss-cut”. An adhesive layer that will eventually become [0157] spacer 433 is preferably obtained from an adhesive structure including an adhesive layer 1030 between a first release liner 1020 and a second release liner 1040. A blade (e.g., a knife or die blade) cuts through the first release liner 1020 and at least a portion of the adhesive layer 1030, but not through the second release liner 1040, as shown in FIG. 14B and 14G, to form release liner sections 1020 a, 1020 b, and adhesive sections 1030 a, 1030 b. The space occupied by 1030 b is the area that will result in the sample chamber of the sensor and can be referred to as “sample chamber region”. A cut configuration such as shown in FIG. 14G allows removal of one release liner section 1030 a, leaving behind release liner section 1030 b. The liner could be cut to provide individual strips extending the entire length of the liner; this would then need removal of each individual liner strip.
  • The [0158] release liner section 1030 a is removed to provide the adhesive configuration shown in FIGS. 14C. The exposed adhesive is positioned over and securely adhered to the substrate 1050, as illustrated in FIG. 14D. The adhesive sections 1030 a without the release liner will adhere to the substrate 1050. As shown in FIG. 14E, the second release liner 1040 is removed, pulling the cut and non-adhered section of adhesive 1030 b and the first liner 1020 b with it; this results in adhesive areas 1030 a providing spacer layer sections 433 a, 433 b, with sample chamber 426 therebetween, as illustrated in FIG. 14F. The second substrate is then positioned over the adhesive layer and laminated to the first substrate via the spacer 433. The thickness of the spacer 433 typically determines the spacing between the working and counter electrodes, and thus impacts the volume of the sample chamber 426. Preferably, the thickness does not vary more than ±5% over the individual sensor and/or among individual sensors in a batch. Use of the “kiss-cut” method for manufacturing the layered sensor structure preserves the integrity of the sample chamber walls during manufacturing, thereby providing for more reliable and reproducible sample chamber volumes.
  • The non-leachable or diffusible redox mediator and/or second electron transfer agent are disposed onto the substrate in at least the sample chamber regions. If either or both of these components is non-leachable, that component or components is preferably disposed on the working electrode. If either or both of these components is diffusible, that component or components can be disposed on any surface of the substrate in the channel region. The redox mediator and/or second electrode transfer agent can be disposed independently or together on the substrate prior to or after disposition of the spacer. The redox mediator and/or second electrode transfer agent may be disposed by a variety of methods including, for example, screen printing, ink jet printing, spraying, painting, striping along a row or column of aligned and/or adjacent electrodes, and the like. Other components can be deposited separately or together with the redox mediator and/or second electrode transfer agent; these components can include, for example, surfactants, polymers, polymer films, preservatives, binders, buffers, and cross-linkers. [0159]
  • After disposing the spacer, redox mediator, second electron transfer agent, sensing layers, and the like, the first and second substrates (having the working and counter electrodes thereon) are positioned opposite each other to form the sensor. The faces of the substrate are joined by the adhesive of the spacer. Preferably, after bringing the faces together, individual sensors are cut out from the web of sensors using a variety of methods including, for example, die cutting, slitting, or otherwise cutting away the excess substrate material and separating the individual sensors. In some embodiments, a combination of cutting or slitting methods is used. As another alternative, the individual sensor components can first be cut out of the substrates and then brought together to form the sensor by adhesively joining the two components, such as by using the spacer adhesive. [0160]
  • The sides of the sensor can be straight to allow the sensor to be cut out from the remainder of the substrate and/or from other sensors by slitting the substrate in parallel directions using, for example, a gang arbor blade system. The edges of the sensor can define edges of the sample chamber and/or measurement zone. By accurately controlling the distance between cuts, variability in sample chamber volume can often be reduced. In some instances, these cuts are preferably parallel to each other, as parallel cuts are typically the easiest to reproduce. [0161]
  • Sensor Connection to Electrical Device [0162]
  • Referring generally now to FIGS. 16A and 16B, [0163] 17A and 17B, and 18A and 18B, the assembled sensor of FIGS. 5A through 5C (as will be referred to as sensor 1420) is typically coupled to a meter or other electrical device by electrical connector 1500 which is configured to couple with and contact the end of the sensor 1420 at contact pads 423, 425, 443, 444. The sensor meter typically includes a potentiostat or other component to provide a potential and/or current for the electrodes of the sensor. The sensor reader also typically includes a processor (e.g., a microprocessor or hardware) for determining analyte concentration from the sensor signals. The sensor meter also includes a display or a port for coupling a display to the sensor. The display displays the sensor signals and/or results determined from the sensor signals including, for example, analyte concentration, rate of change of analyte concentration, and/or the exceeding of a threshold analyte concentration (indicating, for example, hypo- or hyperglycemia).
  • One example of a suitable connector is shown in FIGS. 16A and 16B, [0164] 17A and 17B, and 18A and 18B. Connector 1500 (which is used to connect a sensor to a meter or other electrical device) is generally a two part structure, having top portion 1510 and bottom portion 1520 (see FIG. 16B). Positioned between and secured by top portion 1510 and bottom portion 1520 are contact leads 1423, 1425, 1443, 1444 that provide electrical connection between the sensor 1420 and a meter. These leads 1423, 1425, 1443, 1444 have proximal ends to physically contact pads 423, 425, 443, 444 (in FIGS. 5A and 5B, respectively) and distal ends to connect to any attached meter. The end of the sensor 1420 which has the contact pads can be slid into or mated with the connector 1500 by placing the sensor 1420 into slide area 1530, which provides a support for and retains sensor 1420. It is typically important that the contact structures of the connector 1500 make electrical contact with the correct pads of the sensor so that the working electrode and counter electrode(s) are correctly coupled to the meter.
  • One optional feature is an [0165] insertion monitor 1450, that is illustrated in FIGS. 16A and 16B, which are top views of the sensor prior to insertion into connector 1500. This conductive insertion monitor is positioned on the non-conductive base substrate and has a contact pad for electrical contact with a connector. The insertion monitor is configured and arranged to close an electrical circuit between two contact structures 1451 and 1452 when the sensor is properly inserted into the connector. Proper insertion into the connector 1500 means that the sensor strip 1420 is inserted right side up, that the correct end of the strip is inserted into the connector, and that the strip is inserted far enough into the connector that reliable electrical connections are made between the electrodes' contact pads on the strip and the corresponding contact structures of the connector. Preferably, no closed circuit is made unless all electrode pads have properly contacted the contact structures of connector 1500. The insertion monitor may have shapes other than a stripe across the width of the sensor; for example, other designs include an individual dot, a grid pattern, or may include stylistic features, such as words or letters.
  • Because this [0166] insertion monitor 1450 is not at the end with the contact regions for the electrodes, the insertion monitor 1450 does not require additional width space on the sensor. The width of the contact pads 443, 425, 444, 423 is defined as the width on which a lead could be placed that would result in an electrical connection; typically, the contact width is the width of the exposed contact area. In one embodiment, six contact lead structures on the connector (i.e., 1451, 1443, 1425, 1444, 1423, 1452) can contact sensor 1420 in the same width as the four contact pads (i.e., 443, 425, 444, 423). This concept of having contact points on the sensor that occupy more width than the width of the sensor may be used for any number of contact points; this may be used with or without an insertion monitor.
  • As a particular example, four leads [0167] 1443, 1425, 1444, 1423 make contact with contact pads 443, 425, 444, 423. If each lead and/or contact pad is one millimeter wide, a sensor of at least 4 mm wide is needed to make contact. Additional leads, such as those for insertion monitor 1450 (i.e., contact leads 1451, 1452), can make contact by having leads 1451, 1452 extend along the side of leads 1443 and 1423 and then angle in toward the center of the strip 1420 after the point where leads 1443, 1425, 1444, 1423 contact strip 1420. The insertion monitor stripe leads 1451, 1452 cross side edges of sensor 1420 to make contact with the sensor, thus not requiring additional sensor width.
  • The contact structures are parallel and non-overlapping and they run longitudinally from the distal end to the proximal end. The [0168] lead structures 1443, 1425, 1444, 1423 terminate at their proximal end, but lead structures 1451, 1452 continue longitudinally past the proximal end of lead structures 1443, 1425, 1444, 1423. Once past the proximal end, lead structures 1452, 1452 angle in toward the center of the sensor strip.
  • The insertion monitor can also be used to encode information on a test strip. The encoded information can be, for example, calibration information for that manufacturing lot or for that specific strip. Such calibration information may relate to the sensitivity of the strip or to the y-intercept of its calibration curve. In one embodiment, the insertion monitor comprises two or more contact pads for connection to a meter. The two or more contact pads are connected to each other by a conductive material, such as a conductive ink. The resistance of conductive path between the two or more contact pads is related to the encoded information. As an example of discrete calibration values, resistance values in a given range can correspond to one calibration setting, and resistance values in a different range can correspond to a different calibration setting. As an example of continuous calibration values, the calibration setting may be a continuous function of the resistance. Examples of suitable conductive pathways between contact pads are shown in FIGS. 19A through 19L. [0169]
  • In FIGS. [0170] 19A-19F, multiple conductive pathways with different resistances are printed on the strip. The resistance of the pathway is varied by cutting or scoring some or all of the conductive pathways so that they do not carry charge. In FIGS. 19G-19L, the resistance is controlled by the width or length of the conductive path. While it is preferred to provide this encoded information on the insertion monitor, it should be recognized that the insertion monitor function and the encoding of information can also be implemented separately using separate conductive traces on the strip.
  • In another embodiment to ensure proper insertion of a sensor into a meter, the meter may include a raised area or bump that prevents or hinders the insertion of the sensor in an improper direction, as shown in FIG. 20. To ensure proper insertion of the [0171] sensor 1100 into a connector 1110, the connector 1110 may include a raised area 1140 that prevents or hinders the insertion of the sensor in an improper direction. For example, the width, w2, of the contact region of the second substrate 1130 may be wider than the width, w1, of the contact region of the first substrate 1120. In this instance, the raised area 1140 is positioned to allow sensor 1100 to be slid into the connector so that the first substrate 1120 is next to the surface 1150 from which the raised area 1140 protrudes, but would prevent or hinder having the second substrate 1130 next to the surface 1150 from which the raised area 1140 protrudes. Objects other than a raised area can also be used to guide the user in correct introduction of the sensor into the meter.
  • Integrated Sample Acquisition and Analyte Measurement Device [0172]
  • An analyte measurement device constructed according to the principles of the present invention typically includes a sensor, as described hereinabove, combined with a sample acquisition apparatus to provide an integrated sampling and measurement device. The sample acquisition apparatus typically includes, for example, a skin piercing member, such as a lancet, that can be injected into a patient's skin to cause blood flow. In a preferred embodiment, the integrated sample acquisition and analyte measurement device comprises a lancing instrument that holds a lancet and measurement strip. The lancing instrument preferably requires active cocking. By requiring the user to cock the device prior to use, the risk of inadvertently triggering the lancet is minimized. Preferably, the lancing instrument will also permit the user to adjust the depth of penetration of the lancet into the skin. Such devices are already commercially available from companies such as Boehringer Mannheim and Palco. This feature allows users to adjust the lancing device for differences in skin thickness, skin durability, and pain sensitivity across different sites on the body and across different users. [0173]
  • Typically, a larger sample of body fluid such as blood or interstitial fluid is expressed when pressure is applied around a site where a hole has been created the skin. A sample acquisition device having a protruding ring, such as illustrated in FIG. 21, may be used. [0174] Ring 1200 circumferentially surrounds the lancing site to create increased pressure and extract a larger sample out of the wound. A lancet would protrude from the center 1220 of ring 1200. Ring 1200 has a surface area 1210 that presses against the skin, thus increasing the tension on the skin and often providing a bump of skin. Skin that is more taught, and even extended, provides a large volume of fluid from the wound. The increased surface area 1210 and tighter skin provided by ring 1200, decreases the amount of pain experienced by the patient during the lancing. Further, the tendency to bruise is typically decreased.
  • In one embodiment, the lancing instrument and the meter are integrated into a single device. To operate the device the user need only insert a disposable cartridge containing a measurement sensor and lancing device into the integrated device, cock the lancing instrument, press it against the skin to activate it, and read the result of the measurement. Such an integrated lancing instrument and test reader simplifies the testing procedure for the user and minimizes the handling of body fluids. [0175]
  • Operation of the Sensor and Meter [0176]
  • An electrochemical sensor of the invention can be operated with or without applying a potential across the electrodes. In one embodiment, the electrochemical reaction occurs spontaneously and a potential need not be applied between the working and counter electrodes. In another embodiment, a potential, which may or may not remain constant, is applied between the working and counter electrodes. The magnitude of the required potential depends on the redox mediator used. The potential at which the electrode poises itself, or where it is poised by applying an external bias, and where the analyte is electrolyzed, is typically such that the electrochemical reaction is driven to or near completion, but it is, preferably, not oxidizing enough to result in significant electrochemical reaction of interferents, such as urate, ascorbate, and acetaminophen, that can affect the signal measured. For non-leachable redox mediators, the potential is typically between about −350 mV and about +400 mV versus the standard calemel electrode (SCE). Preferably, the potential of the redox mediator is more negative than +100 mV, more preferably the potential is more negative than 0 mV, and most preferably the potential is about −150 mV versus SCE. [0177]
  • When an external potential is applied, it can be applied either before or after the sample has been placed in the sample chamber. If the measurement zone includes only a portion of the sample chamber then the potential is preferably applied after the sample has come to rest in the sample chamber to prevent electrolysis of sample passing through the measurement zone as the sample chamber is filling. Alternatively, in the case where the measurement zone includes most or all of the sample chamber, the potential can be applied before or during the filling of the sample chamber without affecting the accuracy of the assay. When the potential is applied and the sample is in the measurement zone, an electrical current will flow between the working electrode and the counter electrode. The current is a result, at least in part, of the electrolysis of the analyte in the sample. This electrochemical reaction occurs via the redox mediator and the optional second electron transfer agent. For many biomolecules, B, the process is described by the following reaction equations: [0178] n A ( ox ) + B enzyme n A ( red ) + C ( 1 )
    Figure US20020084196A1-20020704-M00001
    nA(red)→nA(ox)+ne   (2)
  • Biochemical B is oxidized to C by redox mediator A in the presence of an appropriate enzyme. Then the redox mediator A is oxidized at the electrode. Electrons are collected by the electrode and the resulting current is measured. The measured current may also include a background current resulting in a measured background charge, due, at least in part, to the shuttling of a diffusible redox mediator between the working electrode and the counter electrode. This background current can be minimized or accounted for, as described in PCT Application PCT/US99/23425, incorporated herein by reference. [0179]
  • A variety of techniques can be used to determine the concentration of an analyte in a sample. These techniques include, for example, coulometry, amperometry, and potentiometry. To determine the concentration of analyte (e.g., glucose) in the sample by coulometry, the charge passing or projected to pass between the working electrode(s) and counter electrode(s) during electrolysis of the analyte is determined. Knowledge of the charge and the volume of the sample chamber permit the calculation of the concentration of the electrolyzed analyte in the sample. This charge can be determined by several methods. [0180]
  • For example, the charge can be measured directly. This can be accomplished using a coulometer and known coulometric techniques. Typically, the charge is measured during the complete or nearly complete electrolysis of the analyte. [0181]
  • As another example, the charge can be determined from measurements of the electrolysis current, it, over time, t. A series of currents (i[0182] x, ix+1, ix+2, . . . ) is measured for a series of times (tx, tx+1, tx+2, . . . ). The current can then be integrated (e.g., numerically integrated using known numerical methods) to give the charge. In some instances, current can be measured during the entire electrolysis. In other instances, current can be extrapolated after a period of time and the charge determined using a combination of the measured currents and extrapolated currents.
  • Extrapolation of current utilizes a projected relationship between current and time during at least a portion of the electrolysis. Typically, when the system is diffusion limited, the natural logarithm of the current is linearly related to the time. This typically occurs after a period of time during which the sensor “equilibrates”. FIG. 15A is an example of a graph of current versus time for electrolysis of an analyte, such as glucose, in one of the previously described sensors; FIG. 15B is a graph of the natural logarithm of current versus time for the same data. After the sample completely fills the sample chamber, the current increases to a peak current value, designated as “P” in FIGS. 15A and 15B, during which time the sensor is equilibrating. The peak current typically occurs during a period of time in which the system is kinetically, rather than diffusionally, limited. Typically, the current then begins to decrease, although, in some instances, further increases may occur before the current becomes diffusion limited. Eventually, the current values enter a region, designated as “L” in FIG. 15B, where there is a linear relationship between the natural logarithm of current and time. The remaining current needed to electrolyze a remaining portion of the analyte can then be extrapolated using estimation methods, such as nonlinear or, preferably, linear estimation methods (e.g., linear least squares techniques). The region where extrapolation occurs is designated as “E” in FIG. 15B and the extrapolation is indicated as a solid line. [0183]
  • For this discussion, the current values being referred to are the absolute value of the actual current, thus, the sign of the current measurement is ignored. For example, the peak current is the largest deviation from zero current, whether positive or negative. [0184]
  • During the period when the system is diffusion limited the relationship between the natural logarithm of the current and time is linear. The remaining charge required to completely electrolyze the analyte remaining in the sample can be reliably estimated from the slope of this line. Care must be taken to ensure that the system is in the diffusion limited range before performing the estimation. One method of ensuring that the system is in the diffusion limited regime includes observing the current values until the peak current, i[0185] peak, (“P”) is achieved. Current values continue to be observed until the current drops below a threshold value, ithresh, that is typically a fraction of the peak current. For example, the threshold value can be one half, one third, or one quarter of the peak current (e.g., ithresh=j*ipeak where j is, for example, 0.5, 0.33, or 0.25). The threshold value is chosen based on the characteristics of the sensor so that one has a high degree of confidence that the system will be diffusion limited at this time.
  • Many other methods may be used to ensure that the system is in a diffusion limited regime. For example, one could observe the current values after i[0186] peak until an inflection point is reached and the second derivative of the natural log of the current turns positive. At this point the system is typically in a diffusion limited regime.
  • After achieving the threshold value, slope values are determined using natural logarithms of two or more of the measured current values (e.g., m[0187] x=(log(ix)−log(ix−y))/(tx−tx−y) where mx is the slope at time tx, ix is the current at time tx, and ix−y is the current at time tx−y before tx). Although the slope can be determined using natural logarithms of any two current values (e.g., current values measured one directly after the other), preferably the slope is determined using natural logarithms of multiple consecutive current values or current values that are spaced apart by at least about ten (i.e., y=10), and, preferably, at least about thirty (i.e., y=30), current values. This procedure can reduce the effect of random noise in the system. Optionally, the consistency of multiple slope values (e.g., three or five or ten slope values) can be observed for verification. For example, the system can look for ten monotonically decreasing slope values before accepting the slope value for use in the estimation.
  • The determined slope value is used to extrapolate the charge required to completely electrolyze the analyte remaining in the sample. That is, the current is extrapolated to zero current. Known extrapolation techniques (e.g., linear extrapolation techniques) can be used. The total charge required to electrolyze the analyte is determined by adding the measured charge and extrapolated charge. [0188]
  • Current values (or other measured values) can also be used to monitor the operation of the sensor and meter. For example, ratios of current values can be checked to determine if there has been some failure of the measurement (e.g., the sensor has been pulled out of the measuring device, etc.). The acceptable ratio range will typically depend on the type and components of the sensor, the rate at which measurements are made, and the acceptable noise level. As an example, an acceptable ratio range could be, for example, 2:1 to 1:2 for immediately adjacent measurements. [0189]
  • The discussion above has focused on the extrapolation of charge required to complete electrolysis of an analyte in a sample using the slope of the natural logarithm of current versus time under diffusion limited conditions. Those skilled in the art will recognize that this slope is related to a Effective Diffusion Coefficient, and that other linear or non-linear mathematical functions related to the Effective Diffusion Coefficient can also be used to extrapolate the charge. [0190]
  • The extrapolation of current measurements and the determination of charge passed or projected to pass, as well as the concentration of the analyte, and other functions can be performed by a processor with or without a storage medium, in which the desired procedures are performed by software, hardware, or a combination thereof. According to another embodiment, these same procedures are accomplished using discrete or semi-programmable hardware configured, for example, using a hardware descriptive language, such as Verilog. In yet another embodiment, the procedures are performed using a processor having at least one look-up table arrangement with data stored therein to represent the complete result or partial results of the above equations based on a given set of input data. [0191]
  • Current measurements can be made by a variety of methods. For example, the current measurements can be made by measuring the current directly using any known techniques and devices. [0192]
  • Another method of measuring current includes discharging a known amount of charge into the sample (by electrolysis of the analyte) and measuring the time required for the discharge. Current is then calculated as the quotient of charge and discharge time. As an example, a capacitor can be charged by circuitry in the meter and then coupled to the working or counter electrode(s) to discharge by electrolysis of the analyte. The time to discharge to a threshold level can be measured using, for example, a clock circuit that is part of the processing circuitry of the meter. The use of a clock circuit permits very accurate measurements of time. This can be advantageous over designs that directly measure current or charge and must convert these analog measurements to processible digital representations using the more expensive A/D (analog-to-digital) converters. [0193]
  • The accuracy of the charge and time measurement, which provides the current values, affects the accuracy of the final analyte concentration measurement. Although it is desired to use a high-quality and highly accurate measuring device, the capacitor used to store the charge can be a high-quality, expensive capacitor that has a precisely known capacitance. Alternatively, an accurate charge measurement can be obtained by using a calibrating resistor in parallel with the capacitor. During a calibration period, the capacitor discharges through the resistor and the current through the resistor or the time constant of the discharge can be determined. This can then be used to determine the charge stored in the capacitor. A high-quality, very accurate resistor is typically less expensive than a similarly accurate capacitor, and will provide the same amount of accuracy to the charge measurement. [0194]
  • The charge, Q, no matter how determined, is then used to calculate the concentration of the analyte (C[0195] A) by the following equation (when the redox mediator is non-leachable):
  • C A =Q/nFV  (3a)
  • where n is the number of electron equivalents required to electrolyze the analyte, F is Faraday's constant (approximately 96,500 coulombs per equivalent), and V is the volume of sample in the measurement zone. When using a diffusible mediator, the concentration of the analyte can be obtained from the following equation:[0196]
  • C A=(Q tot −Q back)/nFV  (3b)
  • where Q[0197] tot is the total charge transferred during the measurement and Qback is the amount of charge transferred that was not due to the analyte, e.g., charge transferred by the shuttling of the diffusible mediator between the working electrode and the counter electrode. In at least some instances, the sensor is constructed so that the background charge is at most 5 times the size of the charge generated by electrolysis of an amount of analyte. Preferably, the background signal is at most 200%, 100%, 50%, 25%, 10%, or 5% of the charge generated by electrolysis of the analyte.
  • One example of a method for determining the ratio of background signal to signal generated by electrolysis of the analyte is described as follows. If the shuttling of the redox mediator is not disabled by the applied potential, the charge that results from the shuttling may be represented by the following formula:[0198]
  • Q back (AFD M C M /d)(tn M)
  • where A is the area of the working electrode; F is Faraday's constant (96,500 coulombs/equivalent); D[0199] M is the effective diffusion coefficient of the redox mediator; CM is the concentration of the redox mediator in the measurement zone; d is the distance separating facing electrodes; t is the amount of time for the measurement; and nM is the number of electrons gained or lost by the redox mediator.
  • Additionally, the charge of the analyte, when the analyte is electrooxidized to about 90% completion in the measurement period, may be represented by the following formula:[0200]
  • Q G =Ad(0.90)C G n GF
  • where A is the area of the working electrode; d is the distance separating facing electrodes; C[0201] G is the concentration of glucose; n is the number of electrons needed to electrolyze the analyte (e.g., 2 electrons per glucose molecule); and F is Faraday's constant. For glucose, when CG is 5 mM (or 5×10−6 moles/cm3), t is 60 seconds, nG is 2, and nM is 1, the ratio of charge from the redox mediator to the charge from electrooxidation of the analyte may be represented by the following formula:
  • Q Back /Q G=(D M C M /d 2)(tn M/(0.9n G C G))=(D M C M /d 2)×(6.7×106)
  • For example, if the ratio of Q[0202] Back/QG is 5, then (DMCM)/d2 is 7.5×10−7 moles/(cm3 sec). Also for example, if the ratio of QBack/QG is 1, then (DMCM)/d2 is 1.5×10−7 moles/(cm3 sec). Still another example, if the ratio is 0.1, then (DMCM)/d2 is 1.5×10−8 moles/(cm3 sec). Thus, depending on the ratio desired, a sensor may be configured to have the desired ratio by choosing DM, CM, and d accordingly.
  • The ratio can be affected, for example, by reducing the concentration of the redox mediator (i.e., C[0203] M may be reduced). Alternatively, or additionally, the diffusion of the redox mediator may be reduced. Other sensor configurations are also suitable for controlling the ratio of background signal to signal generated by the analyte and will be described below.
  • The background charge, Q[0204] back, can be accounted for in a variety of ways. Qback can be made small, for example, by using only limited amounts of diffusible redox mediator; by providing a membrane over the counter electrode that limits diffusion of the redox mediator to the counter electrode; or by having a relatively small potential difference between the working electrode and the counter electrode. Other examples of sensor configurations and methods suitable for reducing Qback include having a redox mediator reaction rate at the working electrode that is significantly faster than that at the counter electrode; immobilizing the redox mediator on the working electrode; having the redox mediator become immobilized on the counter or counter/reference electrode upon its reaction at the counter or counter/reference electrode; or slowing the diffusion of the redox mediator.
  • For coulometric measurements, at least 20% of the analyte is electrolyzed, preferably at least 50%, more preferably at least 80%, and even more preferably at least 90% of the analyte is electrolyzed. In one embodiment of the invention, the analyte is completely or nearly completely electrolyzed. The charge can then be calculated from current measurements made during the electrochemical reaction, and the concentration of the analyte is determined using equation (3a) or (3b). The completion of the electrochemical reaction is typically signaled when the current reaches a steady-state value. This indicates that all or nearly all of the analyte has been electrolyzed. For this type of measurement, at least 90% of the analyte is typically electrolyzed, preferably, at least 95% of the analyte is electrolyzed and, more preferably, at least 99% of the analyte is electrolyzed. [0205]
  • For coulometry, it is typically desirable that the analyte be electrolyzed quickly. The speed of the electrochemical reaction depends on several factors, including the potential that is applied between the electrodes and the kinetics of reactions (1) and (2). Other significant factors include the size of the measurement zone. In general, the larger the potential, the larger the current through the cell and therefore, the faster the reaction will typically occur. However, if the potential is too large, other electrochemical reactions may introduce significant error in the measurement. Typically, the potential between the electrodes as well as the specific redox mediator and optional second electron transfer agent are chosen so that the analyte will be almost completely electrolyzed in less than 5 minutes, based on the expected concentration of the analyte in the sample. Preferably, the analyte will be almost completely electrolyzed within about 2 minutes and, more preferably, within about 1 minute. [0206]
  • Although coulometry has the disadvantage of requiring the volume of the measured sample be known, coulometry is a preferred technique for the analysis of the small sample because it has the advantages of, for example, no temperature dependence for the measurement, no enzyme activity dependence for the measurement, no redox-mediator activity dependence for the measurement, and no error in the measurement from depletion of analyte in the sample. As already described above, coulometry is a method for determining the amount of charge passed or projected to pass during complete or nearly complete electrolysis of the analyte. One coulometric technique involves electrolyzing the analyte on a working electrode and measuring the resulting current between the working electrode and a counter electrode at two or more times during the electrolysis. The electrolysis is complete when the current reaches a steady state. The charge used to electrolyze the sample is then calculated by integrating the measured currents over time and accounting for any background signal. Because the charge is directly related to the amount of analyte in the sample there is no temperature dependence of the measurement. In addition, the activity of the enzyme does not affect the value of the measurement, but only the time required to obtain the measurement (i.e., less active enzyme requires a longer time to achieve complete electrolysis of the sample) so that decay of the enzyme over time will not render the analyte concentration determination inaccurate. And finally, the depletion of the analyte in the sample by electrolysis is not a source of error, but rather the objective of the technique. (However, the analyte need not be completely electrolyzed if the electrolysis curve is extrapolated from the partial electrolysis curve based on well-known electrochemical principles.) [0207]
  • It may be desirable in some instances to utilize non-coulometric assays, such as amperometric or potentiometric measurement techniques. “Amperometry” and “chronopotentiometry” refer to taking a potentiometric measurement at one or more points in time. These measurement techniques are useful when the volume of the measured sample is unknown; the volume of the sample in the measurement zone of a small volume sensor (i.e., no more than one microliter) may be difficult to accurately reproduce if the manufacturing tolerances of one or more dimensions of the measurement zone have significant variances. For information regarding using non-coulometric measuring, such as amperometric and potentiometric techniques, see, for example, U.S. application Ser. No. 09/295,962, filed Apr. 21, 1999, incorporated herein by reference in its entirety. [0208]
  • Heating of Sample [0209]
  • The sample can be heated to increase the rate of diffusion, oxidation, or reduction of the analyte. This heating can be accomplished by a variety of techniques including placing the sensor in a heated environment or applying a heating unit to the sensor. [0210]
  • Another technique includes providing a thermal heating element, such as, for example, a wire or an ink that is capable of converting electrical energy into heat energy, on the sensor. This wire or ink can be applied, for example, on the opposite side of a base material, such as a polymer film, from one or more of the working, counter, reference, or counter/reference electrodes, or applied around the periphery of the working, counter, reference, or counter/reference electrodes. In some instances, the sample is heated up to 5 to 20° C. above an initial temperature. In other instances, the temperature of the sample may not be known but a constant amount of power or current is applied to the wire or ink. [0211]
  • General Examples [0212]
  • The invention will be further characterized by the following general examples. These examples are not meant to limit the scope of the invention which has been fully set forth in the foregoing description. Variations within the concepts of the invention are apparent to those skilled in the art. [0213]
  • One method for manufacturing the sensor shown in FIGS. 5A through 5C, having a working electrode, multiple counter/reference electrodes, and a side filled sample chamber, is described below. According to the method described herein, a plurality of sensors are produced and then separated. [0214]
  • A first non-conducting substrate, preferably polyester, is provided. A conductive carbon ink, such as that available from Ercon of Wareham, Mass. under the trade designation “Graphite #G4491”, is screen printed onto a first half of the first polymeric substrate in the pattern shown in FIG. 5A and dried, to provide the working [0215] electrode 422, trace 453 and contact pad 423. Once the substrate web is cut to the final size, each working electrode 422 will extend across the width of the sensor and have a trace 453 that extends to the far end of the sensor. As an example, a sensor can be made with a width of about 6.1 mm (0.240 inch). Typical sensor widths are about 2 mm to 20 mm, preferably about 4 mm to 10 mm, but wider or narrower sensors can be used as desired.
  • A sensing layer, as described in U.S. patent application Ser. No. 09/295,962, comprising a diffusible mediator and diffusible glucose dehydrogenase enzyme, is applied to the working electrode in a sample chamber region. The sensing layer can be provided on the electrode prior to or subsequent to providing the sample chamber. On the other half of the polyester substrate, a conductive silver/silver chloride ink, such as that commercially available from Ercon under the trade designation “Silver/Silver Chloride #R414”, is screen printed onto a second half of the first polymeric substrate in the pattern shown in FIG. 5B and dried. In the embodiment shown in FIG. 5B, the Ag/AgCl ink provides a first indicator or [0216] reference electrode 441, a counter electrode 424, and a second indicator electrode 442. Counter electrode may extend across the entire sensor surface, or may extend only a portion thereof. As an example, the width of a counter electrode is about 1 mm to 20 mm, preferably about 2 to 10 mm. In one sensor configuration, the counter electrode 424 has a width of about 3.71 mm (0.146 inch). The indicator electrodes can have a width, for example, of about 0.1 mm to 5 mm, preferably about 0.25 mm to about 1 mm.
  • In one sensor configuration, working electrode, such as working [0217] electrode 422 shown in FIG. 5A, extends the width of the sensor, which is about 6.1 mm (0.240 inch). A counter electrode, such as counter electrode 424, has a width of about 3.71 mm (0.146 inch). Indicator electrodes, such as indicator electrodes 441, 442 in FIG. 5B, each can have a width of about 0.51 mm (0.020 inch). A spacing of 0.30 mm (0.012 inch) is present between these indicator electrodes and the counter electrode. The indicator electrodes may be each set back from the eventual side edge of the sensor strip, for example, by approximately 0.38 mm (0.015 inch), so that the electrodes 441, 442 are not damaged, for example, smeared, streaked, chipped or the like, by the process of slitting the substrate into individual sensors.
  • The invention has been described with reference to various specific and preferred embodiments and techniques. However, it will be apparent to one of ordinarily skill in the art that many variations and modifications may be made while remaining within the spirit and scope of the invention. [0218]
  • All publications and patent applications in this specification are indicative of the level of ordinary skill in the art to which this invention pertains. All publications and patent applications are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually incorporated by reference. [0219]

Claims (22)

We claim:
1. A sensor comprising:
a first substrate having a first major surface and a second major surface opposing the first major surface;
a second substrate having a first major surface and a second major surface opposing the first major surface, the first and second substrates being disposed so that the first major surface of the first substrate is in facing relationship with the first major surface of the second substrate;
a working electrode disposed on the first major surface of the first substrate;
a counter electrode disposed on the first major surface of one of the first substrate and the second substrate; and
an insertion monitor disposed on the second major surface of one of the first substrate and the second substrate, the insertion monitor being configured and arranged to provide a path for electrical current between at least two contact leads of a meter for indication that the sensor has been properly inserted into the meter.
2. The sensor according to claim 1, wherein the insertion monitor is disposed on the second major surface of the first substrate.
3. The sensor according to claim 1, wherein the counter electrode is disposed on the first major surface of the second substrate.
4. The sensor according to claim 1, wherein the sensor has a width, and the insertion monitor is a conductive stripe extending across the width of the sensor.
5. The sensor according to claim 1, wherein the insertion monitor has two or more contact regions for electrical contact with the meter.
6. The sensor of claim 1, wherein the insertion monitor is configured and arranged to provide encoded information about the strip.
7. A sensor strip comprising:
a first substrate having a first major surface and a second major surface opposing the first major surface;
a second substrate having a first major surface and a second major surface opposing the first major surface, the first and second substrates being disposed so that the first major surface of the first substrate is in facing relationship with the first major surface of the second substrate;
a working electrode disposed on the first major surface of the first substrate;
a counter electrode disposed on the first major surface of one of the first substrate and the second substrate; and
a plurality of contact pads disposed on the first and second substrates, at least one of the contact pads being in electrical communication with the working electrode and at least one other contact pad being in electrical communication with the counter electrode, wherein each contact pad has a contact pad width measured parallel to a width of the first and second substrates, and wherein the sum of the contact pad widths is greater than the width of the first substrate and greater than the width of the second substrate.
8. The sensor strip of claim 7 wherein the plurality of contact pads are disposed on at least three of the following surfaces: the first major surface of the first substrate, the second major surface of the first substrate, the first major surface of the second substrate, and the second major surface of the second substrate.
9. A connector comprising:
a plurality of contact structures for releasable connection to an electrochemical analyte sensor, wherein each contact lead comprises
a proximal end for electrical connection to a sensor contact, and
a distal end for electrical connection to an electrical device; and
wherein the plurality of contact leads comprises
one or more first contact leads extending longitudinally from the distal end to the proximal end, and
one or more second contact leads extending longitudinally from the distal end past the proximal end of the one or more first contact leads and angling toward a longitudinal center line of the sensor.
10. The connector of claim 9, wherein the connector comprises at least two second contact leads to make electrical contact with a single conductive surface of the sensor.
11. The connector of claim 10, wherein the first contact leads are configured and arranged to contact at least one of a working electrode and a counter electrode of a sensor, and wherein the second contact leads are configured and arranged to contact an insertion monitor of a sensor.
12. A method for the manufacture of a sensor comprising the steps of:
providing an adhesive having first and second surfaces covered with first and second release liners;
cutting through the first release liner but not through the second release liner to define a plurality of sample chamber regions;
removing a portion of the first release liner to expose a portion of the first adhesive surface leaving a remaining portion of the first release liner over the sample chamber regions;
applying the exposed first adhesive surface to a first substrate;
removing the second release liner together with the adhesive and first release liner of the sample chamber regions to expose the second adhesive surface and to expose the first substrate in the sample chamber region; and
applying a second substrate over the second adhesive surface forming a sample chamber in the sample chamber region, wherein a plurality of conductive traces are disposed on the first substrate, the second substrate, or a combination thereof, the conductive traces defining at least one working electrode and at least one counter electrode, and the sample chambers are disposed to allow an analyte sample disposed in the sample chambers to be electrolyzed by a current flowing between the working electrode and the counter electrode; and
separating a plurality of electrochemical sensors, each electrochemical sensor comprising at least one of the working electrodes, at least one of the counter electrodes, and at least one of the sample chambers.
13. The method of claim 12 wherein the working electrodes are disposed on one of the substrates and the counter electrodes are disposed on the other substrate.
14. A method for determining a concentration of an analyte in a body fluid sample, the method comprising steps of:
disposing a body fluid sample in a sample chamber of an electrochemical sensor, the electrochemical sensor further comprising at least one working electrode and at least one counter electrode for electrolyzing an analyte in the body fluid sample in the sample chamber of the electrochemical sensor;
electrolyzing at least a portion of an analyte in the body fluid sample by causing a current to flow between the at least one working electrode and the at least one counter electrode;
determining, during the electrolyzing of the analyte, a plurality of current values, at least some of the current values being obtained while the electrolysis of the analyte in the sensor is substantially diffusion limited;
determining, from the current values obtained while the electrolysis of the analyte in the sensor is substantially diffusion limited, parameters for extrapolation of a relationship between the current values and time;
determining from the plurality of current values the amount of an actual charge consumed in the partial electrolysis of the analyte in the sample;
determining, from the parameters for extrapolation of the relationship between the current values and time, an extrapolated charge required to electrolyze the analyte remaining in the sample;
determining the concentration of the analyte in the body fluid sample from the actual charge and the extrapolated charge.
15. The method of claim 14, wherein the step of determining parameters for extrapolation of the relationship between current values and time comprises determining a value related to a diffusion coefficient of the analyte in the sensor.
16. The method of claim 14, wherein the step of determining parameters for extrapolation of the relationship between current values and time comprises determining a slope of a natural logarithm of current values versus time obtained while the electrolysis of the analyte in the sensor is substantially diffusion limited.
17. An electrochemical sensor device comprising:
(a) an electrochemical sensor comprising
(i) at least one working electrode,
(ii) at least one counter electrode, and
(iii) a sample chamber for holding a body fluid sample in electrolytic contact with the at least one working electrode and at least one counter electrode; and
(b) a processor coupled to the electrochemical sensor, the processor being configured and arranged to
(i) electrolyze at least a portion of an analyte in the body fluid sample by causing a current to flow between the at least one working electrode and at least one counter electrode;
(ii) determine, during the electrolyzing of the analyte, a plurality of current values, at least some of the current values being obtained while the electrolysis of the analyte in the sensor is substantially diffusion limited;
(iii) determine, from the current values obtained while the electrolysis of the analyte in the sensor is substantially diffusion limited, parameters for extrapolation of a relationship between the current values and time;
(iv) determine the amount of an actual charge consumed in the partial electrolysis of the analyte in the sample;
(v) determine an extrapolated charge required to electrolyze the analyte remaining in the sample; and
(vi) determine, from the actual charge and the extrapolated charge, the concentration of the analyte in the body fluid sample.
18. A method of determining an amount of current used to electrolyze a portion of an analyte in a body fluid sample disposed in an electrochemical sensor, the method comprising:
discharging an amount of charge into the body fluid sample disposed in the electrochemical sensor and electrolyzing the analyte;
determining an amount of time needed to discharge the amount of charge; and
determining the current used to electrolyze the portion of the analyte using the amount of charge and the amount of time.
19. The method of claim 18 wherein the charge is provided by the discharge of a capacitor.
20. The method of claim 19, further comprising calibrating the capacitor by discharging the capacitor through a resistor of known resistance and measuring either a current or a time constant associated with the discharge.
21. A n electrochemical sensor device, comprising:
(a) an electrochemical sensor comprising
(i) at least one working electrode,
(ii) at least one counter electrode, and
(iii) a sample chamber for holding a body fluid sample in electrolytic contact with the at least one working electrode and at least one counter electrode; and
(b) a measuring device comprising
(i) a capacitor configured and arranged for coupling to the at least one working electrode to repeatedly deliver an amount of charge by repeatedly discharging, for electrolyzing at least a portion of an analyte in a body fluid disposed in the sample chamber,
(ii) a clock to measure discharge times of the capacitor, and
(iii) a processor to determine a concentration of the analyte in the body fluid based on the discharge times.
22. A sensor comprising:
a first substrate having a first major surface and a second major surface opposing the first major surface;
a second substrate having a first major surface and a second major surface opposing the first major surface, the first and second substrates being disposed so that the first major surface of the first substrate is in facing relationship with the first major surface of the second substrate;
a working electrode disposed on the first major surface of the first substrate;
a counter electrode disposed on the first major surface of one of the first substrate and the second substrate; and
a conductive trace positioned on the second major surface of one of the first substrate and the second substrate, the conductive trace electrically connected to two or more contact pads for electrical contact with a connector, the conductive trace configured and arranged to close an electrical circuit, and wherein conductive trace has a resistance that carries information related to the sensor.
US10/033,506 1999-11-04 2001-12-28 Small volume in vitro analyte sensor and methods Expired - Lifetime US6942518B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/033,506 US6942518B2 (en) 1999-11-04 2001-12-28 Small volume in vitro analyte sensor and methods

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/434,026 US6616819B1 (en) 1999-11-04 1999-11-04 Small volume in vitro analyte sensor and methods
US10/033,506 US6942518B2 (en) 1999-11-04 2001-12-28 Small volume in vitro analyte sensor and methods

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
US09/434,026 Division US6616819B1 (en) 1999-11-04 1999-11-04 Small volume in vitro analyte sensor and methods
US09/435,026 Division US6289891B1 (en) 1998-11-11 1999-11-05 Safety system and method for preventing mixing of different anaesthetics in an anaesthesia system

Publications (3)

Publication Number Publication Date
US20020084196A1 true US20020084196A1 (en) 2002-07-04
US20020157948A2 US20020157948A2 (en) 2002-10-31
US6942518B2 US6942518B2 (en) 2005-09-13

Family

ID=23722510

Family Applications (8)

Application Number Title Priority Date Filing Date
US09/434,026 Expired - Lifetime US6616819B1 (en) 1999-11-04 1999-11-04 Small volume in vitro analyte sensor and methods
US10/033,506 Expired - Lifetime US6942518B2 (en) 1999-11-04 2001-12-28 Small volume in vitro analyte sensor and methods
US10/033,575 Expired - Lifetime US6749740B2 (en) 1999-11-04 2001-12-28 Small volume in vitro analyte sensor and methods
US10/866,477 Abandoned US20040225230A1 (en) 1999-11-04 2004-06-12 Small volume in vitro analyte sensor and methods
US11/932,658 Expired - Fee Related US8066858B2 (en) 1999-11-04 2007-10-31 Analyte sensor with insertion monitor, and methods
US12/437,141 Abandoned US20090260985A1 (en) 1999-11-04 2009-05-07 Analyte sensor with insertion monitor, and methods
US12/463,187 Abandoned US20090260986A1 (en) 1999-11-04 2009-05-08 Analyte sensor with insertion monitor, and methods
US12/695,913 Abandoned US20100126884A1 (en) 1999-11-04 2010-01-28 Analyte Sensor with Insertion Monitor, and Methods

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/434,026 Expired - Lifetime US6616819B1 (en) 1999-11-04 1999-11-04 Small volume in vitro analyte sensor and methods

Family Applications After (6)

Application Number Title Priority Date Filing Date
US10/033,575 Expired - Lifetime US6749740B2 (en) 1999-11-04 2001-12-28 Small volume in vitro analyte sensor and methods
US10/866,477 Abandoned US20040225230A1 (en) 1999-11-04 2004-06-12 Small volume in vitro analyte sensor and methods
US11/932,658 Expired - Fee Related US8066858B2 (en) 1999-11-04 2007-10-31 Analyte sensor with insertion monitor, and methods
US12/437,141 Abandoned US20090260985A1 (en) 1999-11-04 2009-05-07 Analyte sensor with insertion monitor, and methods
US12/463,187 Abandoned US20090260986A1 (en) 1999-11-04 2009-05-08 Analyte sensor with insertion monitor, and methods
US12/695,913 Abandoned US20100126884A1 (en) 1999-11-04 2010-01-28 Analyte Sensor with Insertion Monitor, and Methods

Country Status (10)

Country Link
US (8) US6616819B1 (en)
EP (1) EP1145000B8 (en)
JP (2) JP2003513279A (en)
KR (1) KR100495935B1 (en)
CN (1) CN1201149C (en)
AT (1) ATE295538T1 (en)
AU (1) AU776764B2 (en)
CA (1) CA2358993C (en)
DE (1) DE60020076T2 (en)
WO (1) WO2001033216A1 (en)

Cited By (183)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030199895A1 (en) * 2002-04-19 2003-10-23 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US20030203498A1 (en) * 2002-04-25 2003-10-30 Home Diagnostics, Inc. System and methods for blood glucose sensing
WO2003091717A1 (en) * 2002-04-25 2003-11-06 Home Diagnostics, Inc. Systems and methods for blood glucose sensing
US20040182703A1 (en) * 2002-04-25 2004-09-23 Home Diagnostics, Inc. Systems and methods for blood glucose sensing
US20040214345A1 (en) * 2003-04-23 2004-10-28 Matzinger David P. Ambidextrous capillary-filled test strip
WO2006065901A1 (en) * 2004-12-13 2006-06-22 Bayer Healthcare Llc Multi-contact connector assembly for a sensor-dispensing instrument
US20060163086A1 (en) * 2002-09-30 2006-07-27 Infopia Co., Ltd. Apparatus and method for measuring reaction result of samples on biosensor
US20060178689A1 (en) * 2001-06-12 2006-08-10 Dominique Freeman Tissue penetration device
US20060231425A1 (en) * 2005-04-15 2006-10-19 Agamatrix, Inc. Method and Apparatus for Detection of Abnormal Traces during Electrochemical Analyte Detection
US20070131549A1 (en) * 2005-12-14 2007-06-14 Nova Biomedical Corporation Glucose biosensor and method
US20080112852A1 (en) * 2002-04-25 2008-05-15 Neel Gary T Test Strips and System for Measuring Analyte Levels in a Fluid Sample
US20090036763A1 (en) * 2004-07-13 2009-02-05 Dexcom, Inc. Analyte sensor
US20090056120A1 (en) * 1999-10-04 2009-03-05 Bhullar Raghbir S Biosensor and method of making
US20090095071A1 (en) * 2006-05-03 2009-04-16 Bayer Healthcare Llc Underfill Detection System For A Biosensor
US20090151864A1 (en) * 2003-06-20 2009-06-18 Burke David W Reagent stripe for test strip
US20090318792A1 (en) * 2007-05-08 2009-12-24 Fennell Martin J Analyte Monitoring System and Methods
US7645421B2 (en) 2003-06-20 2010-01-12 Roche Diagnostics Operations, Inc. System and method for coding information on a biosensor test strip
US7645373B2 (en) 2003-06-20 2010-01-12 Roche Diagnostic Operations, Inc. System and method for coding information on a biosensor test strip
US7648468B2 (en) 2002-04-19 2010-01-19 Pelikon Technologies, Inc. Method and apparatus for penetrating tissue
US7654956B2 (en) 2004-07-13 2010-02-02 Dexcom, Inc. Transcutaneous analyte sensor
US7666149B2 (en) 1997-12-04 2010-02-23 Peliken Technologies, Inc. Cassette of lancet cartridges for sampling blood
US7674232B2 (en) 2002-04-19 2010-03-09 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7682318B2 (en) 2001-06-12 2010-03-23 Pelikan Technologies, Inc. Blood sampling apparatus and method
US7699791B2 (en) 2001-06-12 2010-04-20 Pelikan Technologies, Inc. Method and apparatus for improving success rate of blood yield from a fingerstick
US7708701B2 (en) 2002-04-19 2010-05-04 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device
US7718439B2 (en) 2003-06-20 2010-05-18 Roche Diagnostics Operations, Inc. System and method for coding information on a biosensor test strip
US7717863B2 (en) 2002-04-19 2010-05-18 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7731729B2 (en) 2002-04-19 2010-06-08 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7749174B2 (en) 2001-06-12 2010-07-06 Pelikan Technologies, Inc. Method and apparatus for lancet launching device intergrated onto a blood-sampling cartridge
US7761130B2 (en) 2003-07-25 2010-07-20 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US7771352B2 (en) 1997-03-04 2010-08-10 Dexcom, Inc. Low oxygen in vivo analyte sensor
US7780631B2 (en) 1998-03-30 2010-08-24 Pelikan Technologies, Inc. Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
US7783333B2 (en) 2004-07-13 2010-08-24 Dexcom, Inc. Transcutaneous medical device with variable stiffness
US7822454B1 (en) 2005-01-03 2010-10-26 Pelikan Technologies, Inc. Fluid sampling device with improved analyte detecting member configuration
US20100274220A1 (en) * 2005-11-04 2010-10-28 Abbott Diabetes Care Inc. Method and System for Providing Basal Profile Modification in Analyte Monitoring and Management Systems
US7831287B2 (en) 2006-10-04 2010-11-09 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US7833171B2 (en) 2002-04-19 2010-11-16 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7850621B2 (en) 2003-06-06 2010-12-14 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US7860544B2 (en) 1998-04-30 2010-12-28 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US7857760B2 (en) 2004-07-13 2010-12-28 Dexcom, Inc. Analyte sensor
US7862520B2 (en) 2002-04-19 2011-01-04 Pelikan Technologies, Inc. Body fluid sampling module with a continuous compression tissue interface surface
US7874994B2 (en) 2002-04-19 2011-01-25 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7892185B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US7892183B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US7901362B2 (en) 2002-04-19 2011-03-08 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7901365B2 (en) 2002-04-19 2011-03-08 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US20110060530A1 (en) * 2009-08-31 2011-03-10 Abbott Diabetes Care Inc. Analyte Signal Processing Device and Methods
US7905833B2 (en) 2004-07-13 2011-03-15 Dexcom, Inc. Transcutaneous analyte sensor
US7909778B2 (en) 2002-04-19 2011-03-22 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7909777B2 (en) 2002-04-19 2011-03-22 Pelikan Technologies, Inc Method and apparatus for penetrating tissue
US7914465B2 (en) 2002-04-19 2011-03-29 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7920907B2 (en) 2006-06-07 2011-04-05 Abbott Diabetes Care Inc. Analyte monitoring system and method
US7920906B2 (en) 2005-03-10 2011-04-05 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US7927274B2 (en) 2003-11-19 2011-04-19 Dexcom, Inc. Integrated receiver for continuous analyte sensor
US20110108440A1 (en) * 2009-11-10 2011-05-12 Bayer Healthcare Llc Underfill Recognition System for a Biosensor
US7976492B2 (en) 2004-02-26 2011-07-12 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
US7976476B2 (en) 2002-04-19 2011-07-12 Pelikan Technologies, Inc. Device and method for variable speed lancet
US20110174618A1 (en) * 2008-09-30 2011-07-21 Menai Medical Technologies Limited Sample measurement system
US7988645B2 (en) 2001-06-12 2011-08-02 Pelikan Technologies, Inc. Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties
US8000901B2 (en) 2003-08-01 2011-08-16 Dexcom, Inc. Transcutaneous analyte sensor
US20110231105A1 (en) * 2010-03-22 2011-09-22 Bayer Healthcare Llc Residual Compensation Including Underfill Error
US8026104B2 (en) 2006-10-24 2011-09-27 Bayer Healthcare Llc Transient decay amperometry
US8052601B2 (en) 2003-08-01 2011-11-08 Dexcom, Inc. System and methods for processing analyte sensor data
US8058077B2 (en) 2003-06-20 2011-11-15 Roche Diagnostics Operations, Inc. Method for coding information on a biosensor test strip
US8071030B2 (en) 2003-06-20 2011-12-06 Roche Diagnostics Operations, Inc. Test strip with flared sample receiving chamber
US8071384B2 (en) 1997-12-22 2011-12-06 Roche Diagnostics Operations, Inc. Control and calibration solutions and methods for their use
US20110303539A1 (en) * 2006-10-31 2011-12-15 Abbott Diabetes Care Inc. Analyte Sensors and Methods
US8079960B2 (en) 2002-04-19 2011-12-20 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US8092668B2 (en) 2004-06-18 2012-01-10 Roche Diagnostics Operations, Inc. System and method for quality assurance of a biosensor test strip
US8133178B2 (en) 2006-02-22 2012-03-13 Dexcom, Inc. Analyte sensor
US8148164B2 (en) 2003-06-20 2012-04-03 Roche Diagnostics Operations, Inc. System and method for determining the concentration of an analyte in a sample fluid
US8160671B2 (en) 2003-12-05 2012-04-17 Dexcom, Inc. Calibration techniques for a continuous analyte sensor
US8160669B2 (en) 2003-08-01 2012-04-17 Dexcom, Inc. Transcutaneous analyte sensor
USRE43399E1 (en) 2003-07-25 2012-05-22 Dexcom, Inc. Electrode systems for electrochemical sensors
US8197421B2 (en) 2002-04-19 2012-06-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8206565B2 (en) 2003-06-20 2012-06-26 Roche Diagnostics Operation, Inc. System and method for coding information on a biosensor test strip
US8221334B2 (en) 2002-04-19 2012-07-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8229535B2 (en) 2008-02-21 2012-07-24 Dexcom, Inc. Systems and methods for blood glucose monitoring and alert delivery
US8262614B2 (en) 2003-05-30 2012-09-11 Pelikan Technologies, Inc. Method and apparatus for fluid injection
US8267870B2 (en) 2002-04-19 2012-09-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling with hybrid actuation
US8275437B2 (en) 2003-08-01 2012-09-25 Dexcom, Inc. Transcutaneous analyte sensor
US8280475B2 (en) 2004-07-13 2012-10-02 Dexcom, Inc. Transcutaneous analyte sensor
US8282576B2 (en) 2003-09-29 2012-10-09 Sanofi-Aventis Deutschland Gmbh Method and apparatus for an improved sample capture device
US8287454B2 (en) 1998-04-30 2012-10-16 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8290559B2 (en) 2007-12-17 2012-10-16 Dexcom, Inc. Systems and methods for processing sensor data
US8287453B2 (en) 2003-12-05 2012-10-16 Dexcom, Inc. Analyte sensor
US8337421B2 (en) 2001-06-12 2012-12-25 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US8346337B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8360992B2 (en) 2002-04-19 2013-01-29 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8362904B2 (en) 2007-05-08 2013-01-29 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8396528B2 (en) 2008-03-25 2013-03-12 Dexcom, Inc. Analyte sensor
US8404100B2 (en) 2005-09-30 2013-03-26 Bayer Healthcare Llc Gated voltammetry
US8417312B2 (en) 2007-10-25 2013-04-09 Dexcom, Inc. Systems and methods for processing sensor data
US8423114B2 (en) 2006-10-04 2013-04-16 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8425757B2 (en) 2005-07-20 2013-04-23 Bayer Healthcare Llc Gated amperometry
US8437966B2 (en) 2003-04-04 2013-05-07 Abbott Diabetes Care Inc. Method and system for transferring analyte test data
US8435190B2 (en) 2002-04-19 2013-05-07 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8456301B2 (en) 2007-05-08 2013-06-04 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8461985B2 (en) 2007-05-08 2013-06-11 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8465425B2 (en) 1998-04-30 2013-06-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8509107B2 (en) 2008-05-30 2013-08-13 Abbott Diabetes Care Inc. Close proximity communication device and methods
US8509871B2 (en) 2001-07-27 2013-08-13 Dexcom, Inc. Sensor head for use with implantable devices
US8556829B2 (en) 2002-04-19 2013-10-15 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8560039B2 (en) 2008-09-19 2013-10-15 Dexcom, Inc. Particle-containing membrane and particulate electrode for analyte sensors
US8565848B2 (en) 2004-07-13 2013-10-22 Dexcom, Inc. Transcutaneous analyte sensor
US8562558B2 (en) 2007-06-08 2013-10-22 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
US8574895B2 (en) 2002-12-30 2013-11-05 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
US8593109B2 (en) 2006-03-31 2013-11-26 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US8597188B2 (en) 2007-06-21 2013-12-03 Abbott Diabetes Care Inc. Health management devices and methods
US8597575B2 (en) 2006-03-31 2013-12-03 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US8612159B2 (en) 1998-04-30 2013-12-17 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8617069B2 (en) 2007-06-21 2013-12-31 Abbott Diabetes Care Inc. Health monitor
US8622905B2 (en) 2003-08-01 2014-01-07 Dexcom, Inc. System and methods for processing analyte sensor data
US8641644B2 (en) 2000-11-21 2014-02-04 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
US8652043B2 (en) 2001-01-02 2014-02-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8652831B2 (en) 2004-12-30 2014-02-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte measurement test time
US8663442B2 (en) 2003-06-20 2014-03-04 Roche Diagnostics Operations, Inc. System and method for analyte measurement using dose sufficiency electrodes
US8668656B2 (en) 2003-12-31 2014-03-11 Sanofi-Aventis Deutschland Gmbh Method and apparatus for improving fluidic flow and sample capture
US8679853B2 (en) 2003-06-20 2014-03-25 Roche Diagnostics Operations, Inc. Biosensor with laser-sealed capillary space and method of making
US8688188B2 (en) 1998-04-30 2014-04-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8702624B2 (en) 2006-09-29 2014-04-22 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US8721671B2 (en) 2001-06-12 2014-05-13 Sanofi-Aventis Deutschland Gmbh Electric lancet actuator
US8771183B2 (en) 2004-02-17 2014-07-08 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US8777853B2 (en) 2003-08-22 2014-07-15 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8784335B2 (en) 2002-04-19 2014-07-22 Sanofi-Aventis Deutschland Gmbh Body fluid sampling device with a capacitive sensor
US8792955B2 (en) 2004-05-03 2014-07-29 Dexcom, Inc. Transcutaneous analyte sensor
US8808228B2 (en) 2004-02-26 2014-08-19 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
US8828201B2 (en) 2009-07-02 2014-09-09 Dexcom, Inc. Analyte sensors and methods of manufacturing same
US8828203B2 (en) 2004-05-20 2014-09-09 Sanofi-Aventis Deutschland Gmbh Printable hydrogels for biosensors
US8894832B2 (en) 2010-03-30 2014-11-25 Jabil Circuit (Singapore) Pte, Ltd. Sampling plate
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8993331B2 (en) 2009-08-31 2015-03-31 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
US9011658B2 (en) 2010-03-30 2015-04-21 Jabil Circuit (Singapore) Pte, Ltd. Sampling plate
US9069536B2 (en) 2011-10-31 2015-06-30 Abbott Diabetes Care Inc. Electronic devices having integrated reset systems and methods thereof
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9088452B2 (en) 2009-04-29 2015-07-21 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US9095290B2 (en) 2007-03-01 2015-08-04 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US9135402B2 (en) 2007-12-17 2015-09-15 Dexcom, Inc. Systems and methods for processing sensor data
US9144401B2 (en) 2003-06-11 2015-09-29 Sanofi-Aventis Deutschland Gmbh Low pain penetrating member
US9155496B2 (en) 1997-03-04 2015-10-13 Dexcom, Inc. Low oxygen in vivo analyte sensor
US9214753B2 (en) 2012-06-05 2015-12-15 Panasonic Healthcare Holdings Co., Ltd. Connector for biological information measurement, and biological information measurement device using same
US9222910B2 (en) 2010-06-07 2015-12-29 Bayer Healthcare Llc Underfill management system for a biosensor
US9226701B2 (en) 2009-04-28 2016-01-05 Abbott Diabetes Care Inc. Error detection in critical repeating data in a wireless sensor system
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US9247900B2 (en) 2004-07-13 2016-02-02 Dexcom, Inc. Analyte sensor
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9351677B2 (en) 2009-07-02 2016-05-31 Dexcom, Inc. Analyte sensor with increased reference capacity
US9351680B2 (en) 2003-10-14 2016-05-31 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a variable user interface
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
US9386944B2 (en) 2008-04-11 2016-07-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte detecting device
US9410917B2 (en) 2004-02-06 2016-08-09 Ascensia Diabetes Care Holdings Ag Method of using a biosensor
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9451910B2 (en) 2007-09-13 2016-09-27 Dexcom, Inc. Transcutaneous analyte sensor
US9451908B2 (en) 2006-10-04 2016-09-27 Dexcom, Inc. Analyte sensor
US9532737B2 (en) 2011-02-28 2017-01-03 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
US9574914B2 (en) 2007-05-08 2017-02-21 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US9730584B2 (en) 2003-06-10 2017-08-15 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US9757061B2 (en) 2006-01-17 2017-09-12 Dexcom, Inc. Low oxygen in vivo analyte sensor
US9775553B2 (en) 2004-06-03 2017-10-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
US9775806B2 (en) 2011-09-21 2017-10-03 Ascensia Diabetes Care Holdings Ag Analysis compensation including segmented signals
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US9820684B2 (en) 2004-06-03 2017-11-21 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
US9933385B2 (en) 2007-12-10 2018-04-03 Ascensia Diabetes Care Holdings Ag Method of using an electrochemical test sensor
US9968306B2 (en) 2012-09-17 2018-05-15 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
US9980669B2 (en) 2011-11-07 2018-05-29 Abbott Diabetes Care Inc. Analyte monitoring device and methods
US10022499B2 (en) 2007-02-15 2018-07-17 Abbott Diabetes Care Inc. Device and method for automatic data acquisition and/or detection
US10136816B2 (en) 2009-08-31 2018-11-27 Abbott Diabetes Care Inc. Medical devices and methods
US10653835B2 (en) 2007-10-09 2020-05-19 Dexcom, Inc. Integrated insulin delivery system with continuous glucose sensor
US10750952B2 (en) 2002-12-31 2020-08-25 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US10980461B2 (en) 2008-11-07 2021-04-20 Dexcom, Inc. Advanced analyte sensor calibration and error detection
US11000215B1 (en) 2003-12-05 2021-05-11 Dexcom, Inc. Analyte sensor
US11006872B2 (en) 2009-02-03 2021-05-18 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US11331022B2 (en) 2017-10-24 2022-05-17 Dexcom, Inc. Pre-connected analyte sensors
US11350862B2 (en) 2017-10-24 2022-06-07 Dexcom, Inc. Pre-connected analyte sensors
US11382539B2 (en) 2006-10-04 2022-07-12 Dexcom, Inc. Analyte sensor
US11432772B2 (en) 2006-08-02 2022-09-06 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US11559260B2 (en) 2003-08-22 2023-01-24 Dexcom, Inc. Systems and methods for processing analyte sensor data
US11589823B2 (en) 2003-08-22 2023-02-28 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US11633133B2 (en) 2003-12-05 2023-04-25 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US11793936B2 (en) 2009-05-29 2023-10-24 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
US11918354B2 (en) 2019-12-31 2024-03-05 Dexcom, Inc. Particle-containing membrane and particulate electrode for analyte sensors

Families Citing this family (510)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE227844T1 (en) 1997-02-06 2002-11-15 Therasense Inc SMALL VOLUME SENSOR FOR IN-VITRO DETERMINATION
US6071391A (en) 1997-09-12 2000-06-06 Nok Corporation Enzyme electrode structure
US6103033A (en) 1998-03-04 2000-08-15 Therasense, Inc. Process for producing an electrochemical biosensor
US6338790B1 (en) 1998-10-08 2002-01-15 Therasense, Inc. Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
ATE514372T1 (en) * 1998-10-08 2011-07-15 Medtronic Minimed Inc LICENSE PLATE MONITORING SYSTEM WITH REMOTE MEASUREMENT
US7621893B2 (en) 1998-10-29 2009-11-24 Medtronic Minimed, Inc. Methods and apparatuses for detecting occlusions in an ambulatory infusion pump
US7766873B2 (en) 1998-10-29 2010-08-03 Medtronic Minimed, Inc. Method and apparatus for detecting occlusions in an ambulatory infusion pump
US7806886B2 (en) 1999-06-03 2010-10-05 Medtronic Minimed, Inc. Apparatus and method for controlling insulin infusion with state variable feedback
US6616819B1 (en) 1999-11-04 2003-09-09 Therasense, Inc. Small volume in vitro analyte sensor and methods
US20060091006A1 (en) 1999-11-04 2006-05-04 Yi Wang Analyte sensor with insertion monitor, and methods
DK1230249T3 (en) 1999-11-15 2004-08-30 Therasense Inc Transition metal complexes with bidentate ligand having an imidazole ring
US8268143B2 (en) * 1999-11-15 2012-09-18 Abbott Diabetes Care Inc. Oxygen-effect free analyte sensor
US8444834B2 (en) 1999-11-15 2013-05-21 Abbott Diabetes Care Inc. Redox polymers for use in analyte monitoring
US20030060765A1 (en) * 2000-02-16 2003-03-27 Arthur Campbell Infusion device menu structure and method of using the same
AU2001228915A1 (en) * 2000-03-22 2001-10-03 All Medicus Co., Ltd. Electrochemical biosensor test strip with recognition electrode and readout meter using this test strip
IL151914A0 (en) 2000-03-31 2003-04-10 Lifescan Inc Electrically-conductive patterns for monitoring the filling of medical devices
EP3364187B1 (en) * 2000-11-30 2019-09-18 PHC Holdings Corporation Method of quantifying substrate
US6576102B1 (en) 2001-03-23 2003-06-10 Virotek, L.L.C. Electrochemical sensor and method thereof
US6572745B2 (en) 2001-03-23 2003-06-03 Virotek, L.L.C. Electrochemical sensor and method thereof
EP1397068A2 (en) 2001-04-02 2004-03-17 Therasense, Inc. Blood glucose tracking apparatus and methods
US6676816B2 (en) * 2001-05-11 2004-01-13 Therasense, Inc. Transition metal complexes with (pyridyl)imidazole ligands and sensors using said complexes
US8226814B2 (en) * 2001-05-11 2012-07-24 Abbott Diabetes Care Inc. Transition metal complexes with pyridyl-imidazole ligands
US8070934B2 (en) * 2001-05-11 2011-12-06 Abbott Diabetes Care Inc. Transition metal complexes with (pyridyl)imidazole ligands
EP1277438A1 (en) * 2001-07-10 2003-01-22 Agilent Technologies, Inc. (a Delaware corporation) System for point of care diagnosis and/or analysis
EP1411352B1 (en) * 2001-07-13 2012-01-11 ARKRAY, Inc. Analysing instrument and lancet-integrated attachment for concentration measuring device
US6827702B2 (en) 2001-09-07 2004-12-07 Medtronic Minimed, Inc. Safety limits for closed-loop infusion pump control
USRE44522E1 (en) 2001-09-14 2013-10-08 Arkray, Inc. Concentration measuring method, concentration test instrument, and concentration measuring apparatus
US7491303B2 (en) * 2001-09-28 2009-02-17 Arkray, Inc. Measuring instrument and concentration measuring device
US6797150B2 (en) 2001-10-10 2004-09-28 Lifescan, Inc. Determination of sample volume adequacy in biosensor devices
US20030077205A1 (en) * 2001-10-24 2003-04-24 Xu Tom C. Diagnostic test optical fiber tips
US20030116447A1 (en) 2001-11-16 2003-06-26 Surridge Nigel A. Electrodes, methods, apparatuses comprising micro-electrode arrays
US6872298B2 (en) * 2001-11-20 2005-03-29 Lifescan, Inc. Determination of sample volume adequacy in biosensor devices
US6856125B2 (en) 2001-12-12 2005-02-15 Lifescan, Inc. Biosensor apparatus and method with sample type and volume detection
US6863800B2 (en) * 2002-02-01 2005-03-08 Abbott Laboratories Electrochemical biosensor strip for analysis of liquid samples
US7374544B2 (en) * 2002-04-19 2008-05-20 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7410468B2 (en) * 2002-04-19 2008-08-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
DE60324738D1 (en) * 2002-07-18 2009-01-02 Panasonic Corp Measuring device with a biosensor
US7278983B2 (en) 2002-07-24 2007-10-09 Medtronic Minimed, Inc. Physiological monitoring device for controlling a medication infusion device
US20040068230A1 (en) 2002-07-24 2004-04-08 Medtronic Minimed, Inc. System for providing blood glucose measurements to an infusion device
US8512276B2 (en) 2002-07-24 2013-08-20 Medtronic Minimed, Inc. System for providing blood glucose measurements to an infusion device
US7537684B2 (en) 2002-07-25 2009-05-26 Arkray, Inc. Sample analyzing method and sample analyzing device
DE10234819A1 (en) * 2002-07-31 2004-02-19 Roche Diagnostics Gmbh Test apparatus for blood, comprising compound body with test strip levels and transport channels to give complex tests in compact structure
US9017544B2 (en) 2002-10-04 2015-04-28 Roche Diagnostics Operations, Inc. Determining blood glucose in a small volume sample receiving cavity and in a short time period
US7117754B2 (en) * 2002-10-28 2006-10-10 The Curators Of The University Of Missouri Torque ripple sensor and mitigation mechanism
US7381184B2 (en) 2002-11-05 2008-06-03 Abbott Diabetes Care Inc. Sensor inserter assembly
US7572237B2 (en) 2002-11-06 2009-08-11 Abbott Diabetes Care Inc. Automatic biological analyte testing meter with integrated lancing device and methods of use
EP1422523B1 (en) * 2002-11-21 2007-05-23 Lifescan, Inc. Determination of sample volume adequacy in biosensors
US20040118704A1 (en) * 2002-12-19 2004-06-24 Yi Wang Analyte test intrument having improved versatility
US20040122353A1 (en) 2002-12-19 2004-06-24 Medtronic Minimed, Inc. Relay device for transferring information between a sensor system and a fluid delivery system
US7514250B2 (en) 2002-12-24 2009-04-07 Ikeda Food Research Co., Ltd. Coenzyme-binding glucose dehydrogenase
AU2003302263A1 (en) * 2002-12-26 2004-07-29 Meso Scale Technologies, Llc. Assay cartridges and methods of using the same
TW200411178A (en) * 2002-12-31 2004-07-01 Veutron Corp Method for determining the resolution of blood glucose by using rising time curve
TW592667B (en) * 2003-04-04 2004-06-21 Veutron Corp Method for determining the resolution of blood glucose
US8460243B2 (en) 2003-06-10 2013-06-11 Abbott Diabetes Care Inc. Glucose measuring module and insulin pump combination
US7488601B2 (en) 2003-06-20 2009-02-10 Roche Diagnostic Operations, Inc. System and method for determining an abused sensor during analyte measurement
GB0314944D0 (en) * 2003-06-26 2003-07-30 Univ Cranfield Electrochemical detector for metabolites in physiological fluids
US7722536B2 (en) * 2003-07-15 2010-05-25 Abbott Diabetes Care Inc. Glucose measuring device integrated into a holster for a personal area network device
BRPI0413213A (en) * 2003-08-21 2006-10-03 Agamatrix Inc method and apparatus for determining the presence of a selected analyte in a sample arranged in an electrochemical cell, method for determining the effective separation distance between a first electrode and a second electrode in an electrochemical cell, and method for determining an effective electrode transport property. a species in a liquid sample disposed between a first electrode and a second electrode in an electrochemical cell
CA2544424A1 (en) * 2003-10-31 2005-05-19 Lifescan Scotland Limited Electrochemical test strip for reducing the effect of direct interference current
USD902408S1 (en) 2003-11-05 2020-11-17 Abbott Diabetes Care Inc. Analyte sensor control unit
TW200516247A (en) * 2003-11-05 2005-05-16 Bionime Corp Electrochemical sensing device
WO2005054840A1 (en) * 2003-12-04 2005-06-16 Matsushita Electric Industrial Co., Ltd. Blood component measuring method, sensor used therefor, and measuring instrument
US8088271B2 (en) * 2003-12-04 2012-01-03 Panasonic Corporation Method of measuring hematocrit (Hct), sensor used in the method, and measuring device
US9012232B2 (en) * 2005-07-15 2015-04-21 Nipro Diagnostics, Inc. Diagnostic strip coding system and related methods of use
DE102004011648A1 (en) 2004-03-10 2005-09-29 Roche Diagnostics Gmbh Test element analysis system with hard-coated contact surfaces
KR101108381B1 (en) * 2004-04-19 2012-01-30 파나소닉 주식회사 Method for measuring blood components and biosensor and measuring instrument for use therein
JP5215661B2 (en) 2004-05-21 2013-06-19 アガマトリックス インコーポレーテッド Electrochemical cell and method for making an electrochemical cell
CA3090413C (en) 2004-06-04 2023-10-10 Abbott Diabetes Care Inc. Glucose monitoring and graphical representations in a data management system
US20070100222A1 (en) * 2004-06-14 2007-05-03 Metronic Minimed, Inc. Analyte sensing apparatus for hospital use
US7601299B2 (en) 2004-06-18 2009-10-13 Roche Diagnostics Operations, Inc. System and method for coding information on a biosensor test strip
US7344500B2 (en) 2004-07-27 2008-03-18 Medtronic Minimed, Inc. Sensing system with auxiliary display
CA2583396C (en) 2004-10-12 2015-06-23 Bayer Healthcare Llc Concentration determination in a diffusion barrier layer
JP4807493B2 (en) * 2004-12-03 2011-11-02 住友電気工業株式会社 Sensor chip and manufacturing method thereof
US7303543B1 (en) * 2004-12-03 2007-12-04 Medtronic Minimed, Inc. Medication infusion set
RU2430264C2 (en) * 2004-12-16 2011-09-27 Индепендент Нэчурэл Ресорсиз, Инк. Power system built around float-type pump
US9743862B2 (en) 2011-03-31 2017-08-29 Abbott Diabetes Care Inc. Systems and methods for transcutaneously implanting medical devices
US20090105569A1 (en) 2006-04-28 2009-04-23 Abbott Diabetes Care, Inc. Introducer Assembly and Methods of Use
US9398882B2 (en) 2005-09-30 2016-07-26 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor and data processing device
US8333714B2 (en) 2006-09-10 2012-12-18 Abbott Diabetes Care Inc. Method and system for providing an integrated analyte sensor insertion device and data processing unit
US9259175B2 (en) 2006-10-23 2016-02-16 Abbott Diabetes Care, Inc. Flexible patch for fluid delivery and monitoring body analytes
US9636450B2 (en) 2007-02-19 2017-05-02 Udo Hoss Pump system modular components for delivering medication and analyte sensing at seperate insertion sites
US9572534B2 (en) 2010-06-29 2017-02-21 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US9788771B2 (en) 2006-10-23 2017-10-17 Abbott Diabetes Care Inc. Variable speed sensor insertion devices and methods of use
US7883464B2 (en) 2005-09-30 2011-02-08 Abbott Diabetes Care Inc. Integrated transmitter unit and sensor introducer mechanism and methods of use
US8029441B2 (en) 2006-02-28 2011-10-04 Abbott Diabetes Care Inc. Analyte sensor transmitter unit configuration for a data monitoring and management system
US7697967B2 (en) 2005-12-28 2010-04-13 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US8512243B2 (en) 2005-09-30 2013-08-20 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
US10226207B2 (en) 2004-12-29 2019-03-12 Abbott Diabetes Care Inc. Sensor inserter having introducer
US8571624B2 (en) 2004-12-29 2013-10-29 Abbott Diabetes Care Inc. Method and apparatus for mounting a data transmission device in a communication system
US7731657B2 (en) 2005-08-30 2010-06-08 Abbott Diabetes Care Inc. Analyte sensor introducer and methods of use
US9351669B2 (en) 2009-09-30 2016-05-31 Abbott Diabetes Care Inc. Interconnect for on-body analyte monitoring device
US7704229B2 (en) 2005-02-03 2010-04-27 Medtronic Minimed, Inc. Insertion device
US7545272B2 (en) 2005-02-08 2009-06-09 Therasense, Inc. RF tag on test strips, test strip vials and boxes
US20060184104A1 (en) * 2005-02-15 2006-08-17 Medtronic Minimed, Inc. Needle guard
EP2380980B1 (en) 2005-03-25 2014-11-05 Ikeda Food Research Co. Ltd. Coenzyme-linked glucose dehydrogenase and polynucleotide encoding the same
US7713392B2 (en) * 2005-04-15 2010-05-11 Agamatrix, Inc. Test strip coding and quality measurement
US7645374B2 (en) 2005-04-15 2010-01-12 Agamatrix, Inc. Method for determination of analyte concentrations and related apparatus
US7964089B2 (en) 2005-04-15 2011-06-21 Agamatrix, Inc. Analyte determination method and analyte meter
US7547382B2 (en) * 2005-04-15 2009-06-16 Agamatrix, Inc. Determination of partial fill in electrochemical strips
US7517439B2 (en) * 2005-04-15 2009-04-14 Agamatrix, Inc. Error detection in analyte measurements based on measurement of system resistance
US8192599B2 (en) * 2005-05-25 2012-06-05 Universal Biosensors Pty Ltd Method and apparatus for electrochemical analysis
US8323464B2 (en) * 2005-05-25 2012-12-04 Universal Biosensors Pty Ltd Method and apparatus for electrochemical analysis
JP4682706B2 (en) * 2005-05-31 2011-05-11 オムロン株式会社 connector
US20070033074A1 (en) * 2005-06-03 2007-02-08 Medtronic Minimed, Inc. Therapy management system
US20060272652A1 (en) * 2005-06-03 2006-12-07 Medtronic Minimed, Inc. Virtual patient software system for educating and treating individuals with diabetes
US7905999B2 (en) * 2005-06-08 2011-03-15 Abbott Laboratories Biosensor strips and methods of preparing same
US7922883B2 (en) * 2005-06-08 2011-04-12 Abbott Laboratories Biosensors and methods of using the same
JP4595070B2 (en) * 2005-06-27 2010-12-08 独立行政法人産業技術総合研究所 Needle integrated biosensor
JP4893921B2 (en) * 2005-06-27 2012-03-07 独立行政法人産業技術総合研究所 Biosensor
US20090093695A1 (en) * 2005-06-27 2009-04-09 National Institute Of Advanced Industrial Science And Technology Biosensor
US20070016449A1 (en) * 2005-06-29 2007-01-18 Gary Cohen Flexible glucose analysis using varying time report deltas and configurable glucose target ranges
US8999125B2 (en) 2005-07-15 2015-04-07 Nipro Diagnostics, Inc. Embedded strip lot autocalibration
US7955856B2 (en) * 2005-07-15 2011-06-07 Nipro Diagnostics, Inc. Method of making a diagnostic test strip having a coding system
US20070066956A1 (en) * 2005-07-27 2007-03-22 Medtronic Minimed, Inc. Systems and methods for entering temporary basal rate pattern in an infusion device
US20070093786A1 (en) * 2005-08-16 2007-04-26 Medtronic Minimed, Inc. Watch controller for a medical device
US20070060869A1 (en) * 2005-08-16 2007-03-15 Tolle Mike C V Controller device for an infusion pump
US20090227855A1 (en) * 2005-08-16 2009-09-10 Medtronic Minimed, Inc. Controller device for an infusion pump
US20070060870A1 (en) * 2005-08-16 2007-03-15 Tolle Mike Charles V Controller device for an infusion pump
US7737581B2 (en) 2005-08-16 2010-06-15 Medtronic Minimed, Inc. Method and apparatus for predicting end of battery life
CA2620586A1 (en) 2005-08-31 2007-03-08 Boris P. Kovatchev Improving the accuracy of continuous glucose sensors
US8298389B2 (en) * 2005-09-12 2012-10-30 Abbott Diabetes Care Inc. In vitro analyte sensor, and methods
US7713240B2 (en) 2005-09-13 2010-05-11 Medtronic Minimed, Inc. Modular external infusion device
US9072476B2 (en) 2005-09-23 2015-07-07 Medtronic Minimed, Inc. Flexible sensor apparatus
US7725148B2 (en) * 2005-09-23 2010-05-25 Medtronic Minimed, Inc. Sensor with layered electrodes
US7846311B2 (en) * 2005-09-27 2010-12-07 Abbott Diabetes Care Inc. In vitro analyte sensor and methods of use
US9521968B2 (en) 2005-09-30 2016-12-20 Abbott Diabetes Care Inc. Analyte sensor retention mechanism and methods of use
US7749371B2 (en) * 2005-09-30 2010-07-06 Lifescan, Inc. Method and apparatus for rapid electrochemical analysis
US8880138B2 (en) 2005-09-30 2014-11-04 Abbott Diabetes Care Inc. Device for channeling fluid and methods of use
JP4965955B2 (en) * 2005-09-30 2012-07-04 キヤノン株式会社 Enzyme electrode, sensor using the same, and biofuel cell
US20070095661A1 (en) * 2005-10-31 2007-05-03 Yi Wang Method of making, and, analyte sensor
US7918975B2 (en) * 2005-11-17 2011-04-05 Abbott Diabetes Care Inc. Analytical sensors for biological fluid
US7674864B2 (en) * 2005-12-23 2010-03-09 Boston Scientific Scimed, Inc. Polymeric hybrid precursors, polymeric hybrid precursor composite matrices, medical devices, and methods
US8455088B2 (en) 2005-12-23 2013-06-04 Boston Scientific Scimed, Inc. Spun nanofiber, medical devices, and methods
CA2636034A1 (en) 2005-12-28 2007-10-25 Abbott Diabetes Care Inc. Medical device insertion
US11298058B2 (en) 2005-12-28 2022-04-12 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US8114269B2 (en) 2005-12-30 2012-02-14 Medtronic Minimed, Inc. System and method for determining the point of hydration and proper time to apply potential to a glucose sensor
US20070173712A1 (en) * 2005-12-30 2007-07-26 Medtronic Minimed, Inc. Method of and system for stabilization of sensors
US7985330B2 (en) * 2005-12-30 2011-07-26 Medtronic Minimed, Inc. Method and system for detecting age, hydration, and functional states of sensors using electrochemical impedance spectroscopy
US7774038B2 (en) 2005-12-30 2010-08-10 Medtronic Minimed, Inc. Real-time self-calibrating sensor system and method
US8114268B2 (en) 2005-12-30 2012-02-14 Medtronic Minimed, Inc. Method and system for remedying sensor malfunctions detected by electrochemical impedance spectroscopy
US20070169533A1 (en) * 2005-12-30 2007-07-26 Medtronic Minimed, Inc. Methods and systems for detecting the hydration of sensors
US7736310B2 (en) 2006-01-30 2010-06-15 Abbott Diabetes Care Inc. On-body medical device securement
US7826879B2 (en) 2006-02-28 2010-11-02 Abbott Diabetes Care Inc. Analyte sensors and methods of use
US7885698B2 (en) 2006-02-28 2011-02-08 Abbott Diabetes Care Inc. Method and system for providing continuous calibration of implantable analyte sensors
US7811430B2 (en) 2006-02-28 2010-10-12 Abbott Diabetes Care Inc. Biosensors and methods of making
US20070205114A1 (en) * 2006-03-01 2007-09-06 Mathur Vijaywanth P Method of detecting biosensor filling
US7887682B2 (en) * 2006-03-29 2011-02-15 Abbott Diabetes Care Inc. Analyte sensors and methods of use
US9339217B2 (en) 2011-11-25 2016-05-17 Abbott Diabetes Care Inc. Analyte monitoring system and methods of use
US8219173B2 (en) 2008-09-30 2012-07-10 Abbott Diabetes Care Inc. Optimizing analyte sensor calibration
US8140312B2 (en) 2007-05-14 2012-03-20 Abbott Diabetes Care Inc. Method and system for determining analyte levels
US8374668B1 (en) 2007-10-23 2013-02-12 Abbott Diabetes Care Inc. Analyte sensor with lag compensation
US7630748B2 (en) 2006-10-25 2009-12-08 Abbott Diabetes Care Inc. Method and system for providing analyte monitoring
US7618369B2 (en) 2006-10-02 2009-11-17 Abbott Diabetes Care Inc. Method and system for dynamically updating calibration parameters for an analyte sensor
US7801582B2 (en) 2006-03-31 2010-09-21 Abbott Diabetes Care Inc. Analyte monitoring and management system and methods therefor
US9392969B2 (en) 2008-08-31 2016-07-19 Abbott Diabetes Care Inc. Closed loop control and signal attenuation detection
US8473022B2 (en) 2008-01-31 2013-06-25 Abbott Diabetes Care Inc. Analyte sensor with time lag compensation
US7653425B2 (en) 2006-08-09 2010-01-26 Abbott Diabetes Care Inc. Method and system for providing calibration of an analyte sensor in an analyte monitoring system
US9326709B2 (en) 2010-03-10 2016-05-03 Abbott Diabetes Care Inc. Systems, devices and methods for managing glucose levels
US8346335B2 (en) 2008-03-28 2013-01-01 Abbott Diabetes Care Inc. Analyte sensor calibration management
US8224415B2 (en) 2009-01-29 2012-07-17 Abbott Diabetes Care Inc. Method and device for providing offset model based calibration for analyte sensor
US9675290B2 (en) 2012-10-30 2017-06-13 Abbott Diabetes Care Inc. Sensitivity calibration of in vivo sensors used to measure analyte concentration
GB0607205D0 (en) * 2006-04-10 2006-05-17 Diagnoswiss Sa Miniaturised biosensor with optimized anperimetric detection
US20070255125A1 (en) 2006-04-28 2007-11-01 Moberg Sheldon B Monitor devices for networked fluid infusion systems
US8073008B2 (en) 2006-04-28 2011-12-06 Medtronic Minimed, Inc. Subnetwork synchronization and variable transmit synchronization techniques for a wireless medical device network
EP2018556A2 (en) * 2006-05-08 2009-01-28 Bayer Healthcare, LLC Electrochemical test sensor with reduced sample volume
US8492130B2 (en) 2006-06-29 2013-07-23 Ikeda Food Research Co., Ltd. FAD-conjugated glucose dehydrogenase gene
US20080020452A1 (en) * 2006-07-18 2008-01-24 Natasha Popovich Diagnostic strip coding system with conductive layers
EP1882745A1 (en) * 2006-07-25 2008-01-30 The Swatch Group Research and Development Ltd. Electrochemical system for dosing of a biological compound by an enzyme
US20080083618A1 (en) * 2006-09-05 2008-04-10 Neel Gary T System and Methods for Determining an Analyte Concentration Incorporating a Hematocrit Correction
US7655120B2 (en) * 2006-10-11 2010-02-02 Infopia Co., Ltd. Biosensor
CN101162213B (en) * 2006-10-13 2012-03-07 因福皮亚有限公司 Biologic sensor
US8052618B2 (en) * 2006-10-15 2011-11-08 Roche Diagnostics Operations, Inc. Diagnostic test element and process for its production
WO2008049074A2 (en) * 2006-10-18 2008-04-24 Agamatrix, Inc. Error detection in analyte measurements based on measurement of system resistance
AU2007308804A1 (en) 2006-10-26 2008-05-02 Abbott Diabetes Care, Inc. Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors
US8158081B2 (en) * 2006-10-31 2012-04-17 Abbott Diabetes Care Inc. Analyte monitoring devices
US7740580B2 (en) * 2006-10-31 2010-06-22 Abbott Diabetes Care Inc. Analyte monitoring
US20080139910A1 (en) * 2006-12-06 2008-06-12 Metronic Minimed, Inc. Analyte sensor and method of using the same
US7932034B2 (en) 2006-12-20 2011-04-26 The Board Of Trustees Of The Leland Stanford Junior University Heat and pH measurement for sequencing of DNA
WO2008082987A2 (en) * 2006-12-26 2008-07-10 Abbott Diabetes Care Inc Analyte meter protectors and methods
WO2008085251A1 (en) * 2007-01-05 2008-07-17 Bayer Healthcare Llc Electrochemical test sensor with light guide
US10154804B2 (en) * 2007-01-31 2018-12-18 Medtronic Minimed, Inc. Model predictive method and system for controlling and supervising insulin infusion
US8121857B2 (en) 2007-02-15 2012-02-21 Abbott Diabetes Care Inc. Device and method for automatic data acquisition and/or detection
US8930203B2 (en) 2007-02-18 2015-01-06 Abbott Diabetes Care Inc. Multi-function analyte test device and methods therefor
KR100874158B1 (en) * 2007-03-14 2008-12-15 주식회사 아이센스 Electrochemical Biosensors and Measuring Instruments
US20080237040A1 (en) * 2007-03-27 2008-10-02 Paul Wessel Test strip and monitoring device
CA2683959C (en) 2007-04-14 2017-08-29 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
WO2008130896A1 (en) 2007-04-14 2008-10-30 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in medical communication system
WO2009096992A1 (en) 2007-04-14 2009-08-06 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in medical communication system
US9008743B2 (en) 2007-04-14 2015-04-14 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
ES2645096T3 (en) * 2007-04-18 2017-12-04 Becton, Dickinson And Company Method and apparatus for determining the dispensing volume
US20080269714A1 (en) 2007-04-25 2008-10-30 Medtronic Minimed, Inc. Closed loop/semi-closed loop therapy modification system
CN101715555A (en) * 2007-04-27 2010-05-26 艾伯特糖尿病护理公司 Test strip identification using conductive patterns
US8444560B2 (en) 2007-05-14 2013-05-21 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8600681B2 (en) 2007-05-14 2013-12-03 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US9125548B2 (en) 2007-05-14 2015-09-08 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8560038B2 (en) 2007-05-14 2013-10-15 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8239166B2 (en) 2007-05-14 2012-08-07 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10002233B2 (en) 2007-05-14 2018-06-19 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8260558B2 (en) 2007-05-14 2012-09-04 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8103471B2 (en) 2007-05-14 2012-01-24 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8709709B2 (en) 2007-05-18 2014-04-29 Luoxis Diagnostics, Inc. Measurement and uses of oxidative status
WO2008144481A1 (en) 2007-05-18 2008-11-27 Institute For Molecular Medicine, Inc. Measurement and uses of oxidative status
WO2008150917A1 (en) 2007-05-31 2008-12-11 Abbott Diabetes Care, Inc. Insertion devices and methods
US8080153B2 (en) * 2007-05-31 2011-12-20 Abbott Diabetes Care Inc. Analyte determination methods and devices
US20080300572A1 (en) * 2007-06-01 2008-12-04 Medtronic Minimed, Inc. Wireless monitor for a personal medical device system
GB0711780D0 (en) * 2007-06-18 2007-07-25 Oxford Biosensors Ltd Electrochemical data rejection methodology
GB0711849D0 (en) * 2007-06-19 2007-07-25 Oxford Biosensors Ltd Redox Mediators
US8160900B2 (en) 2007-06-29 2012-04-17 Abbott Diabetes Care Inc. Analyte monitoring and management device and method to analyze the frequency of user interaction with the device
US7875461B2 (en) * 2007-07-24 2011-01-25 Lifescan Scotland Limited Test strip and connector
US8834366B2 (en) 2007-07-31 2014-09-16 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor calibration
WO2009051901A2 (en) 2007-08-30 2009-04-23 Pepex Biomedical, Llc Electrochemical sensor and method for manufacturing
WO2009032760A2 (en) 2007-08-30 2009-03-12 Pepex Biomedical Llc Electrochmical sensor and method for manufacturing
WO2009027445A2 (en) * 2007-08-31 2009-03-05 Evonik Degussa Gmbh Plug-type connection between a flexible component part and a contact plug
JP2010525353A (en) * 2007-09-05 2010-07-22 ライフスキャン・スコットランド・リミテッド Strip for electrochemical measurements
EP2194849A4 (en) * 2007-09-25 2013-08-28 Isense Corp Method and apparatus for treating skin prior to biosensor insertion
EP2201136B1 (en) 2007-10-01 2017-12-06 Nabsys 2.0 LLC Nanopore sequencing by hybridization of probes to form ternary complexes and variable range alignment
US8409093B2 (en) 2007-10-23 2013-04-02 Abbott Diabetes Care Inc. Assessing measures of glycemic variability
US8377031B2 (en) 2007-10-23 2013-02-19 Abbott Diabetes Care Inc. Closed loop control system with safety parameters and methods
US8000918B2 (en) 2007-10-23 2011-08-16 Edwards Lifesciences Corporation Monitoring and compensating for temperature-related error in an electrochemical sensor
TWI516601B (en) * 2007-10-26 2016-01-11 環球生物醫療感測器私人有限公司 Apparatus and method for electrochemical detection
US20090112626A1 (en) * 2007-10-30 2009-04-30 Cary Talbot Remote wireless monitoring, processing, and communication of patient data
US20090115434A1 (en) * 2007-11-02 2009-05-07 Hirthe Richard W Sample Cell for Hand-Held Impedance Spectroscopy Device
US20090188811A1 (en) 2007-11-28 2009-07-30 Edwards Lifesciences Corporation Preparation and maintenance of sensors
US20090164239A1 (en) 2007-12-19 2009-06-25 Abbott Diabetes Care, Inc. Dynamic Display Of Glucose Information
US8313467B2 (en) 2007-12-27 2012-11-20 Medtronic Minimed, Inc. Reservoir pressure equalization systems and methods
US20090259112A1 (en) * 2008-04-09 2009-10-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Sensors
US20090259217A1 (en) * 2008-04-09 2009-10-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems associated with delivery of one or more agents to an individual
EP2982383B1 (en) 2008-04-10 2019-05-15 Abbott Diabetes Care, Inc. Method for sterilizing an analyte sensor
US8262874B2 (en) * 2008-04-14 2012-09-11 Abbott Diabetes Care Inc. Biosensor coating composition and methods thereof
US9295786B2 (en) * 2008-05-28 2016-03-29 Medtronic Minimed, Inc. Needle protective device for subcutaneous sensors
US8591410B2 (en) 2008-05-30 2013-11-26 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
US8924159B2 (en) 2008-05-30 2014-12-30 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
JP5405916B2 (en) * 2008-06-24 2014-02-05 パナソニック株式会社 Biosensor, method for manufacturing the same, and detection system including the same
US8876755B2 (en) 2008-07-14 2014-11-04 Abbott Diabetes Care Inc. Closed loop control system interface and methods
US7896703B2 (en) * 2008-07-17 2011-03-01 Abbott Diabetes Care Inc. Strip connectors for measurement devices
GB0814238D0 (en) * 2008-08-04 2008-09-10 Oxford Biosensors Ltd Enhancement of electrochemical response
US8900431B2 (en) 2008-08-27 2014-12-02 Edwards Lifesciences Corporation Analyte sensor
US9943644B2 (en) 2008-08-31 2018-04-17 Abbott Diabetes Care Inc. Closed loop control with reference measurement and methods thereof
US20100057040A1 (en) 2008-08-31 2010-03-04 Abbott Diabetes Care, Inc. Robust Closed Loop Control And Methods
US9650668B2 (en) 2008-09-03 2017-05-16 Nabsys 2.0 Llc Use of longitudinally displaced nanoscale electrodes for voltage sensing of biomolecules and other analytes in fluidic channels
US8882980B2 (en) 2008-09-03 2014-11-11 Nabsys, Inc. Use of longitudinally displaced nanoscale electrodes for voltage sensing of biomolecules and other analytes in fluidic channels
US8262879B2 (en) 2008-09-03 2012-09-11 Nabsys, Inc. Devices and methods for determining the length of biopolymers and distances between probes bound thereto
EP2169391B1 (en) * 2008-09-30 2013-04-03 ibidi GmbH Device for mounting a sample chamber and system consisting of the sample chamber and the mounting device
US8986208B2 (en) 2008-09-30 2015-03-24 Abbott Diabetes Care Inc. Analyte sensor sensitivity attenuation mitigation
WO2010040089A1 (en) 2008-10-03 2010-04-08 Abbott Diabetes Care Inc. Integrated lancet and analyte testing apparatus
KR101003077B1 (en) * 2008-10-16 2010-12-21 세종공업 주식회사 Electrochemical biosensor structure and measuring method using the same
CN102197304B (en) 2008-11-04 2013-08-28 松下电器产业株式会社 Measurement device, insulin infusion device, measurement method, method for controlling insulin infusion device, and program
US8208973B2 (en) 2008-11-05 2012-06-26 Medtronic Minimed, Inc. System and method for variable beacon timing with wireless devices
US9326707B2 (en) 2008-11-10 2016-05-03 Abbott Diabetes Care Inc. Alarm characterization for analyte monitoring devices and systems
US8951377B2 (en) 2008-11-14 2015-02-10 Pepex Biomedical, Inc. Manufacturing electrochemical sensor module
WO2010056878A2 (en) 2008-11-14 2010-05-20 Pepex Biomedical, Llc Electrochemical sensor module
US8506740B2 (en) 2008-11-14 2013-08-13 Pepex Biomedical, Llc Manufacturing electrochemical sensor module
US9330237B2 (en) 2008-12-24 2016-05-03 Medtronic Minimed, Inc. Pattern recognition and filtering in a therapy management system
US8103456B2 (en) 2009-01-29 2012-01-24 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
WO2011034629A1 (en) * 2009-02-05 2011-03-24 Abbott Diabetes Care Inc. Devices and methods for metering insoluble active agent particles
DK3912551T3 (en) 2009-02-26 2023-10-30 Abbott Diabetes Care Inc Procedure for calibrating an analyte sensor
US9339229B2 (en) 2009-02-26 2016-05-17 Abbott Diabetes Care Inc. Analyte monitoring devices and methods
US8497777B2 (en) 2009-04-15 2013-07-30 Abbott Diabetes Care Inc. Analyte monitoring system having an alert
US8758583B2 (en) 2009-04-28 2014-06-24 Abbott Diabetes Care Inc. Smart sensor ports and methods of using same
EP2425247A4 (en) * 2009-04-28 2013-01-23 Innovative Lab Technologies Inc Lateral-flow immuno-chromatographic assay devices
EP2425209A4 (en) 2009-04-29 2013-01-09 Abbott Diabetes Care Inc Method and system for providing real time analyte sensor calibration with retrospective backfill
US8236254B2 (en) * 2009-05-14 2012-08-07 Abbott Diabetes Care Inc. Cap-linked test strip carrier for vial augmentation
EP2434944B1 (en) 2009-05-29 2014-12-03 Abbott Diabetes Care, Inc. Glucose monitoring system with wireless communications
EP2438527B1 (en) 2009-06-04 2018-05-02 Abbott Diabetes Care, Inc. Method and system for updating a medical device
EP2266458A1 (en) * 2009-06-23 2010-12-29 Roche Diagnostics GmbH Sensor for in-vivo measurements
US8613892B2 (en) 2009-06-30 2013-12-24 Abbott Diabetes Care Inc. Analyte meter with a moveable head and methods of using the same
US8000763B2 (en) * 2009-06-30 2011-08-16 Abbott Diabetes Care Inc. Integrated devices having extruded electrode structures and methods of using same
US8437827B2 (en) * 2009-06-30 2013-05-07 Abbott Diabetes Care Inc. Extruded analyte sensors and methods of using same
US8344847B2 (en) 2009-07-09 2013-01-01 Medtronic Minimed, Inc. Coordination of control commands in a medical device system having at least one therapy delivery device and at least one wireless controller device
EP3932309A1 (en) 2009-07-23 2022-01-05 Abbott Diabetes Care, Inc. Continuous analyte measurement system
US20110040208A1 (en) * 2009-08-11 2011-02-17 Abbott Diabetes Care Inc. Integrated lancet and test strip and methods of making and using same
US9125603B2 (en) 2009-08-11 2015-09-08 Abbott Diabetes Care Inc. Analyte sensor ports
ES2912584T3 (en) 2009-08-31 2022-05-26 Abbott Diabetes Care Inc A glucose monitoring system and method
US8357276B2 (en) 2009-08-31 2013-01-22 Abbott Diabetes Care Inc. Small volume test strips with large sample fill ports, supported test strips, and methods of making and using same
US8487758B2 (en) 2009-09-02 2013-07-16 Medtronic Minimed, Inc. Medical device having an intelligent alerting scheme, and related operating methods
US9320461B2 (en) 2009-09-29 2016-04-26 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
WO2011053881A1 (en) 2009-10-30 2011-05-05 Abbott Diabetes Care Inc. Method and apparatus for detecting false hypoglycemic conditions
US8386042B2 (en) 2009-11-03 2013-02-26 Medtronic Minimed, Inc. Omnidirectional accelerometer device and medical device incorporating same
WO2011075575A1 (en) 2009-12-17 2011-06-23 Bayer Healthcare Llc Transdermal systems, devices, and methods to optically analyze an analyte
US8574201B2 (en) 2009-12-22 2013-11-05 Medtronic Minimed, Inc. Syringe piston with check valve seal
US8755269B2 (en) 2009-12-23 2014-06-17 Medtronic Minimed, Inc. Ranking and switching of wireless channels in a body area network of medical devices
US8828330B2 (en) * 2010-01-28 2014-09-09 Abbott Diabetes Care Inc. Universal test strip port
US20110186428A1 (en) * 2010-01-29 2011-08-04 Roche Diagnostics Operations, Inc. Electrode arrangements for biosensors
USD924406S1 (en) 2010-02-01 2021-07-06 Abbott Diabetes Care Inc. Analyte sensor inserter
CN102548476A (en) 2010-03-24 2012-07-04 雅培糖尿病护理公司 Medical device inserters and processes of inserting and using medical devices
WO2013066362A1 (en) 2011-02-17 2013-05-10 Abbott Diabetes Care Inc. Analyte meter communication module
CA2766947A1 (en) 2010-04-16 2011-10-20 Abbott Diabetes Care Inc. Analyte monitoring device and methods
US8919607B2 (en) 2010-04-16 2014-12-30 Abbott Diabetes Care Inc. Analyte test strip vial
US9198623B2 (en) 2010-04-22 2015-12-01 Abbott Diabetes Care Inc. Devices, systems, and methods related to analyte monitoring and management
US8235897B2 (en) 2010-04-27 2012-08-07 A.D. Integrity Applications Ltd. Device for non-invasively measuring glucose
WO2011149857A1 (en) 2010-05-24 2011-12-01 Abbott Diabetes Care Inc. Method and system for updating a medical device
US8635046B2 (en) 2010-06-23 2014-01-21 Abbott Diabetes Care Inc. Method and system for evaluating analyte sensor response characteristics
US10092229B2 (en) 2010-06-29 2018-10-09 Abbott Diabetes Care Inc. Calibration of analyte measurement system
US11064921B2 (en) 2010-06-29 2021-07-20 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
ES2630755T3 (en) 2010-07-09 2017-08-23 Case Western Reserve University In vitro sensor for the point of care and use procedure
DK2598021T3 (en) 2010-07-28 2015-09-28 Abbott Diabetes Care Inc Analyte sensors with temperature-independent membranes
US8715933B2 (en) 2010-09-27 2014-05-06 Nabsys, Inc. Assay methods using nicking endonucleases
US8757386B2 (en) 2010-09-30 2014-06-24 Abbott Diabetes Care Inc. Analyte test strip containers and inserts
US9184099B2 (en) 2010-10-04 2015-11-10 The Board Of Trustees Of The Leland Stanford Junior University Biosensor devices, systems and methods therefor
NZ610129A (en) 2010-10-04 2014-08-29 Genapsys Inc Systems and methods for automated reusable parallel biological reactions
US8562565B2 (en) 2010-10-15 2013-10-22 Medtronic Minimed, Inc. Battery shock absorber for a portable medical device
US8603033B2 (en) 2010-10-15 2013-12-10 Medtronic Minimed, Inc. Medical device and related assembly having an offset element for a piezoelectric speaker
US8603032B2 (en) 2010-10-15 2013-12-10 Medtronic Minimed, Inc. Medical device with membrane keypad sealing element, and related manufacturing method
US8495918B2 (en) 2010-10-20 2013-07-30 Medtronic Minimed, Inc. Sensor assembly and medical device incorporating same
US8479595B2 (en) 2010-10-20 2013-07-09 Medtronic Minimed, Inc. Sensor assembly and medical device incorporating same
US8474332B2 (en) 2010-10-20 2013-07-02 Medtronic Minimed, Inc. Sensor assembly and medical device incorporating same
WO2012058237A1 (en) * 2010-10-26 2012-05-03 Abbott Diabetes Care Inc. Analyte measurement devices and systems, and components and methods related thereto
KR101831365B1 (en) * 2010-11-01 2018-02-22 카프센제 에이치비 Method of measuring a capacitance
US20130229288A1 (en) * 2010-11-15 2013-09-05 Lifescan Scotland Limited Server-side initiated communication with analyte meter-side completed data transfer
JP5998148B2 (en) 2010-11-16 2016-09-28 ナブシス 2.0 エルエルシー Method for sequencing biomolecules by detecting the relative position of hybridized probes
US8702928B2 (en) 2010-11-22 2014-04-22 Abbott Diabetes Care Inc. Modular analyte measurement system with extendable strip port
US9713440B2 (en) 2010-12-08 2017-07-25 Abbott Diabetes Care Inc. Modular analyte measurement systems, modular components thereof and related methods
AU2011338255B2 (en) 2010-12-09 2016-06-02 Abbott Diabetes Care Inc. Analyte sensors with a sensing surface having small sensing spots
US8628510B2 (en) 2010-12-22 2014-01-14 Medtronic Minimed, Inc. Monitoring the operating health of a force sensor in a fluid infusion device
US8197444B1 (en) 2010-12-22 2012-06-12 Medtronic Minimed, Inc. Monitoring the seating status of a fluid reservoir in a fluid infusion device
US8690855B2 (en) 2010-12-22 2014-04-08 Medtronic Minimed, Inc. Fluid reservoir seating procedure for a fluid infusion device
US8469942B2 (en) 2010-12-22 2013-06-25 Medtronic Minimed, Inc. Occlusion detection for a fluid infusion device
WO2012108938A1 (en) 2011-02-11 2012-08-16 Abbott Diabetes Care Inc. Software applications residing on handheld analyte determining devices
WO2012109574A2 (en) 2011-02-11 2012-08-16 Nabsys, Inc. Assay methods using dna binding proteins
US20140088392A1 (en) 2011-02-11 2014-03-27 Abbott Diabetes Care Inc. Feedback from Cloud or HCP to Payer or Patient via Meter or Cell Phone
WO2012108936A1 (en) 2011-02-11 2012-08-16 Abbott Diabetes Care Inc. Data synchronization between two or more analyte detecting devices in a database
US9283318B2 (en) 2011-02-22 2016-03-15 Medtronic Minimed, Inc. Flanged sealing element and needle guide pin assembly for a fluid infusion device having a needled fluid reservoir
US9463309B2 (en) 2011-02-22 2016-10-11 Medtronic Minimed, Inc. Sealing assembly and structure for a fluid infusion device having a needled fluid reservoir
US9393399B2 (en) 2011-02-22 2016-07-19 Medtronic Minimed, Inc. Sealing assembly for a fluid reservoir of a fluid infusion device
US20120211946A1 (en) 2011-02-22 2012-08-23 Medtronic Minimed, Inc. Sealing element for a hollow needle of a fluid infusion device
US10136845B2 (en) 2011-02-28 2018-11-27 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
US8614596B2 (en) 2011-02-28 2013-12-24 Medtronic Minimed, Inc. Systems and methods for initializing a voltage bus and medical devices incorporating same
SG10201403561WA (en) 2011-02-28 2014-09-26 Luoxis Diagnostics Inc Method and apparatus for measuring oxidation-reduction potential
US9101305B2 (en) 2011-03-09 2015-08-11 Medtronic Minimed, Inc. Glucose sensor product and related manufacturing and packaging methods
US10010273B2 (en) 2011-03-10 2018-07-03 Abbott Diabetes Care, Inc. Multi-function analyte monitor device and methods of use
JP2014514141A (en) * 2011-03-15 2014-06-19 カルクロ テクニカル プラスチックス リミテッド Surface formation
US9018893B2 (en) 2011-03-18 2015-04-28 Medtronic Minimed, Inc. Power control techniques for an electronic device
US8564447B2 (en) 2011-03-18 2013-10-22 Medtronic Minimed, Inc. Battery life indication techniques for an electronic device
WO2012131903A1 (en) * 2011-03-29 2012-10-04 株式会社テクノメデイカ Biosensor
US8956518B2 (en) * 2011-04-20 2015-02-17 Lifescan, Inc. Electrochemical sensors with carrier field
US9504162B2 (en) 2011-05-20 2016-11-22 Pepex Biomedical, Inc. Manufacturing electrochemical sensor modules
US9926596B2 (en) 2011-05-27 2018-03-27 Genapsys, Inc. Systems and methods for genetic and biological analysis
US8585973B2 (en) 2011-05-27 2013-11-19 The Board Of Trustees Of The Leland Stanford Junior University Nano-sensor array
EP3556285B1 (en) 2011-06-16 2022-08-31 Abbott Diabetes Care, Inc. Temperature-compensated analyte monitoring devices, systems, and methods thereof
WO2013003735A1 (en) 2011-06-30 2013-01-03 Abbott Diabetes Care Inc. Methods for generating hybrid analyte level output, and devices and systems related thereto
US8560251B2 (en) * 2011-08-16 2013-10-15 Instrumentation Laboratory Company System and method of increasing sample throughput by estimation of a sensor endpoint
ES2608592T3 (en) * 2011-08-16 2017-04-12 Instrumentation Laboratory Company Extrapolation of data from interpolated sensors to increase sample throughput
EP3689235A1 (en) 2011-09-28 2020-08-05 Abbott Diabetes Care, Inc. Methods for analyte monitoring management and analyte measurement data management, and articles of manufacture related thereto
US20130093605A1 (en) * 2011-10-17 2013-04-18 Ching-Te CHEN Signal generation circuit for keyboards
USD680454S1 (en) 2011-10-25 2013-04-23 Abbott Diabetes Care Inc. Analyte meter and strip port
US9622691B2 (en) 2011-10-31 2017-04-18 Abbott Diabetes Care Inc. Model based variable risk false glucose threshold alarm prevention mechanism
US8710993B2 (en) 2011-11-23 2014-04-29 Abbott Diabetes Care Inc. Mitigating single point failure of devices in an analyte monitoring system and methods thereof
US9317656B2 (en) 2011-11-23 2016-04-19 Abbott Diabetes Care Inc. Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof
CN104105797B (en) 2011-12-01 2016-08-31 吉纳普赛斯股份有限公司 System and method for efficent electronic order-checking with detection
US8887911B2 (en) 2011-12-09 2014-11-18 Abbott Diabetes Care Inc. Packages and kits for analyte monitoring devices, and methods related thereto
FI4056105T3 (en) 2011-12-11 2023-12-28 Abbott Diabetes Care Inc Analyte sensor devices
US9610401B2 (en) 2012-01-13 2017-04-04 Medtronic Minimed, Inc. Infusion set component with modular fluid channel element
US8603027B2 (en) 2012-03-20 2013-12-10 Medtronic Minimed, Inc. Occlusion detection using pulse-width modulation and medical device incorporating same
US8523803B1 (en) 2012-03-20 2013-09-03 Medtronic Minimed, Inc. Motor health monitoring and medical device incorporating same
US8603026B2 (en) 2012-03-20 2013-12-10 Medtronic Minimed, Inc. Dynamic pulse-width modulation motor control and medical device incorporating same
KR20150013146A (en) 2012-04-19 2015-02-04 로익스 다이어그노스틱스, 아이엔씨. Multiple layer gel
US20130338630A1 (en) 2012-06-07 2013-12-19 Medtronic Minimed, Inc. Diabetes therapy management system for recommending adjustments to an insulin infusion device
US9333292B2 (en) 2012-06-26 2016-05-10 Medtronic Minimed, Inc. Mechanically actuated fluid infusion device
DE102012210921A1 (en) * 2012-06-27 2014-01-23 Robert Bosch Gmbh Contact element for connection to a printed circuit board, contact system and method
US9535027B2 (en) 2012-07-25 2017-01-03 Abbott Diabetes Care Inc. Analyte sensors and methods of using same
US8808269B2 (en) 2012-08-21 2014-08-19 Medtronic Minimed, Inc. Reservoir plunger position monitoring and medical device incorporating same
US9623179B2 (en) 2012-08-30 2017-04-18 Medtronic Minimed, Inc. Safeguarding techniques for a closed-loop insulin infusion system
US9662445B2 (en) 2012-08-30 2017-05-30 Medtronic Minimed, Inc. Regulating entry into a closed-loop operating mode of an insulin infusion system
US10496797B2 (en) 2012-08-30 2019-12-03 Medtronic Minimed, Inc. Blood glucose validation for a closed-loop operating mode of an insulin infusion system
US10130767B2 (en) 2012-08-30 2018-11-20 Medtronic Minimed, Inc. Sensor model supervisor for a closed-loop insulin infusion system
US20140066884A1 (en) 2012-08-30 2014-03-06 Medtronic Minimed, Inc. Sensor model supervisor for a closed-loop insulin infusion system
US9878096B2 (en) 2012-08-30 2018-01-30 Medtronic Minimed, Inc. Generation of target glucose values for a closed-loop operating mode of an insulin infusion system
US10132793B2 (en) 2012-08-30 2018-11-20 Abbott Diabetes Care Inc. Dropout detection in continuous analyte monitoring data during data excursions
US9849239B2 (en) 2012-08-30 2017-12-26 Medtronic Minimed, Inc. Generation and application of an insulin limit for a closed-loop operating mode of an insulin infusion system
WO2014047484A1 (en) 2012-09-21 2014-03-27 Abbott Diabetes Care Inc. Test strips having ceria nanoparticle electrodes
US9907492B2 (en) 2012-09-26 2018-03-06 Abbott Diabetes Care Inc. Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data
EP2885636B1 (en) 2012-10-23 2018-02-14 Aytu BioScience, Inc. Methods and systems for measuring oxidation-reduction potential of a biological sample
US8870818B2 (en) 2012-11-15 2014-10-28 Medtronic Minimed, Inc. Systems and methods for alignment and detection of a consumable component
BR112015012958B1 (en) 2012-12-03 2022-03-15 Pepex Biomedical, Inc Sensor module to detect an analyte in a blood sample
US9157882B2 (en) 2012-12-20 2015-10-13 Cilag Gmbh International Analytical test strip
US9914966B1 (en) 2012-12-20 2018-03-13 Nabsys 2.0 Llc Apparatus and methods for analysis of biomolecules using high frequency alternating current excitation
US8926369B2 (en) * 2012-12-20 2015-01-06 Lifescan Scotland Limited Electrical connector for substrate having conductive tracks
ES2670702T3 (en) 2012-12-21 2018-05-31 Abbott Diabetes Care, Inc. Procedure to improve the accuracy of a measurement and related devices and systems
US20140186866A1 (en) * 2012-12-27 2014-07-03 General Electric Company Glucose Control Test Strip
EP2956550B1 (en) 2013-01-18 2020-04-08 Nabsys 2.0 LLC Enhanced probe binding
US9522223B2 (en) 2013-01-18 2016-12-20 Medtronic Minimed, Inc. Systems for fluid reservoir retention
US9107994B2 (en) 2013-01-18 2015-08-18 Medtronic Minimed, Inc. Systems for fluid reservoir retention
US9033924B2 (en) 2013-01-18 2015-05-19 Medtronic Minimed, Inc. Systems for fluid reservoir retention
US9308321B2 (en) 2013-02-18 2016-04-12 Medtronic Minimed, Inc. Infusion device having gear assembly initialization
US9097659B2 (en) * 2013-03-14 2015-08-04 Bayer Healthcare Llc Maintaining electrode function during manufacture with a protective layer
US9121050B2 (en) 2013-03-15 2015-09-01 American Sterilizer Company Non-enzyme based detection method for electronic monitoring of biological indicator
US9474475B1 (en) 2013-03-15 2016-10-25 Abbott Diabetes Care Inc. Multi-rate analyte sensor data collection with sample rate configurable signal processing
US10168313B2 (en) 2013-03-15 2019-01-01 Agamatrix, Inc. Analyte detection meter and associated method of use
CN105377118B (en) 2013-03-15 2019-09-17 雅培糖尿病护理公司 Equipment, system and method associated with analyte supervision equipment and the equipment comprising it
WO2014152034A1 (en) 2013-03-15 2014-09-25 Abbott Diabetes Care Inc. Sensor fault detection using analyte sensor data pattern comparison
US9809852B2 (en) 2013-03-15 2017-11-07 Genapsys, Inc. Systems and methods for biological analysis
US8858884B2 (en) 2013-03-15 2014-10-14 American Sterilizer Company Coupled enzyme-based method for electronic monitoring of biological indicator
US10433773B1 (en) 2013-03-15 2019-10-08 Abbott Diabetes Care Inc. Noise rejection methods and apparatus for sparsely sampled analyte sensor data
US10041901B2 (en) 2013-03-15 2018-08-07 Roche Diabetes Care, Inc. Electrode configuration for a biosensor
US8920381B2 (en) 2013-04-12 2014-12-30 Medtronic Minimed, Inc. Infusion set with improved bore configuration
EP2991552A4 (en) 2013-04-30 2017-01-11 Abbott Diabetes Care Inc. Systems, devices, and methods for energy efficient electrical device activation
KR101447970B1 (en) 2013-06-13 2014-10-13 명지대학교 산학협력단 Sensor strip for blood glucose monitoring, method of manufacturing the sensor strip, and monitoring device using the same
US9433731B2 (en) 2013-07-19 2016-09-06 Medtronic Minimed, Inc. Detecting unintentional motor motion and infusion device incorporating same
EP3033614A1 (en) * 2013-08-12 2016-06-22 Ascensia Diabetes Care Holdings AG Washable analyte meters, sealed connectors, and methods of manufacturing and using same
US9402949B2 (en) 2013-08-13 2016-08-02 Medtronic Minimed, Inc. Detecting conditions associated with medical device operations using matched filters
US9889257B2 (en) 2013-08-21 2018-02-13 Medtronic Minimed, Inc. Systems and methods for updating medical devices
US9880528B2 (en) 2013-08-21 2018-01-30 Medtronic Minimed, Inc. Medical devices and related updating methods and systems
US9259528B2 (en) 2013-08-22 2016-02-16 Medtronic Minimed, Inc. Fluid infusion device with safety coupling
US20150096906A1 (en) * 2013-10-07 2015-04-09 Cilag Gmbh International Biosensor with bypass electrodes
EP3066744B1 (en) 2013-11-05 2019-10-23 Abbott Diabetes Care Inc. Systems, devices, and methods for control of a power supply connection
US9750877B2 (en) 2013-12-11 2017-09-05 Medtronic Minimed, Inc. Predicted time to assess and/or control a glycemic state
US9750878B2 (en) 2013-12-11 2017-09-05 Medtronic Minimed, Inc. Closed-loop control of glucose according to a predicted blood glucose trajectory
EP3792921A1 (en) 2013-12-11 2021-03-17 Genapsys, Inc. Systems and methods for biological analysis and computation
US9849240B2 (en) 2013-12-12 2017-12-26 Medtronic Minimed, Inc. Data modification for predictive operations and devices incorporating same
US10105488B2 (en) 2013-12-12 2018-10-23 Medtronic Minimed, Inc. Predictive infusion device operations and related methods and systems
US9694132B2 (en) 2013-12-19 2017-07-04 Medtronic Minimed, Inc. Insertion device for insertion set
EP3780689A1 (en) 2013-12-27 2021-02-17 Abbott Diabetes Care, Inc. Systems, devices, and methods for authentication in an analyte monitoring environment
WO2015100142A1 (en) 2013-12-27 2015-07-02 Abbott Diabetes Care Inc. Application interface and display control in an analyte monitoring environment
WO2015102745A1 (en) 2013-12-31 2015-07-09 Abbott Diabetes Care Inc. Self-powered analyte sensor and devices using the same
JP6346749B2 (en) * 2014-01-27 2018-06-20 株式会社タニタ Defective physical condition determination apparatus, method, and program
US9399096B2 (en) 2014-02-06 2016-07-26 Medtronic Minimed, Inc. Automatic closed-loop control adjustments and infusion systems incorporating same
US9861748B2 (en) 2014-02-06 2018-01-09 Medtronic Minimed, Inc. User-configurable closed-loop notifications and infusion systems incorporating same
US9610402B2 (en) 2014-03-24 2017-04-04 Medtronic Minimed, Inc. Transcutaneous conduit insertion mechanism with a living hinge for use with a fluid infusion patch pump device
WO2015153482A1 (en) 2014-03-30 2015-10-08 Abbott Diabetes Care Inc. Method and apparatus for determining meal start and peak events in analyte monitoring systems
EP3556864B1 (en) 2014-04-18 2020-12-09 Genapsys, Inc. Methods and systems for nucleic acid amplification
US10001450B2 (en) 2014-04-18 2018-06-19 Medtronic Minimed, Inc. Nonlinear mapping technique for a physiological characteristic sensor
US10232113B2 (en) 2014-04-24 2019-03-19 Medtronic Minimed, Inc. Infusion devices and related methods and systems for regulating insulin on board
US10275572B2 (en) 2014-05-01 2019-04-30 Medtronic Minimed, Inc. Detecting blockage of a reservoir cavity during a seating operation of a fluid infusion device
US9681828B2 (en) 2014-05-01 2017-06-20 Medtronic Minimed, Inc. Physiological characteristic sensors and methods for forming such sensors
JP2015232550A (en) * 2014-05-13 2015-12-24 アークレイ株式会社 Sensor body, manufacturing method of sensor body, and sensor cartridge
US10274349B2 (en) 2014-05-19 2019-04-30 Medtronic Minimed, Inc. Calibration factor adjustments for infusion devices and related methods and systems
US10152049B2 (en) 2014-05-19 2018-12-11 Medtronic Minimed, Inc. Glucose sensor health monitoring and related methods and systems
US10007765B2 (en) 2014-05-19 2018-06-26 Medtronic Minimed, Inc. Adaptive signal processing for infusion devices and related methods and systems
US11045124B2 (en) 2014-06-04 2021-06-29 Pepex Biomedical, Inc. Electrochemical sensors and methods for making electrochemical sensors using advanced printing technology
US10042006B2 (en) * 2014-06-11 2018-08-07 GM Global Technology Operations LLC Battery state of health estimation using charging resistance equivalent
MX2017000584A (en) 2014-07-17 2017-07-05 Siemens Healthcare Diagnostics Inc Sensor array.
GB201413628D0 (en) * 2014-07-31 2014-09-17 Inside Biometrics Ltd Method and device for determining volumetric sufficiency in an electrochemical test strip
US9839753B2 (en) 2014-09-26 2017-12-12 Medtronic Minimed, Inc. Systems for managing reservoir chamber pressure
US9833563B2 (en) 2014-09-26 2017-12-05 Medtronic Minimed, Inc. Systems for managing reservoir chamber pressure
US10279126B2 (en) 2014-10-07 2019-05-07 Medtronic Minimed, Inc. Fluid conduit assembly with gas trapping filter in the fluid flow path
US9833564B2 (en) 2014-11-25 2017-12-05 Medtronic Minimed, Inc. Fluid conduit assembly with air venting features
US9987420B2 (en) 2014-11-26 2018-06-05 Medtronic Minimed, Inc. Systems and methods for fluid infusion device with automatic reservoir fill
US10195341B2 (en) 2014-11-26 2019-02-05 Medtronic Minimed, Inc. Systems and methods for fluid infusion device with automatic reservoir fill
US9636453B2 (en) 2014-12-04 2017-05-02 Medtronic Minimed, Inc. Advance diagnosis of infusion device operating mode viability
US9943645B2 (en) 2014-12-04 2018-04-17 Medtronic Minimed, Inc. Methods for operating mode transitions and related infusion devices and systems
US9937292B2 (en) 2014-12-09 2018-04-10 Medtronic Minimed, Inc. Systems for filling a fluid infusion device reservoir
US10265031B2 (en) 2014-12-19 2019-04-23 Medtronic Minimed, Inc. Infusion devices and related methods and systems for automatic alert clearing
US10307535B2 (en) 2014-12-19 2019-06-04 Medtronic Minimed, Inc. Infusion devices and related methods and systems for preemptive alerting
WO2016106320A2 (en) * 2014-12-22 2016-06-30 Siemens Healthcare Diagnostics Inc. Foldable opposing sensor array
US10161897B2 (en) * 2015-01-09 2018-12-25 Xerox Corporation Sensors incorporating palladium electrodes
US10307528B2 (en) 2015-03-09 2019-06-04 Medtronic Minimed, Inc. Extensible infusion devices and related methods
US9904890B2 (en) 2015-03-13 2018-02-27 Instrumentation Laboratory Company Detecting a transient error in a body fluid sample
US10449298B2 (en) 2015-03-26 2019-10-22 Medtronic Minimed, Inc. Fluid injection devices and related methods
GB201507508D0 (en) * 2015-04-30 2015-06-17 Inside Biometrics Ltd Electrochemical Test Device
US10674944B2 (en) 2015-05-14 2020-06-09 Abbott Diabetes Care Inc. Compact medical device inserters and related systems and methods
US10213139B2 (en) 2015-05-14 2019-02-26 Abbott Diabetes Care Inc. Systems, devices, and methods for assembling an applicator and sensor control device
US10137243B2 (en) 2015-05-26 2018-11-27 Medtronic Minimed, Inc. Infusion devices with distributed motor control and related operating methods
US9999721B2 (en) 2015-05-26 2018-06-19 Medtronic Minimed, Inc. Error handling in infusion devices with distributed motor control and related operating methods
US10575767B2 (en) 2015-05-29 2020-03-03 Medtronic Minimed, Inc. Method for monitoring an analyte, analyte sensor and analyte monitoring apparatus
US10010668B2 (en) 2015-06-22 2018-07-03 Medtronic Minimed, Inc. Occlusion detection techniques for a fluid infusion device having a rotary pump mechanism and a force sensor
US9878095B2 (en) 2015-06-22 2018-01-30 Medtronic Minimed, Inc. Occlusion detection techniques for a fluid infusion device having a rotary pump mechanism and multiple sensor contact elements
US9987425B2 (en) 2015-06-22 2018-06-05 Medtronic Minimed, Inc. Occlusion detection techniques for a fluid infusion device having a rotary pump mechanism and sensor contact elements
US9879668B2 (en) 2015-06-22 2018-01-30 Medtronic Minimed, Inc. Occlusion detection techniques for a fluid infusion device having a rotary pump mechanism and an optical sensor
US9993594B2 (en) 2015-06-22 2018-06-12 Medtronic Minimed, Inc. Occlusion detection techniques for a fluid infusion device having a rotary pump mechanism and rotor position sensors
GB201511299D0 (en) * 2015-06-26 2015-08-12 Inside Biometrics Ltd Test device and method of using a test device
US10888272B2 (en) 2015-07-10 2021-01-12 Abbott Diabetes Care Inc. Systems, devices, and methods for meal information collection, meal assessment, and analyte data correlation
US11553883B2 (en) 2015-07-10 2023-01-17 Abbott Diabetes Care Inc. System, device and method of dynamic glucose profile response to physiological parameters
US10478557B2 (en) 2015-08-21 2019-11-19 Medtronic Minimed, Inc. Personalized parameter modeling methods and related devices and systems
US10201657B2 (en) 2015-08-21 2019-02-12 Medtronic Minimed, Inc. Methods for providing sensor site rotation feedback and related infusion devices and systems
US20170053552A1 (en) 2015-08-21 2017-02-23 Medtronic Minimed, Inc. Management and prioritization of the delivery of glycemic insight messages
US10463297B2 (en) 2015-08-21 2019-11-05 Medtronic Minimed, Inc. Personalized event detection methods and related devices and systems
US10293108B2 (en) 2015-08-21 2019-05-21 Medtronic Minimed, Inc. Infusion devices and related patient ratio adjustment methods
US10117992B2 (en) 2015-09-29 2018-11-06 Medtronic Minimed, Inc. Infusion devices and related rescue detection methods
US11666702B2 (en) 2015-10-19 2023-06-06 Medtronic Minimed, Inc. Medical devices and related event pattern treatment recommendation methods
US11501867B2 (en) 2015-10-19 2022-11-15 Medtronic Minimed, Inc. Medical devices and related event pattern presentation methods
US10146911B2 (en) 2015-10-23 2018-12-04 Medtronic Minimed, Inc. Medical devices and related methods and systems for data transfer
US10037722B2 (en) 2015-11-03 2018-07-31 Medtronic Minimed, Inc. Detecting breakage in a display element
US10827959B2 (en) * 2015-11-11 2020-11-10 Medtronic Minimed, Inc. Sensor set
US20170127985A1 (en) * 2015-11-11 2017-05-11 Medtronic Minimed, Inc. Sensor set
US10449306B2 (en) 2015-11-25 2019-10-22 Medtronics Minimed, Inc. Systems for fluid delivery with wicking membrane
CN205282702U (en) * 2015-12-03 2016-06-01 美国莫列斯有限公司 Electronic card connector
US11382185B2 (en) * 2016-01-08 2022-07-05 Siemens Healthcare Diagnostics Inc. Heating element for sensor array
KR101723785B1 (en) * 2016-02-01 2017-04-19 주식회사 아이센스 Strip Discharger for Portable Blood Glucose Tester
EP3427042B1 (en) 2016-03-08 2020-05-13 Roche Diagnostics GmbH Test element analysis system
WO2017173434A1 (en) * 2016-04-02 2017-10-05 Peabody Steven R Medical diagnostic device, system, and method of use
US10589038B2 (en) 2016-04-27 2020-03-17 Medtronic Minimed, Inc. Set connector systems for venting a fluid reservoir
CN116397014A (en) 2016-07-20 2023-07-07 测序健康公司 Systems and methods for nucleic acid sequencing
US11097051B2 (en) 2016-11-04 2021-08-24 Medtronic Minimed, Inc. Methods and apparatus for detecting and reacting to insufficient hypoglycemia response
US10238030B2 (en) 2016-12-06 2019-03-26 Medtronic Minimed, Inc. Wireless medical device with a complementary split ring resonator arrangement for suppression of electromagnetic interference
US20180172664A1 (en) 2016-12-20 2018-06-21 Abbott Diabetes Care Inc. Systems, devices, and methods for wireless communications in analyte monitoring systems
US10272201B2 (en) 2016-12-22 2019-04-30 Medtronic Minimed, Inc. Insertion site monitoring methods and related infusion devices and systems
WO2018136898A1 (en) 2017-01-23 2018-07-26 Abbott Diabetes Care Inc. Systems, devices and methods for analyte sensor insertion
US10500135B2 (en) 2017-01-30 2019-12-10 Medtronic Minimed, Inc. Fluid reservoir and systems for filling a fluid reservoir of a fluid infusion device
US10532165B2 (en) 2017-01-30 2020-01-14 Medtronic Minimed, Inc. Fluid reservoir and systems for filling a fluid reservoir of a fluid infusion device
US10363365B2 (en) 2017-02-07 2019-07-30 Medtronic Minimed, Inc. Infusion devices and related consumable calibration methods
US10552580B2 (en) 2017-02-07 2020-02-04 Medtronic Minimed, Inc. Infusion system consumables and related calibration methods
US11207463B2 (en) 2017-02-21 2021-12-28 Medtronic Minimed, Inc. Apparatuses, systems, and methods for identifying an infusate in a reservoir of an infusion device
US10646649B2 (en) 2017-02-21 2020-05-12 Medtronic Minimed, Inc. Infusion devices and fluid identification apparatuses and methods
US11596330B2 (en) 2017-03-21 2023-03-07 Abbott Diabetes Care Inc. Methods, devices and system for providing diabetic condition diagnosis and therapy
KR101953012B1 (en) * 2017-03-28 2019-02-27 고려대학교 산학협력단 Chamber chip, blood testing device including the chamber chip and method of manufacturing the blood testing device
JP2019002738A (en) 2017-06-13 2019-01-10 アークレイ株式会社 Biosensor and measurement method using the same
DE202018006591U1 (en) 2017-08-18 2021-07-21 Abbott Diabetes Care, Inc. Systems and devices relating to the individualized calibration and / or manufacture of medical devices
CN111566224A (en) 2017-09-21 2020-08-21 吉纳普赛斯股份有限公司 Systems and methods for nucleic acid sequencing
GB2567681B (en) * 2017-10-20 2022-05-04 Palintest Ltd Amperometric instrument for an electrochemical sensor
WO2019152966A1 (en) 2018-02-05 2019-08-08 Abbott Diabetes Care Inc. Notes and event log information associated with analyte sensors
GB201804812D0 (en) * 2018-03-26 2018-05-09 Univ Swansea Biosensor
TWI696830B (en) * 2019-06-05 2020-06-21 國立中山大學 Combined electrochemical analyzing device
USD1002852S1 (en) 2019-06-06 2023-10-24 Abbott Diabetes Care Inc. Analyte sensor device
TWI706131B (en) * 2019-08-26 2020-10-01 臺灣塑膠工業股份有限公司 Urine testing strip and urine testing system
USD957438S1 (en) 2020-07-29 2022-07-12 Abbott Diabetes Care Inc. Display screen or portion thereof with graphical user interface
USD999913S1 (en) 2020-12-21 2023-09-26 Abbott Diabetes Care Inc Analyte sensor inserter
EP4016068A1 (en) * 2020-12-21 2022-06-22 F. Hoffmann-La Roche AG Sensor assembly
US20220233116A1 (en) 2021-01-26 2022-07-28 Abbott Diabetes Care Inc. Systems, devices, and methods related to ketone sensors
JP2023116144A (en) 2022-02-09 2023-08-22 アークレイ株式会社 Testing tool and measurement apparatus
TWI814562B (en) * 2022-08-31 2023-09-01 超極生技股份有限公司 Electrochemical test strip for measuring gas ph

Citations (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3653841A (en) * 1969-12-19 1972-04-04 Hoffmann La Roche Methods and compositions for determining glucose in blood
US3719564A (en) * 1971-05-10 1973-03-06 Philip Morris Inc Method of determining a reducible gas concentration and sensor therefor
US4008717A (en) * 1973-01-15 1977-02-22 The Johns Hopkins University System for continuous withdrawal and analysis of blood
US4016866A (en) * 1975-12-18 1977-04-12 General Electric Company Implantable electrochemical sensor
US4076596A (en) * 1976-10-07 1978-02-28 Leeds & Northrup Company Apparatus for electrolytically determining a species in a fluid and method of use
US4151845A (en) * 1977-11-25 1979-05-01 Miles Laboratories, Inc. Blood glucose control apparatus
US4247297A (en) * 1979-02-23 1981-01-27 Miles Laboratories, Inc. Test means and method for interference resistant determination of oxidizing substances
US4318784A (en) * 1978-08-15 1982-03-09 National Research Development Corporation Enzymatic processes
US4375399A (en) * 1978-09-08 1983-03-01 Radelkis Elektrokemiai Miszergyarto Szovetkezet Molecule selective sensor for industrial use and procedure for its preparation
US4384586A (en) * 1978-02-17 1983-05-24 Christiansen Torben F Method and apparatus for pH recording
US4427770A (en) * 1982-06-14 1984-01-24 Miles Laboratories, Inc. High glucose-determining analytical element
US4431004A (en) * 1981-10-27 1984-02-14 Bessman Samuel P Implantable glucose sensor
US4436094A (en) * 1981-03-09 1984-03-13 Evreka, Inc. Monitor for continuous in vivo measurement of glucose concentration
US4440175A (en) * 1981-08-10 1984-04-03 University Patents, Inc. Membrane electrode for non-ionic species
US4444892A (en) * 1980-10-20 1984-04-24 Malmros Mark K Analytical device having semiconductive organic polymeric element associated with analyte-binding substance
US4450842A (en) * 1980-04-25 1984-05-29 Cordis Corporation Solid state reference electrode
US4571292A (en) * 1982-08-12 1986-02-18 Case Western Reserve University Apparatus for electrochemical measurements
US4573994A (en) * 1979-04-27 1986-03-04 The Johns Hopkins University Refillable medication infusion apparatus
US4581336A (en) * 1982-04-26 1986-04-08 Uop Inc. Surface-modified electrodes
US4633878A (en) * 1983-04-18 1987-01-06 Guiseppe Bombardieri Device for the automatic insulin or glucose infusion in diabetic subjects, based on the continuous monitoring of the patient's glucose, obtained without blood withdrawal
US4637403A (en) * 1985-04-08 1987-01-20 Garid, Inc. Glucose medical monitoring system
US4650547A (en) * 1983-05-19 1987-03-17 The Regents Of The University Of California Method and membrane applicable to implantable sensor
US4654197A (en) * 1983-10-18 1987-03-31 Aktiebolaget Leo Cuvette for sampling and analysis
US4655880A (en) * 1983-08-01 1987-04-07 Case Western Reserve University Apparatus and method for sensing species, substances and substrates using oxidase
US4655885A (en) * 1985-01-11 1987-04-07 National Research Development Corporation Surface-modified electrode and its use in a bioelectrochemical process
US4717673A (en) * 1984-11-23 1988-01-05 Massachusetts Institute Of Technology Microelectrochemical devices
US4721601A (en) * 1984-11-23 1988-01-26 Massachusetts Institute Of Technology Molecule-based microelectronic devices
US4726378A (en) * 1986-04-11 1988-02-23 Minnesota Mining And Manufacturing Company Adjustable magnetic supercutaneous device and transcutaneous coupling apparatus
US4795707A (en) * 1984-11-27 1989-01-03 Hitachi, Ltd. Electrochemical sensor having three layer membrane containing immobilized enzymes
US4805624A (en) * 1985-09-09 1989-02-21 The Montefiore Hospital Association Of Western Pa Low-potential electrochemical redox sensors
US4813424A (en) * 1987-12-23 1989-03-21 University Of New Mexico Long-life membrane electrode for non-ionic species
US4815469A (en) * 1987-10-08 1989-03-28 Siemens-Pacesetter, Inc. Implantable blood oxygen sensor and method of use
US4820399A (en) * 1984-08-31 1989-04-11 Shimadzu Corporation Enzyme electrodes
US4822337A (en) * 1987-06-22 1989-04-18 Stanley Newhouse Insulin delivery method and apparatus
US4830959A (en) * 1985-11-11 1989-05-16 Medisense, Inc. Electrochemical enzymic assay procedures
US4890620A (en) * 1985-09-20 1990-01-02 The Regents Of The University Of California Two-dimensional diffusion glucose substrate sensing electrode
US4894137A (en) * 1986-09-12 1990-01-16 Omron Tateisi Electronics Co. Enzyme electrode
US4897173A (en) * 1985-06-21 1990-01-30 Matsushita Electric Industrial Co., Ltd. Biosensor and method for making the same
US4897162A (en) * 1986-11-14 1990-01-30 The Cleveland Clinic Foundation Pulse voltammetry
US4909908A (en) * 1986-04-24 1990-03-20 Pepi Ross Electrochemical cncentration detector method
US4911794A (en) * 1986-06-20 1990-03-27 Molecular Devices Corporation Measuring with zero volume cell
US4918860A (en) * 1989-05-09 1990-04-24 Dennis Breadner Tree branch spreader
US4919141A (en) * 1987-01-03 1990-04-24 Institute fur Diabetestechnologie Gemeinnutzige Forschungs- und Entwicklungsgesellschaft mbH Implantable electrochemical sensor
US4919767A (en) * 1987-08-04 1990-04-24 Imperial Chemical Industries Plc Sensor and method for analyte determination
US4986271A (en) * 1989-07-19 1991-01-22 The University Of New Mexico Vivo refillable glucose sensor
US4994167A (en) * 1986-04-15 1991-02-19 Markwell Medical Institute, Inc. Biological fluid measuring device
US4999582A (en) * 1989-12-15 1991-03-12 Boehringer Mannheim Corp. Biosensor electrode excitation circuit
US5078854A (en) * 1990-01-22 1992-01-07 Mallinckrodt Sensor Systems, Inc. Polarographic chemical sensor with external reference electrode
US5082550A (en) * 1989-12-11 1992-01-21 The United States Of America As Represented By The Department Of Energy Enzyme electrochemical sensor electrode and method of making it
US5089112A (en) * 1989-03-20 1992-02-18 Associated Universities, Inc. Electrochemical biosensor based on immobilized enzymes and redox polymers
US5094931A (en) * 1987-04-15 1992-03-10 Hoechst Celanese Corporation Image transfer to diverse paper stocks
US5096560A (en) * 1989-05-30 1992-03-17 Mitsubishi Petrochemical Co., Ltd. Electrode for electrochemical detectors
US5096836A (en) * 1987-06-27 1992-03-17 Boehringer Mannheim Gmbh Diagnostic test carrier
US5101814A (en) * 1989-08-11 1992-04-07 Palti Yoram Prof System for monitoring and controlling blood glucose
US5108564A (en) * 1988-03-15 1992-04-28 Tall Oak Ventures Method and apparatus for amperometric diagnostic analysis
US5185256A (en) * 1985-06-21 1993-02-09 Matsushita Electric Industrial Co., Ltd. Method for making a biosensor
US5192416A (en) * 1991-04-09 1993-03-09 New Mexico State University Technology Transfer Corporation Method and apparatus for batch injection analysis
US5192415A (en) * 1991-03-04 1993-03-09 Matsushita Electric Industrial Co., Ltd. Biosensor utilizing enzyme and a method for producing the same
US5198367A (en) * 1989-06-09 1993-03-30 Masuo Aizawa Homogeneous amperometric immunoassay
US5200051A (en) * 1988-11-14 1993-04-06 I-Stat Corporation Wholly microfabricated biosensors and process for the manufacture and use thereof
US5202261A (en) * 1990-07-19 1993-04-13 Miles Inc. Conductive sensors and their use in diagnostic assays
US5205920A (en) * 1989-03-03 1993-04-27 Noboru Oyama Enzyme sensor and method of manufacturing the same
US5206145A (en) * 1988-05-19 1993-04-27 Thorn Emi Plc Method of measuring the concentration of a substance in a sample solution
US5278079A (en) * 1992-09-02 1994-01-11 Enzymatics, Inc. Sealing device and method for inhibition of flow in capillary measuring devices
US5286362A (en) * 1990-02-03 1994-02-15 Boehringer Mannheim Gmbh Method and sensor electrode system for the electrochemical determination of an analyte or an oxidoreductase as well as the use of suitable compounds therefor
US5286364A (en) * 1987-06-08 1994-02-15 Rutgers University Surface-modified electochemical biosensor
US5288636A (en) * 1989-12-15 1994-02-22 Boehringer Mannheim Corporation Enzyme electrode system
US5293546A (en) * 1991-04-17 1994-03-08 Martin Marietta Corporation Oxide coated metal grid electrode structure in display devices
US5378628A (en) * 1991-02-21 1995-01-03 Asulab, S.A. Sensor for measuring the amount of a component in solution
US5380422A (en) * 1991-07-18 1995-01-10 Agency Of Industrial Science And Technology Micro-electrode and method for preparing it
US5382346A (en) * 1991-05-17 1995-01-17 Kyoto Daiichi Kagaku Co., Ltd. Biosensor and method of quantitative analysis using the same
US5384028A (en) * 1992-08-28 1995-01-24 Nec Corporation Biosensor with a data memory
US5387327A (en) * 1992-10-19 1995-02-07 Duquesne University Of The Holy Ghost Implantable non-enzymatic electrochemical glucose sensor
US5391250A (en) * 1994-03-15 1995-02-21 Minimed Inc. Method of fabricating thin film sensors
US5390671A (en) * 1994-03-15 1995-02-21 Minimed Inc. Transcutaneous sensor insertion set
US5393903A (en) * 1991-02-21 1995-02-28 Asulab S.A. Mono, bis or tris(substituted 2,2'-bipyridine) iron, ruthenium, osmium or vanadium complexes and their methods of preparation
US5395504A (en) * 1993-02-04 1995-03-07 Asulab S.A. Electrochemical measuring system with multizone sensors
US5410474A (en) * 1993-07-27 1995-04-25 Miles Inc. Buttonless memory system for an electronic measurement device
US5494562A (en) * 1994-06-27 1996-02-27 Ciba Corning Diagnostics Corp. Electrochemical sensors
US5497772A (en) * 1993-11-19 1996-03-12 Alfred E. Mann Foundation For Scientific Research Glucose monitoring system
US5502396A (en) * 1993-09-21 1996-03-26 Asulab S.A. Measuring device with connection for a removable sensor
US5501956A (en) * 1990-03-23 1996-03-26 Molecular Devices Corporation Polyredox couples in analyte determinations
US5508171A (en) * 1989-12-15 1996-04-16 Boehringer Mannheim Corporation Assay method with enzyme electrode system
US5507288A (en) * 1994-05-05 1996-04-16 Boehringer Mannheim Gmbh Analytical system for monitoring a substance to be analyzed in patient-blood
US5593852A (en) * 1993-12-02 1997-01-14 Heller; Adam Subcutaneous glucose electrode
US5595479A (en) * 1993-04-05 1997-01-21 Danfoss A/S Hydraulic machine having teeth formed by rollers
US5596150A (en) * 1995-03-08 1997-01-21 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Capacitance probe for fluid flow and volume measurements
US5708247A (en) * 1996-02-14 1998-01-13 Selfcare, Inc. Disposable glucose test strips, and methods and compositions for making same
US5711862A (en) * 1995-03-15 1998-01-27 Omron Corporation Portable biochemical measurement device using an enzyme sensor
US5711861A (en) * 1995-11-22 1998-01-27 Ward; W. Kenneth Device for monitoring changes in analyte concentration
US5720028A (en) * 1995-06-07 1998-02-17 Hitachi, Ltd. External storage system
US5720862A (en) * 1995-04-07 1998-02-24 Kyoto Daiichi Kagaku Co., Ltd. Sensor and production method of and measurement method using the same
US5727548A (en) * 1983-05-05 1998-03-17 Medisense, Inc. Strip electrode with screen printing
US5741688A (en) * 1994-05-03 1998-04-21 Novo Nordisk A/S Alkaline glucose oxidase obtained from cladosporium oxysporum
US5741211A (en) * 1995-10-26 1998-04-21 Medtronic, Inc. System and method for continuous monitoring of diabetes-related blood constituents
US5857983A (en) * 1996-05-17 1999-01-12 Mercury Diagnostics, Inc. Methods and apparatus for sampling body fluid
US5879311A (en) * 1996-05-17 1999-03-09 Mercury Diagnostics, Inc. Body fluid sampling device and methods of use
US6033866A (en) * 1997-12-08 2000-03-07 Biomedix, Inc. Highly sensitive amperometric bi-mediator-based glucose biosensor

Family Cites Families (262)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3260656A (en) 1962-09-27 1966-07-12 Corning Glass Works Method and apparatus for electrolytically determining a species in a fluid
US3776832A (en) 1970-11-10 1973-12-04 Energetics Science Electrochemical detection cell
US3837339A (en) 1972-02-03 1974-09-24 Whittaker Corp Blood glucose level monitoring-alarm system and method therefor
GB1394171A (en) 1973-05-16 1975-05-14 Whittaker Corp Blood glucose level monitoring-alarm system and method therefor
US4100048A (en) 1973-09-20 1978-07-11 U.S. Philips Corporation Polarographic cell
US3972320A (en) 1974-08-12 1976-08-03 Gabor Ujhelyi Kalman Patient monitoring system
US3979274A (en) 1975-09-24 1976-09-07 The Yellow Springs Instrument Company, Inc. Membrane for enzyme electrodes
US4055175A (en) 1976-05-07 1977-10-25 Miles Laboratories, Inc. Blood glucose control apparatus
DE2625834B2 (en) 1976-06-09 1978-10-12 Boehringer Mannheim Gmbh, 6800 Mannheim Method for the determination of substrates or enzyme activities
US4059406A (en) 1976-07-12 1977-11-22 E D T Supplies Limited Electrochemical detector system
FR2387659A1 (en) 1977-04-21 1978-11-17 Armines GLYCEMIA CONTROL AND REGULATION DEVICE
US4098574A (en) 1977-08-01 1978-07-04 Eastman Kodak Company Glucose detection system free from fluoride-ion interference
US4178916A (en) 1977-09-26 1979-12-18 Mcnamara Elger W Diabetic insulin alarm system
JPS5912135B2 (en) 1977-09-28 1984-03-21 松下電器産業株式会社 enzyme electrode
JPS5921500B2 (en) 1978-01-28 1984-05-21 東洋紡績株式会社 Enzyme membrane for oxygen electrode
US4172770A (en) 1978-03-27 1979-10-30 Technicon Instruments Corporation Flow-through electrochemical system analytical method
DE2817363C2 (en) 1978-04-20 1984-01-26 Siemens AG, 1000 Berlin und 8000 München Method for determining the concentration of sugar and a suitable electrocatalytic sugar sensor
US4240438A (en) 1978-10-02 1980-12-23 Wisconsin Alumni Research Foundation Method for monitoring blood glucose levels and elements
JPS584982B2 (en) 1978-10-31 1983-01-28 松下電器産業株式会社 enzyme electrode
US4365637A (en) 1979-07-05 1982-12-28 Dia-Med, Inc. Perspiration indicating alarm for diabetics
US4271119A (en) 1979-07-23 1981-06-02 Eastman Kodak Company Capillary transport device having connected transport zones
US4401122A (en) 1979-08-02 1983-08-30 Children's Hospital Medical Center Cutaneous methods of measuring body substances
DE3114441A1 (en) 1980-04-11 1982-03-04 Radiometer A/S, 2400 Koebenhavn ELECTROCHEMICAL MEASURING ELECTRODE DEVICE
US4340458A (en) 1980-06-02 1982-07-20 Joslin Diabetes Center, Inc. Glucose sensor
US4356074A (en) 1980-08-25 1982-10-26 The Yellow Springs Instrument Company, Inc. Substrate specific galactose oxidase enzyme electrodes
US4404066A (en) 1980-08-25 1983-09-13 The Yellow Springs Instrument Company Method for quantitatively determining a particular substrate catalyzed by a multisubstrate enzyme
US4407959A (en) 1980-10-29 1983-10-04 Fuji Electric Co., Ltd. Blood sugar analyzing apparatus
US4420564A (en) 1980-11-21 1983-12-13 Fuji Electric Company, Ltd. Blood sugar analyzer having fixed enzyme membrane sensor
US4483924A (en) 1980-12-09 1984-11-20 Fuji Electric Company, Ltd. System for controlling a printer in a blood sugar analyzer
AT369254B (en) 1981-05-07 1982-12-27 Otto Dipl Ing Dr Tech Prohaska MEDICAL PROBE
FR2508305B1 (en) 1981-06-25 1986-04-11 Slama Gerard DEVICE FOR CAUSING A LITTLE BITE TO COLLECT A BLOOD DROP
DE3278334D1 (en) 1981-10-23 1988-05-19 Genetics Int Inc Sensor for components of a liquid mixture
US4418148A (en) 1981-11-05 1983-11-29 Miles Laboratories, Inc. Multilayer enzyme electrode membrane
JPS5886083A (en) 1981-11-12 1983-05-23 Wako Pure Chem Ind Ltd Stabilizing agent for glycerol-3-phosphoric acid oxidase
JPS58153154A (en) 1982-03-09 1983-09-12 Ajinomoto Co Inc Qualified electrode
DE3221339A1 (en) 1982-06-05 1983-12-08 Basf Ag, 6700 Ludwigshafen METHOD FOR THE ELECTROCHEMICAL HYDRATION OF NICOTINAMIDADENINE-DINUCLEOTIDE
US4534356A (en) 1982-07-30 1985-08-13 Diamond Shamrock Chemicals Company Solid state transcutaneous blood gas sensors
DE3228551A1 (en) 1982-07-30 1984-02-02 Siemens AG, 1000 Berlin und 8000 München METHOD FOR DETERMINING SUGAR CONCENTRATION
US4595479A (en) 1982-11-09 1986-06-17 Ajinomoto Co., Inc. Modified electrode
US4552840A (en) 1982-12-02 1985-11-12 California And Hawaiian Sugar Company Enzyme electrode and method for dextran analysis
US4461691A (en) 1983-02-10 1984-07-24 The United States Of America As Represented By The United States Department Of Energy Organic conductive films for semiconductor electrodes
US4679562A (en) 1983-02-16 1987-07-14 Cardiac Pacemakers, Inc. Glucose sensor
EP0136362B1 (en) 1983-03-11 1990-12-19 Matsushita Electric Industrial Co., Ltd. Biosensor
CA1220818A (en) 1983-05-05 1987-04-21 Hugh A.O. Hill Assay techniques utilising specific binding agents
CA1226036A (en) 1983-05-05 1987-08-25 Irving J. Higgins Analytical equipment and sensor electrodes therefor
CA1218704A (en) 1983-05-05 1987-03-03 Graham Davis Assay systems using more than one enzyme
CA1219040A (en) 1983-05-05 1987-03-10 Elliot V. Plotkin Measurement of enzyme-catalysed reactions
GB2154003B (en) 1983-12-16 1988-02-17 Genetics Int Inc Diagnostic aid
US4484987A (en) 1983-05-19 1984-11-27 The Regents Of The University Of California Method and membrane applicable to implantable sensor
US4580564A (en) * 1983-06-07 1986-04-08 Andersen Michael A Finger pricking device
US4524114A (en) 1983-07-05 1985-06-18 Allied Corporation Bifunctional air electrode
US4538616A (en) 1983-07-25 1985-09-03 Robert Rogoff Blood sugar level sensing and monitoring transducer
US4543955A (en) 1983-08-01 1985-10-01 Cordis Corporation System for controlling body implantable action device
US4560534A (en) 1983-11-02 1985-12-24 Miles Laboratories, Inc. Polymer catalyst transducers
US4522690A (en) 1983-12-01 1985-06-11 Honeywell Inc. Electrochemical sensing of carbon monoxide
AU583258B2 (en) 1983-12-16 1989-04-27 Medisense Inc. Assay for nucleic acids
SU1281988A1 (en) 1984-03-15 1987-01-07 Институт биохимии АН ЛитССР Electrochemical transducer for measuring glucose concentration
US4654127A (en) 1984-04-11 1987-03-31 Sentech Medical Corporation Self-calibrating single-use sensing device for clinical chemistry and method of use
JPS61502402A (en) 1984-04-30 1986-10-23 エル エ− シユテイツフツング Sensitization method for oxidation/reduction photoreaction catalyst and photoreaction catalyst
WO1986000135A1 (en) 1984-06-13 1986-01-03 Unilever Plc Photometric instruments, their use in methods of optical analyses, and ancillary devices therefor
US5141868A (en) 1984-06-13 1992-08-25 Internationale Octrooi Maatschappij "Octropa" Bv Device for use in chemical test procedures
GB8417301D0 (en) 1984-07-06 1984-08-08 Serono Diagnostics Ltd Assay
DK8601218A (en) 1984-07-18 1986-03-17
CA1254091A (en) 1984-09-28 1989-05-16 Vladimir Feingold Implantable medication infusion system
GB2168815A (en) 1984-11-13 1986-06-25 Genetics Int Inc Bioelectrochemical assay electrode
US4936956A (en) 1984-11-23 1990-06-26 Massachusetts Institute Of Technology Microelectrochemical devices based on inorganic redox active material and method for sensing
US5034192A (en) 1984-11-23 1991-07-23 Massachusetts Institute Of Technology Molecule-based microelectronic devices
EP0186210B1 (en) 1984-12-28 1992-04-22 TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION Ion sensor
AU5481786A (en) 1985-03-20 1986-09-25 Hochmair, E.S. Transcutaneous power and signal transmission system
US4781798A (en) 1985-04-19 1988-11-01 The Regents Of The University Of California Transparent multi-oxygen sensor array and method of using same
US4671288A (en) 1985-06-13 1987-06-09 The Regents Of The University Of California Electrochemical cell sensor for continuous short-term use in tissues and blood
US4938860A (en) 1985-06-28 1990-07-03 Miles Inc. Electrode for electrochemical sensors
GB8522834D0 (en) 1985-09-16 1985-10-23 Ici Plc Sensor
US4680268A (en) 1985-09-18 1987-07-14 Children's Hospital Medical Center Implantable gas-containing biosensor and method for measuring an analyte such as glucose
US5140393A (en) 1985-10-08 1992-08-18 Sharp Kabushiki Kaisha Sensor device
US4714874A (en) * 1985-11-12 1987-12-22 Miles Inc. Test strip identification and instrument calibration
GB8529300D0 (en) 1985-11-28 1986-01-02 Ici Plc Membrane
US4794736A (en) * 1985-12-27 1989-01-03 Citizen Watch Co., Ltd. Arrangement for mechanically and accurately processing a workpiece with a position detecting pattern or patterns
US4776944A (en) 1986-03-20 1988-10-11 Jiri Janata Chemical selective sensors utilizing admittance modulated membranes
US4685463A (en) 1986-04-03 1987-08-11 Williams R Bruce Device for continuous in vivo measurement of blood glucose concentrations
GB8608700D0 (en) 1986-04-10 1986-05-14 Genetics Int Inc Measurement of electroactive species in solution
US4757022A (en) 1986-04-15 1988-07-12 Markwell Medical Institute, Inc. Biological fluid measuring device
DE3614821A1 (en) 1986-05-02 1987-11-05 Siemens Ag IMPLANTABLE, CALIBRABLE MEASURING DEVICE FOR A BODY SUBSTANCE AND CALIBRATION METHOD
US4703756A (en) 1986-05-06 1987-11-03 The Regents Of The University Of California Complete glucose monitoring system with an implantable, telemetered sensor module
GB8612861D0 (en) 1986-05-27 1986-07-02 Cambridge Life Sciences Immobilised enzyme biosensors
US4750496A (en) 1987-01-28 1988-06-14 Xienta, Inc. Method and apparatus for measuring blood glucose concentration
JPS636451A (en) 1986-06-27 1988-01-12 Terumo Corp Enzyme sensor
US4764416A (en) 1986-07-01 1988-08-16 Mitsubishi Denki Kabushiki Kaisha Electric element circuit using oxidation-reduction substances
US4784736A (en) 1986-07-07 1988-11-15 Bend Research, Inc. Functional, photochemically active, and chemically asymmetric membranes by interfacial polymerization of derivatized multifunctional prepolymers
GB8618022D0 (en) 1986-07-23 1986-08-28 Unilever Plc Electrochemical measurements
JPS63131057A (en) 1986-11-20 1988-06-03 Terumo Corp Enzyme sensor
ES2036564T3 (en) 1986-12-05 1993-06-01 Sumitomo Electric Industries, Ltd. AUTOMATIC CALIBRATION DEVICE FOR A SENSOR FOR MEASURING THE PARTIAL PRESSURE OF A GAS.
EP0278647A3 (en) 1987-02-09 1989-09-20 AT&T Corp. Electronchemical processes involving enzymes
GB2201248B (en) 1987-02-24 1991-04-17 Ici Plc Enzyme electrode sensors
US4848351A (en) 1987-03-04 1989-07-18 Sentry Medical Products, Inc. Medical electrode assembly
GB2204408A (en) 1987-03-04 1988-11-09 Plessey Co Plc Biosensor device
US4923586A (en) 1987-03-31 1990-05-08 Daikin Industries, Ltd. Enzyme electrode unit
IL82131A0 (en) 1987-04-07 1987-10-30 Univ Ramot Coulometric assay system
US4935345A (en) 1987-04-07 1990-06-19 Arizona Board Of Regents Implantable microelectronic biochemical sensor incorporating thin film thermopile
US4759828A (en) 1987-04-09 1988-07-26 Nova Biomedical Corporation Glucose electrode and method of determining glucose
US5352348A (en) 1987-04-09 1994-10-04 Nova Biomedical Corporation Method of using enzyme electrode
JPH07122624B2 (en) 1987-07-06 1995-12-25 ダイキン工業株式会社 Biosensor
JPS6423155A (en) 1987-07-17 1989-01-25 Daikin Ind Ltd Electrode refreshing device for biosensor
US5037527A (en) 1987-08-28 1991-08-06 Kanzaki Paper Mfg. Co., Ltd. Reference electrode and a measuring apparatus using the same
US4974929A (en) 1987-09-22 1990-12-04 Baxter International, Inc. Fiber optical probe connector for physiologic measurement devices
NL8702370A (en) 1987-10-05 1989-05-01 Groningen Science Park METHOD AND SYSTEM FOR GLUCOSE DETERMINATION AND USEABLE MEASURING CELL ASSEMBLY.
JPH01140054A (en) 1987-11-26 1989-06-01 Nec Corp Glucose sensor
US5126247A (en) 1988-02-26 1992-06-30 Enzymatics, Inc. Method, system and devices for the assay and detection of biochemical molecules
US5128015A (en) 1988-03-15 1992-07-07 Tall Oak Ventures Method and apparatus for amperometric diagnostic analysis
DE68924026T3 (en) 1988-03-31 2008-01-10 Matsushita Electric Industrial Co., Ltd., Kadoma BIOSENSOR AND ITS MANUFACTURE.
US4954087A (en) 1988-04-27 1990-09-04 I-Stat Corporation Static-free interrogating connector for electric components
US4942127A (en) 1988-05-06 1990-07-17 Molecular Devices Corporation Polyredox couples in analyte determinations
US5094951A (en) 1988-06-21 1992-03-10 Chiron Corporation Production of glucose oxidase in recombinant systems
US5599479A (en) 1988-06-24 1997-02-04 Canon Kabushiki Kaisha Ferroelectric chiral smectic liquid crystal composition and liquid crystal device using same
GB8817421D0 (en) 1988-07-21 1988-08-24 Medisense Inc Bioelectrochemical electrodes
US5264106A (en) 1988-10-07 1993-11-23 Medisense, Inc. Enhanced amperometric sensor
US4895147A (en) * 1988-10-28 1990-01-23 Sherwood Medical Company Lancet injector
US5282050A (en) * 1988-10-31 1994-01-25 Canon Kabushiki Kaisha Dual-side recording apparatus
JPH02128152A (en) 1988-11-08 1990-05-16 Nec Corp Immobilization of enzyme and biosensor
DE3842700A1 (en) 1988-12-19 1990-06-21 Boehringer Mannheim Gmbh METHOD FOR PROTEIN IMMOBILIZATION ON A SOLID PHASE, PROTEIN-CARRYING SOLID PHASE PRODUCED THEREOF AND THE USE THEREOF
AT392847B (en) 1989-01-27 1991-06-25 Avl Verbrennungskraft Messtech SENSOR ELECTRODE ARRANGEMENT
US5053199A (en) 1989-02-21 1991-10-01 Boehringer Mannheim Corporation Electronically readable information carrier
JPH02298855A (en) 1989-03-20 1990-12-11 Assoc Univ Inc Electrochemical biosensor using immobilized enzyme and redox polymer
US5054499A (en) * 1989-03-27 1991-10-08 Swierczek Remi D Disposable skin perforator and blood testing device
US4953552A (en) 1989-04-21 1990-09-04 Demarzo Arthur P Blood glucose monitoring system
US5236567A (en) 1989-05-31 1993-08-17 Nakano Vinegar Co., Ltd. Enzyme sensor
CH677149A5 (en) 1989-07-07 1991-04-15 Disetronic Ag
JPH0737991B2 (en) 1989-07-13 1995-04-26 株式会社京都第一科学 Method for measuring glucose concentration
US5272060A (en) 1989-07-13 1993-12-21 Kyoto Daiichi Kagaku Co., Ltd. Method for determination of glucose concentration in whole blood
US5262035A (en) 1989-08-02 1993-11-16 E. Heller And Company Enzyme electrodes
US5320725A (en) 1989-08-02 1994-06-14 E. Heller & Company Electrode and method for the detection of hydrogen peroxide
US5026388A (en) 1989-09-26 1991-06-25 Ingalz Thomas J Single-use skin puncture device
FR2652736A1 (en) 1989-10-06 1991-04-12 Neftel Frederic IMPLANTABLE DEVICE FOR EVALUATING THE RATE OF GLUCOSE.
EP0429076B1 (en) 1989-11-24 1996-01-31 Matsushita Electric Industrial Co., Ltd. Preparation of biosensor
US5109850A (en) 1990-02-09 1992-05-05 Massachusetts Institute Of Technology Automatic blood monitoring for medication delivery method and apparatus
US5161532A (en) 1990-04-19 1992-11-10 Teknekron Sensor Development Corporation Integral interstitial fluid sensor
US5165407A (en) 1990-04-19 1992-11-24 The University Of Kansas Implantable glucose sensor
DE4014109A1 (en) 1990-05-02 1991-11-07 Siemens Ag ELECROCHEMICAL DETERMINATION OF THE OXYGEN CONCENTRATION
GB2245665A (en) 1990-06-30 1992-01-08 Draftex Ind Ltd Flexible protective bellows.
US5250439A (en) 1990-07-19 1993-10-05 Miles Inc. Use of conductive sensors in diagnostic assays
US5320732A (en) 1990-07-20 1994-06-14 Matsushita Electric Industrial Co., Ltd. Biosensor and measuring apparatus using the same
JPH0820412B2 (en) * 1990-07-20 1996-03-04 松下電器産業株式会社 Quantitative analysis method and device using disposable sensor
US5120421A (en) 1990-08-31 1992-06-09 The United States Of America As Represented By The United States Department Of Energy Electrochemical sensor/detector system and method
GB9019126D0 (en) 1990-09-01 1990-10-17 Cranfield Biotech Ltd Electrochemical biosensor stability
US5160278A (en) 1990-10-22 1992-11-03 Miles Inc. Reagent strip calibration system
NL9002764A (en) 1990-12-14 1992-07-01 Tno ELECTRODE, FITTED WITH A POLYMER COATING WITH A REDOX ENZYM BOND TO IT.
JPH04278450A (en) 1991-03-04 1992-10-05 Adam Heller Biosensor and method for analyzing subject
US5262305A (en) 1991-03-04 1993-11-16 E. Heller & Company Interferant eliminating biosensors
US5208154A (en) 1991-04-08 1993-05-04 The United States Of America As Represented By The Department Of Energy Reversibly immobilized biological materials in monolayer films on electrodes
DE4123348A1 (en) 1991-07-15 1993-01-21 Boehringer Mannheim Gmbh ELECTROCHEMICAL ANALYSIS SYSTEM
US5264103A (en) 1991-10-18 1993-11-23 Matsushita Electric Industrial Co., Ltd. Biosensor and a method for measuring a concentration of a substrate in a sample
US5217595A (en) 1991-10-25 1993-06-08 The Yellow Springs Instrument Company, Inc. Electrochemical gas sensor
JPH05149910A (en) * 1991-11-29 1993-06-15 Kanzaki Paper Mfg Co Ltd Cell for electrochemical measurement
US5271815A (en) 1991-12-26 1993-12-21 Via Medical Corporation Method for measuring glucose
AU3274693A (en) 1991-12-31 1993-07-28 Abbott Laboratories Composite membrane
NL9200207A (en) 1992-02-05 1993-09-01 Nedap Nv IMPLANTABLE BIOMEDICAL SENSOR DEVICE, IN PARTICULAR FOR MEASUREMENT OF THE GLUCOSE CONCENTRATION.
GR1002549B (en) 1992-05-12 1997-01-28 Lifescan Inc. Fluid conducting test strip with Transport Medium
US5227042A (en) 1992-05-15 1993-07-13 The United States Of America As Represented By The United States Department Of Energy Catalyzed enzyme electrodes
US5580527A (en) 1992-05-18 1996-12-03 Moltech Corporation Polymeric luminophores for sensing of oxygen
GB9211402D0 (en) 1992-05-29 1992-07-15 Univ Manchester Sensor devices
US5421816A (en) 1992-10-14 1995-06-06 Endodermic Medical Technologies Company Ultrasonic transdermal drug delivery system
ZA938555B (en) 1992-11-23 1994-08-02 Lilly Co Eli Technique to improve the performance of electrochemical sensors
DK148592D0 (en) 1992-12-10 1992-12-10 Novo Nordisk As APPARATUS
US5435735A (en) * 1993-02-22 1995-07-25 The Whitaker Corporation Catalytic converter sensor connector
CH685458A5 (en) 1993-03-01 1995-07-14 Disetronic Ag Sensor array for selective detection or measurement of at least one material component in an aqueous solution.
US5364797A (en) 1993-05-20 1994-11-15 Mobil Oil Corp. Sensor device containing mesoporous crystalline material
ES2107833T3 (en) 1993-05-29 1997-12-01 Cambridge Life Sciences SENSORS BASED ON TRANSFORMATION OF POLYMERS.
DE4318519C2 (en) 1993-06-03 1996-11-28 Fraunhofer Ges Forschung Electrochemical sensor
JP2704046B2 (en) 1993-06-08 1998-01-26 ベーリンガー マンハイム コーポレーション Biosensing meter that detects the appropriate electrode connection and distinguishes between sample and check pieces
US5352351A (en) 1993-06-08 1994-10-04 Boehringer Mannheim Corporation Biosensing meter with fail/safe procedures to prevent erroneous indications
US5366609A (en) * 1993-06-08 1994-11-22 Boehringer Mannheim Corporation Biosensing meter with pluggable memory key
US5413690A (en) 1993-07-23 1995-05-09 Boehringer Mannheim Corporation Potentiometric biosensor and the method of its use
JP3494183B2 (en) 1993-08-10 2004-02-03 株式会社アドバンス Simple blood collection device
US5837546A (en) 1993-08-24 1998-11-17 Metrika, Inc. Electronic assay device and method
EP0644266A1 (en) 1993-09-22 1995-03-22 Siemens Aktiengesellschaft Working electrode for electrochemical-enzymatical sensor systems
US5582184A (en) 1993-10-13 1996-12-10 Integ Incorporated Interstitial fluid collection and constituent measurement
US5781455A (en) 1993-11-02 1998-07-14 Kyoto Daiichi Kagaku Co., Ltd. Article of manufacture comprising computer usable medium for a portable blood sugar value measuring apparatus
JPH07128338A (en) 1993-11-02 1995-05-19 Kyoto Daiichi Kagaku:Kk Convenient blood sugar meter and data managing method therefor
US5791344A (en) 1993-11-19 1998-08-11 Alfred E. Mann Foundation For Scientific Research Patient monitoring system
US5478751A (en) 1993-12-29 1995-12-26 Abbott Laboratories Self-venting immunodiagnositic devices and methods of performing assays
US5589326A (en) 1993-12-30 1996-12-31 Boehringer Mannheim Corporation Osmium-containing redox mediator
AU1911795A (en) 1994-02-09 1995-08-29 Abbott Laboratories Diagnostic flow cell device
FI95574C (en) 1994-02-16 1996-02-26 Valtion Teknillinen Electron-conducting molecular preparations
US5437999A (en) 1994-02-22 1995-08-01 Boehringer Mannheim Corporation Electrochemical sensor
US5569186A (en) 1994-04-25 1996-10-29 Minimed Inc. Closed loop infusion pump system with removable glucose sensor
JP3061351B2 (en) 1994-04-25 2000-07-10 松下電器産業株式会社 Method and apparatus for quantifying specific compounds
JPH07326439A (en) * 1994-05-31 1995-12-12 Sumitomo Wiring Syst Ltd Structure for attaching flat cable to printed board and connector for printed board
JP3027306B2 (en) 1994-06-02 2000-04-04 松下電器産業株式会社 Biosensor and manufacturing method thereof
US5514253A (en) 1994-07-13 1996-05-07 I-Stat Corporation Method of measuring gas concentrations and microfabricated sensing device for practicing same
DE4430023A1 (en) 1994-08-24 1996-02-29 Boehringer Mannheim Gmbh Electrochemical sensor
JP3488925B2 (en) 1994-09-08 2004-01-19 ライフスキヤン・インコーポレーテツド Optically readable strip for analyte detection with strip-on-standard
US5526120A (en) 1994-09-08 1996-06-11 Lifescan, Inc. Test strip with an asymmetrical end insuring correct insertion for measuring
US6153069A (en) 1995-02-09 2000-11-28 Tall Oak Ventures Apparatus for amperometric Diagnostic analysis
US5586553A (en) 1995-02-16 1996-12-24 Minimed Inc. Transcutaneous sensor insertion set
US5568806A (en) 1995-02-16 1996-10-29 Minimed Inc. Transcutaneous sensor insertion set
US5651869A (en) 1995-02-28 1997-07-29 Matsushita Electric Industrial Co., Ltd. Biosensor
US5650062A (en) 1995-03-17 1997-07-22 Matsushita Electric Industrial Co., Ltd. Biosensor, and a method and a device for quantifying a substrate in a sample liquid using the same
US5582697A (en) 1995-03-17 1996-12-10 Matsushita Electric Industrial Co., Ltd. Biosensor, and a method and a device for quantifying a substrate in a sample liquid using the same
US5571132A (en) 1995-06-06 1996-11-05 International Technidyne Corporation Self activated finger lancet
US5567302A (en) 1995-06-07 1996-10-22 Molecular Devices Corporation Electrochemical system for rapid detection of biochemical agents that catalyze a redox potential change
JP3638958B2 (en) * 1995-07-28 2005-04-13 アプルス株式会社 Assembly for adjusting the penetration depth of the lancet
DE19530376C2 (en) 1995-08-18 1999-09-02 Fresenius Ag Biosensor
US5873990A (en) * 1995-08-22 1999-02-23 Andcare, Inc. Handheld electromonitor device
US5682233A (en) 1995-09-08 1997-10-28 Integ, Inc. Interstitial fluid sampler
US5665215A (en) 1995-09-25 1997-09-09 Bayer Corporation Method and apparatus for making predetermined events with a biosensor
US5628890A (en) 1995-09-27 1997-05-13 Medisense, Inc. Electrochemical sensor
JP2976327B2 (en) * 1995-09-29 1999-11-10 日本航空電子工業株式会社 connector
JP3365184B2 (en) 1996-01-10 2003-01-08 松下電器産業株式会社 Biosensor
US5830341A (en) 1996-01-23 1998-11-03 Gilmartin; Markas A. T. Electrodes and metallo isoindole ringed compounds
US5801057A (en) 1996-03-22 1998-09-01 Smart; Wilson H. Microsampling device and method of construction
US6015392A (en) * 1996-05-17 2000-01-18 Mercury Diagnostics, Inc. Apparatus for sampling body fluid
US6332871B1 (en) 1996-05-17 2001-12-25 Amira Medical Blood and interstitial fluid sampling device
SE9602298D0 (en) 1996-06-11 1996-06-11 Siemens Elema Ab Arrangement for analyzing body fluids
US5804048A (en) 1996-08-15 1998-09-08 Via Medical Corporation Electrode assembly for assaying glucose
US5856195A (en) * 1996-10-30 1999-01-05 Bayer Corporation Method and apparatus for calibrating a sensor element
DE19653436C1 (en) * 1996-12-20 1998-08-13 Inst Chemo Biosensorik Electrochemical sensor
ATE227844T1 (en) 1997-02-06 2002-11-15 Therasense Inc SMALL VOLUME SENSOR FOR IN-VITRO DETERMINATION
JP3181850B2 (en) 1997-02-14 2001-07-03 キヤノン株式会社 Ink jet recording apparatus and recording method
AUPO581397A0 (en) * 1997-03-21 1997-04-17 Memtec America Corporation Sensor connection means
US5759364A (en) 1997-05-02 1998-06-02 Bayer Corporation Electrochemical biosensor
JP3702582B2 (en) * 1997-06-03 2005-10-05 Nok株式会社 Measuring method using biosensor
JP2002505008A (en) * 1997-06-16 2002-02-12 エラン コーポレーション ピーエルシー Methods for calibrating and testing sensors for in vivo measurement of analytes and devices for use in such methods
US5934933A (en) * 1997-06-20 1999-08-10 Cts Corporation Snap lock membrane connector
US6168957B1 (en) * 1997-06-25 2001-01-02 Lifescan, Inc. Diagnostic test strip having on-strip calibration
US6599406B1 (en) 1997-07-22 2003-07-29 Kyoto Daiichi Kagaku Co., Ltd. Concentration measuring apparatus, test strip for the concentration measuring apparatus, biosensor system and method for forming terminal on the test strip
US6071391A (en) 1997-09-12 2000-06-06 Nok Corporation Enzyme electrode structure
JP3510461B2 (en) * 1997-09-30 2004-03-29 セラセンス インコーポレーテッド Biosensor device
US5964718A (en) 1997-11-21 1999-10-12 Mercury Diagnostics, Inc. Body fluid sampling device
US5971941A (en) 1997-12-04 1999-10-26 Hewlett-Packard Company Integrated system and method for sampling blood and analysis
CA2547299C (en) * 1997-12-04 2009-03-03 Roche Diagnostics Corporation Instrument and method
US5997817A (en) 1997-12-05 1999-12-07 Roche Diagnostics Corporation Electrochemical biosensor test strip
DE19815684A1 (en) * 1998-04-08 1999-10-14 Roche Diagnostics Gmbh Process for the preparation of analytical aids
US6053930A (en) 1998-05-11 2000-04-25 Ruppert; Norbert Single use lancet assembly
US6162397A (en) 1998-08-13 2000-12-19 Lifescan, Inc. Visual blood glucose test strip
DE29814996U1 (en) 1998-08-20 1998-12-03 Lre Technology Partner Gmbh Measuring device for the amperometric measurement of test strips
WO2000018290A1 (en) * 1998-09-29 2000-04-06 Mallinckrodt Inc. Oximeter sensor with encoded temperature characteristic
US6338790B1 (en) 1998-10-08 2002-01-15 Therasense, Inc. Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
JP4749549B2 (en) 1998-11-30 2011-08-17 アボット・ラボラトリーズ Analytical testing instrument with improved calibration and communication process
US6287451B1 (en) * 1999-06-02 2001-09-11 Handani Winarta Disposable sensor and method of making
US6258229B1 (en) 1999-06-02 2001-07-10 Handani Winarta Disposable sub-microliter volume sensor and method of making
US6558402B1 (en) 1999-08-03 2003-05-06 Becton, Dickinson And Company Lancer
US6283982B1 (en) 1999-10-19 2001-09-04 Facet Technologies, Inc. Lancing device and method of sample collection
US20060091006A1 (en) 1999-11-04 2006-05-04 Yi Wang Analyte sensor with insertion monitor, and methods
US6616819B1 (en) 1999-11-04 2003-09-09 Therasense, Inc. Small volume in vitro analyte sensor and methods
KR100445489B1 (en) 1999-11-15 2004-08-21 마츠시타 덴끼 산교 가부시키가이샤 Biosensor, method of forming thin-film electrode, and method and apparatus for quantitative determination
EP3364187B1 (en) 2000-11-30 2019-09-18 PHC Holdings Corporation Method of quantifying substrate
US6562625B2 (en) 2001-02-28 2003-05-13 Home Diagnostics, Inc. Distinguishing test types through spectral analysis
US6766817B2 (en) 2001-07-25 2004-07-27 Tubarc Technologies, Llc Fluid conduction utilizing a reversible unsaturated siphon with tubarc porosity action
US6814844B2 (en) 2001-08-29 2004-11-09 Roche Diagnostics Corporation Biosensor with code pattern
US7491303B2 (en) 2001-09-28 2009-02-17 Arkray, Inc. Measuring instrument and concentration measuring device
US6866758B2 (en) * 2002-03-21 2005-03-15 Roche Diagnostics Corporation Biosensor
US6881578B2 (en) * 2002-04-02 2005-04-19 Lifescan, Inc. Analyte concentration determination meters and methods of using the same
US6743635B2 (en) * 2002-04-25 2004-06-01 Home Diagnostics, Inc. System and methods for blood glucose sensing
US6780645B2 (en) 2002-08-21 2004-08-24 Lifescan, Inc. Diagnostic kit with a memory storing test strip calibration codes and related methods
AU2003293559A1 (en) * 2002-12-16 2004-07-22 Meagan Medical, Inc. Controlling the depth of percutaneous applications
US8206565B2 (en) * 2003-06-20 2012-06-26 Roche Diagnostics Operation, Inc. System and method for coding information on a biosensor test strip
JP5215661B2 (en) * 2004-05-21 2013-06-19 アガマトリックス インコーポレーテッド Electrochemical cell and method for making an electrochemical cell
US20060029479A1 (en) * 2004-08-03 2006-02-09 Ford Motor Company Tool holder assembly
US7749371B2 (en) * 2005-09-30 2010-07-06 Lifescan, Inc. Method and apparatus for rapid electrochemical analysis
US20080105024A1 (en) 2006-11-07 2008-05-08 Bayer Healthcare Llc Method of making an auto-calibrating test sensor
USD587142S1 (en) 2006-12-22 2009-02-24 Abbott Diabetes Care Inc. Sensors
US7875461B2 (en) * 2007-07-24 2011-01-25 Lifescan Scotland Limited Test strip and connector

Patent Citations (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3653841A (en) * 1969-12-19 1972-04-04 Hoffmann La Roche Methods and compositions for determining glucose in blood
US3719564A (en) * 1971-05-10 1973-03-06 Philip Morris Inc Method of determining a reducible gas concentration and sensor therefor
US4008717A (en) * 1973-01-15 1977-02-22 The Johns Hopkins University System for continuous withdrawal and analysis of blood
US4016866A (en) * 1975-12-18 1977-04-12 General Electric Company Implantable electrochemical sensor
US4076596A (en) * 1976-10-07 1978-02-28 Leeds & Northrup Company Apparatus for electrolytically determining a species in a fluid and method of use
US4151845A (en) * 1977-11-25 1979-05-01 Miles Laboratories, Inc. Blood glucose control apparatus
US4384586A (en) * 1978-02-17 1983-05-24 Christiansen Torben F Method and apparatus for pH recording
US4318784A (en) * 1978-08-15 1982-03-09 National Research Development Corporation Enzymatic processes
US4375399A (en) * 1978-09-08 1983-03-01 Radelkis Elektrokemiai Miszergyarto Szovetkezet Molecule selective sensor for industrial use and procedure for its preparation
US4247297A (en) * 1979-02-23 1981-01-27 Miles Laboratories, Inc. Test means and method for interference resistant determination of oxidizing substances
US4573994A (en) * 1979-04-27 1986-03-04 The Johns Hopkins University Refillable medication infusion apparatus
US4450842A (en) * 1980-04-25 1984-05-29 Cordis Corporation Solid state reference electrode
US4444892A (en) * 1980-10-20 1984-04-24 Malmros Mark K Analytical device having semiconductive organic polymeric element associated with analyte-binding substance
US4436094A (en) * 1981-03-09 1984-03-13 Evreka, Inc. Monitor for continuous in vivo measurement of glucose concentration
US4440175A (en) * 1981-08-10 1984-04-03 University Patents, Inc. Membrane electrode for non-ionic species
US4431004A (en) * 1981-10-27 1984-02-14 Bessman Samuel P Implantable glucose sensor
US4581336A (en) * 1982-04-26 1986-04-08 Uop Inc. Surface-modified electrodes
US4427770A (en) * 1982-06-14 1984-01-24 Miles Laboratories, Inc. High glucose-determining analytical element
US4571292A (en) * 1982-08-12 1986-02-18 Case Western Reserve University Apparatus for electrochemical measurements
US4633878A (en) * 1983-04-18 1987-01-06 Guiseppe Bombardieri Device for the automatic insulin or glucose infusion in diabetic subjects, based on the continuous monitoring of the patient's glucose, obtained without blood withdrawal
US5727548A (en) * 1983-05-05 1998-03-17 Medisense, Inc. Strip electrode with screen printing
US4650547A (en) * 1983-05-19 1987-03-17 The Regents Of The University Of California Method and membrane applicable to implantable sensor
US4655880A (en) * 1983-08-01 1987-04-07 Case Western Reserve University Apparatus and method for sensing species, substances and substrates using oxidase
US4654197A (en) * 1983-10-18 1987-03-31 Aktiebolaget Leo Cuvette for sampling and analysis
US4820399A (en) * 1984-08-31 1989-04-11 Shimadzu Corporation Enzyme electrodes
US4721601A (en) * 1984-11-23 1988-01-26 Massachusetts Institute Of Technology Molecule-based microelectronic devices
US4717673A (en) * 1984-11-23 1988-01-05 Massachusetts Institute Of Technology Microelectrochemical devices
US4795707A (en) * 1984-11-27 1989-01-03 Hitachi, Ltd. Electrochemical sensor having three layer membrane containing immobilized enzymes
US4655885A (en) * 1985-01-11 1987-04-07 National Research Development Corporation Surface-modified electrode and its use in a bioelectrochemical process
US4637403A (en) * 1985-04-08 1987-01-20 Garid, Inc. Glucose medical monitoring system
US4897173A (en) * 1985-06-21 1990-01-30 Matsushita Electric Industrial Co., Ltd. Biosensor and method for making the same
US5185256A (en) * 1985-06-21 1993-02-09 Matsushita Electric Industrial Co., Ltd. Method for making a biosensor
US4805624A (en) * 1985-09-09 1989-02-21 The Montefiore Hospital Association Of Western Pa Low-potential electrochemical redox sensors
US4890620A (en) * 1985-09-20 1990-01-02 The Regents Of The University Of California Two-dimensional diffusion glucose substrate sensing electrode
US4830959A (en) * 1985-11-11 1989-05-16 Medisense, Inc. Electrochemical enzymic assay procedures
US4726378A (en) * 1986-04-11 1988-02-23 Minnesota Mining And Manufacturing Company Adjustable magnetic supercutaneous device and transcutaneous coupling apparatus
US4994167A (en) * 1986-04-15 1991-02-19 Markwell Medical Institute, Inc. Biological fluid measuring device
US4909908A (en) * 1986-04-24 1990-03-20 Pepi Ross Electrochemical cncentration detector method
US4911794A (en) * 1986-06-20 1990-03-27 Molecular Devices Corporation Measuring with zero volume cell
US4894137A (en) * 1986-09-12 1990-01-16 Omron Tateisi Electronics Co. Enzyme electrode
US4897162A (en) * 1986-11-14 1990-01-30 The Cleveland Clinic Foundation Pulse voltammetry
US4919141A (en) * 1987-01-03 1990-04-24 Institute fur Diabetestechnologie Gemeinnutzige Forschungs- und Entwicklungsgesellschaft mbH Implantable electrochemical sensor
US5094931A (en) * 1987-04-15 1992-03-10 Hoechst Celanese Corporation Image transfer to diverse paper stocks
US5286364A (en) * 1987-06-08 1994-02-15 Rutgers University Surface-modified electochemical biosensor
US4822337A (en) * 1987-06-22 1989-04-18 Stanley Newhouse Insulin delivery method and apparatus
US5096836A (en) * 1987-06-27 1992-03-17 Boehringer Mannheim Gmbh Diagnostic test carrier
US4919767A (en) * 1987-08-04 1990-04-24 Imperial Chemical Industries Plc Sensor and method for analyte determination
US4815469A (en) * 1987-10-08 1989-03-28 Siemens-Pacesetter, Inc. Implantable blood oxygen sensor and method of use
US4813424A (en) * 1987-12-23 1989-03-21 University Of New Mexico Long-life membrane electrode for non-ionic species
US5108564A (en) * 1988-03-15 1992-04-28 Tall Oak Ventures Method and apparatus for amperometric diagnostic analysis
US5206145A (en) * 1988-05-19 1993-04-27 Thorn Emi Plc Method of measuring the concentration of a substance in a sample solution
US5200051A (en) * 1988-11-14 1993-04-06 I-Stat Corporation Wholly microfabricated biosensors and process for the manufacture and use thereof
US5205920A (en) * 1989-03-03 1993-04-27 Noboru Oyama Enzyme sensor and method of manufacturing the same
US5089112A (en) * 1989-03-20 1992-02-18 Associated Universities, Inc. Electrochemical biosensor based on immobilized enzymes and redox polymers
US4918860A (en) * 1989-05-09 1990-04-24 Dennis Breadner Tree branch spreader
US5096560A (en) * 1989-05-30 1992-03-17 Mitsubishi Petrochemical Co., Ltd. Electrode for electrochemical detectors
US5198367A (en) * 1989-06-09 1993-03-30 Masuo Aizawa Homogeneous amperometric immunoassay
US4986271A (en) * 1989-07-19 1991-01-22 The University Of New Mexico Vivo refillable glucose sensor
US5101814A (en) * 1989-08-11 1992-04-07 Palti Yoram Prof System for monitoring and controlling blood glucose
US5082550A (en) * 1989-12-11 1992-01-21 The United States Of America As Represented By The Department Of Energy Enzyme electrochemical sensor electrode and method of making it
US5288636A (en) * 1989-12-15 1994-02-22 Boehringer Mannheim Corporation Enzyme electrode system
US5508171A (en) * 1989-12-15 1996-04-16 Boehringer Mannheim Corporation Assay method with enzyme electrode system
US4999582A (en) * 1989-12-15 1991-03-12 Boehringer Mannheim Corp. Biosensor electrode excitation circuit
US5078854A (en) * 1990-01-22 1992-01-07 Mallinckrodt Sensor Systems, Inc. Polarographic chemical sensor with external reference electrode
US5286362A (en) * 1990-02-03 1994-02-15 Boehringer Mannheim Gmbh Method and sensor electrode system for the electrochemical determination of an analyte or an oxidoreductase as well as the use of suitable compounds therefor
US5501956A (en) * 1990-03-23 1996-03-26 Molecular Devices Corporation Polyredox couples in analyte determinations
US5202261A (en) * 1990-07-19 1993-04-13 Miles Inc. Conductive sensors and their use in diagnostic assays
US5378628A (en) * 1991-02-21 1995-01-03 Asulab, S.A. Sensor for measuring the amount of a component in solution
US5393903A (en) * 1991-02-21 1995-02-28 Asulab S.A. Mono, bis or tris(substituted 2,2'-bipyridine) iron, ruthenium, osmium or vanadium complexes and their methods of preparation
US5192415A (en) * 1991-03-04 1993-03-09 Matsushita Electric Industrial Co., Ltd. Biosensor utilizing enzyme and a method for producing the same
US5192416A (en) * 1991-04-09 1993-03-09 New Mexico State University Technology Transfer Corporation Method and apparatus for batch injection analysis
US5293546A (en) * 1991-04-17 1994-03-08 Martin Marietta Corporation Oxide coated metal grid electrode structure in display devices
US5382346A (en) * 1991-05-17 1995-01-17 Kyoto Daiichi Kagaku Co., Ltd. Biosensor and method of quantitative analysis using the same
US5496453A (en) * 1991-05-17 1996-03-05 Kyoto Daiichi Kagaku Co., Ltd. Biosensor and method of quantitative analysis using the same
US5380422A (en) * 1991-07-18 1995-01-10 Agency Of Industrial Science And Technology Micro-electrode and method for preparing it
US5384028A (en) * 1992-08-28 1995-01-24 Nec Corporation Biosensor with a data memory
US5278079A (en) * 1992-09-02 1994-01-11 Enzymatics, Inc. Sealing device and method for inhibition of flow in capillary measuring devices
US5387327A (en) * 1992-10-19 1995-02-07 Duquesne University Of The Holy Ghost Implantable non-enzymatic electrochemical glucose sensor
US5395504A (en) * 1993-02-04 1995-03-07 Asulab S.A. Electrochemical measuring system with multizone sensors
US5595479A (en) * 1993-04-05 1997-01-21 Danfoss A/S Hydraulic machine having teeth formed by rollers
US5410474A (en) * 1993-07-27 1995-04-25 Miles Inc. Buttonless memory system for an electronic measurement device
US5502396A (en) * 1993-09-21 1996-03-26 Asulab S.A. Measuring device with connection for a removable sensor
US5497772A (en) * 1993-11-19 1996-03-12 Alfred E. Mann Foundation For Scientific Research Glucose monitoring system
US5593852A (en) * 1993-12-02 1997-01-14 Heller; Adam Subcutaneous glucose electrode
US5391250A (en) * 1994-03-15 1995-02-21 Minimed Inc. Method of fabricating thin film sensors
US5390671A (en) * 1994-03-15 1995-02-21 Minimed Inc. Transcutaneous sensor insertion set
US5741688A (en) * 1994-05-03 1998-04-21 Novo Nordisk A/S Alkaline glucose oxidase obtained from cladosporium oxysporum
US5507288A (en) * 1994-05-05 1996-04-16 Boehringer Mannheim Gmbh Analytical system for monitoring a substance to be analyzed in patient-blood
US5507288B1 (en) * 1994-05-05 1997-07-08 Boehringer Mannheim Gmbh Analytical system for monitoring a substance to be analyzed in patient-blood
US5494562A (en) * 1994-06-27 1996-02-27 Ciba Corning Diagnostics Corp. Electrochemical sensors
US5596150A (en) * 1995-03-08 1997-01-21 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Capacitance probe for fluid flow and volume measurements
US5711862A (en) * 1995-03-15 1998-01-27 Omron Corporation Portable biochemical measurement device using an enzyme sensor
US5720862A (en) * 1995-04-07 1998-02-24 Kyoto Daiichi Kagaku Co., Ltd. Sensor and production method of and measurement method using the same
US5720028A (en) * 1995-06-07 1998-02-17 Hitachi, Ltd. External storage system
US5741211A (en) * 1995-10-26 1998-04-21 Medtronic, Inc. System and method for continuous monitoring of diabetes-related blood constituents
US5711861A (en) * 1995-11-22 1998-01-27 Ward; W. Kenneth Device for monitoring changes in analyte concentration
US5708247A (en) * 1996-02-14 1998-01-13 Selfcare, Inc. Disposable glucose test strips, and methods and compositions for making same
US5857983A (en) * 1996-05-17 1999-01-12 Mercury Diagnostics, Inc. Methods and apparatus for sampling body fluid
US5879311A (en) * 1996-05-17 1999-03-09 Mercury Diagnostics, Inc. Body fluid sampling device and methods of use
US6033866A (en) * 1997-12-08 2000-03-07 Biomedix, Inc. Highly sensitive amperometric bi-mediator-based glucose biosensor

Cited By (597)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7901354B2 (en) 1997-03-04 2011-03-08 Dexcom, Inc. Low oxygen in vivo analyte sensor
US9155496B2 (en) 1997-03-04 2015-10-13 Dexcom, Inc. Low oxygen in vivo analyte sensor
US7771352B2 (en) 1997-03-04 2010-08-10 Dexcom, Inc. Low oxygen in vivo analyte sensor
US7666149B2 (en) 1997-12-04 2010-02-23 Peliken Technologies, Inc. Cassette of lancet cartridges for sampling blood
US8071384B2 (en) 1997-12-22 2011-12-06 Roche Diagnostics Operations, Inc. Control and calibration solutions and methods for their use
US8439872B2 (en) 1998-03-30 2013-05-14 Sanofi-Aventis Deutschland Gmbh Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
US7780631B2 (en) 1998-03-30 2010-08-24 Pelikan Technologies, Inc. Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
US8409131B2 (en) 1998-04-30 2013-04-02 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9014773B2 (en) 1998-04-30 2015-04-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8734348B2 (en) 1998-04-30 2014-05-27 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US7860544B2 (en) 1998-04-30 2010-12-28 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8734346B2 (en) 1998-04-30 2014-05-27 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8649841B2 (en) 1998-04-30 2014-02-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8688188B2 (en) 1998-04-30 2014-04-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8162829B2 (en) 1998-04-30 2012-04-24 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8641619B2 (en) 1998-04-30 2014-02-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8175673B2 (en) 1998-04-30 2012-05-08 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8622906B2 (en) 1998-04-30 2014-01-07 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8177716B2 (en) 1998-04-30 2012-05-15 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8738109B2 (en) 1998-04-30 2014-05-27 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8617071B2 (en) 1998-04-30 2013-12-31 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8346336B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8744545B2 (en) 1998-04-30 2014-06-03 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8774887B2 (en) 1998-04-30 2014-07-08 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8612159B2 (en) 1998-04-30 2013-12-17 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8597189B2 (en) 1998-04-30 2013-12-03 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8840553B2 (en) 1998-04-30 2014-09-23 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8224413B2 (en) 1998-04-30 2012-07-17 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US10478108B2 (en) 1998-04-30 2019-11-19 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8226557B2 (en) 1998-04-30 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8880137B2 (en) 1998-04-30 2014-11-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8346337B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8226558B2 (en) 1998-04-30 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8226555B2 (en) 1998-04-30 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8231532B2 (en) 1998-04-30 2012-07-31 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9326714B2 (en) 1998-04-30 2016-05-03 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8235896B2 (en) 1998-04-30 2012-08-07 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8306598B2 (en) 1998-04-30 2012-11-06 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8473021B2 (en) 1998-04-30 2013-06-25 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9011331B2 (en) 1998-04-30 2015-04-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8255031B2 (en) 1998-04-30 2012-08-28 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8465425B2 (en) 1998-04-30 2013-06-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8666469B2 (en) 1998-04-30 2014-03-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8670815B2 (en) 1998-04-30 2014-03-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9042953B2 (en) 1998-04-30 2015-05-26 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9066694B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9066697B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8260392B2 (en) 1998-04-30 2012-09-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9072477B2 (en) 1998-04-30 2015-07-07 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8265726B2 (en) 1998-04-30 2012-09-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8672844B2 (en) 1998-04-30 2014-03-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8391945B2 (en) 1998-04-30 2013-03-05 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8273022B2 (en) 1998-04-30 2012-09-25 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8275439B2 (en) 1998-04-30 2012-09-25 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8660627B2 (en) 1998-04-30 2014-02-25 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8480580B2 (en) 1998-04-30 2013-07-09 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US7869853B1 (en) 1998-04-30 2011-01-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8380273B2 (en) 1998-04-30 2013-02-19 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8372005B2 (en) 1998-04-30 2013-02-12 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8366614B2 (en) 1998-04-30 2013-02-05 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8287454B2 (en) 1998-04-30 2012-10-16 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US7885699B2 (en) 1998-04-30 2011-02-08 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8357091B2 (en) 1998-04-30 2013-01-22 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8353829B2 (en) 1998-04-30 2013-01-15 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8551308B2 (en) 1999-10-04 2013-10-08 Roche Diagnostics Operations, Inc. Biosensor and method of making
US20090056120A1 (en) * 1999-10-04 2009-03-05 Bhullar Raghbir S Biosensor and method of making
US8287703B2 (en) 1999-10-04 2012-10-16 Roche Diagnostics Operations, Inc. Biosensor and method of making
US8641644B2 (en) 2000-11-21 2014-02-04 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
US8652043B2 (en) 2001-01-02 2014-02-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9498159B2 (en) 2001-01-02 2016-11-22 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9011332B2 (en) 2001-01-02 2015-04-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9610034B2 (en) 2001-01-02 2017-04-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8668645B2 (en) 2001-01-02 2014-03-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8211037B2 (en) 2001-06-12 2012-07-03 Pelikan Technologies, Inc. Tissue penetration device
US7981055B2 (en) 2001-06-12 2011-07-19 Pelikan Technologies, Inc. Tissue penetration device
US8360991B2 (en) 2001-06-12 2013-01-29 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7850622B2 (en) 2001-06-12 2010-12-14 Pelikan Technologies, Inc. Tissue penetration device
US8123700B2 (en) 2001-06-12 2012-02-28 Pelikan Technologies, Inc. Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7909775B2 (en) 2001-06-12 2011-03-22 Pelikan Technologies, Inc. Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge
US7749174B2 (en) 2001-06-12 2010-07-06 Pelikan Technologies, Inc. Method and apparatus for lancet launching device intergrated onto a blood-sampling cartridge
US9694144B2 (en) 2001-06-12 2017-07-04 Sanofi-Aventis Deutschland Gmbh Sampling module device and method
US9802007B2 (en) 2001-06-12 2017-10-31 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US20060178689A1 (en) * 2001-06-12 2006-08-10 Dominique Freeman Tissue penetration device
US8382683B2 (en) 2001-06-12 2013-02-26 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9937298B2 (en) 2001-06-12 2018-04-10 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US8641643B2 (en) 2001-06-12 2014-02-04 Sanofi-Aventis Deutschland Gmbh Sampling module device and method
US7699791B2 (en) 2001-06-12 2010-04-20 Pelikan Technologies, Inc. Method and apparatus for improving success rate of blood yield from a fingerstick
US8282577B2 (en) 2001-06-12 2012-10-09 Sanofi-Aventis Deutschland Gmbh Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge
US7682318B2 (en) 2001-06-12 2010-03-23 Pelikan Technologies, Inc. Blood sampling apparatus and method
US8721671B2 (en) 2001-06-12 2014-05-13 Sanofi-Aventis Deutschland Gmbh Electric lancet actuator
US7988645B2 (en) 2001-06-12 2011-08-02 Pelikan Technologies, Inc. Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties
US8845550B2 (en) 2001-06-12 2014-09-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US8216154B2 (en) 2001-06-12 2012-07-10 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US8016774B2 (en) 2001-06-12 2011-09-13 Pelikan Technologies, Inc. Tissue penetration device
US8337421B2 (en) 2001-06-12 2012-12-25 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US8206317B2 (en) 2001-06-12 2012-06-26 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US8679033B2 (en) 2001-06-12 2014-03-25 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US8206319B2 (en) 2001-06-12 2012-06-26 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US8622930B2 (en) 2001-06-12 2014-01-07 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US8509871B2 (en) 2001-07-27 2013-08-13 Dexcom, Inc. Sensor head for use with implantable devices
US9804114B2 (en) 2001-07-27 2017-10-31 Dexcom, Inc. Sensor head for use with implantable devices
US9328371B2 (en) 2001-07-27 2016-05-03 Dexcom, Inc. Sensor head for use with implantable devices
US9560993B2 (en) 2001-11-21 2017-02-07 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
US7901362B2 (en) 2002-04-19 2011-03-08 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8556829B2 (en) 2002-04-19 2013-10-15 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8079960B2 (en) 2002-04-19 2011-12-20 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US8157748B2 (en) 2002-04-19 2012-04-17 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US8062231B2 (en) 2002-04-19 2011-11-22 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8197421B2 (en) 2002-04-19 2012-06-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7833171B2 (en) 2002-04-19 2010-11-16 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9089294B2 (en) 2002-04-19 2015-07-28 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US8388551B2 (en) 2002-04-19 2013-03-05 Sanofi-Aventis Deutschland Gmbh Method and apparatus for multi-use body fluid sampling device with sterility barrier release
US8382682B2 (en) 2002-04-19 2013-02-26 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7862520B2 (en) 2002-04-19 2011-01-04 Pelikan Technologies, Inc. Body fluid sampling module with a continuous compression tissue interface surface
US7874994B2 (en) 2002-04-19 2011-01-25 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8372016B2 (en) 2002-04-19 2013-02-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling and analyte sensing
US7875047B2 (en) 2002-04-19 2011-01-25 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device with sterility barrier release
US8197423B2 (en) 2002-04-19 2012-06-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8202231B2 (en) 2002-04-19 2012-06-19 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8414503B2 (en) 2002-04-19 2013-04-09 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US8366637B2 (en) 2002-04-19 2013-02-05 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8636673B2 (en) 2002-04-19 2014-01-28 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9498160B2 (en) 2002-04-19 2016-11-22 Sanofi-Aventis Deutschland Gmbh Method for penetrating tissue
US9907502B2 (en) 2002-04-19 2018-03-06 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8784335B2 (en) 2002-04-19 2014-07-22 Sanofi-Aventis Deutschland Gmbh Body fluid sampling device with a capacitive sensor
US8007446B2 (en) 2002-04-19 2011-08-30 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8808201B2 (en) 2002-04-19 2014-08-19 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for penetrating tissue
US8221334B2 (en) 2002-04-19 2012-07-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US20030199895A1 (en) * 2002-04-19 2003-10-23 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7988644B2 (en) * 2002-04-19 2011-08-02 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device with sterility barrier release
US8579831B2 (en) 2002-04-19 2013-11-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7981056B2 (en) 2002-04-19 2011-07-19 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US8845549B2 (en) 2002-04-19 2014-09-30 Sanofi-Aventis Deutschland Gmbh Method for penetrating tissue
US9339612B2 (en) 2002-04-19 2016-05-17 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7976476B2 (en) 2002-04-19 2011-07-12 Pelikan Technologies, Inc. Device and method for variable speed lancet
US7648468B2 (en) 2002-04-19 2010-01-19 Pelikon Technologies, Inc. Method and apparatus for penetrating tissue
US8562545B2 (en) 2002-04-19 2013-10-22 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US8235915B2 (en) 2002-04-19 2012-08-07 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7674232B2 (en) 2002-04-19 2010-03-09 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8905945B2 (en) 2002-04-19 2014-12-09 Dominique M. Freeman Method and apparatus for penetrating tissue
US9724021B2 (en) 2002-04-19 2017-08-08 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7938787B2 (en) 2002-04-19 2011-05-10 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8403864B2 (en) 2002-04-19 2013-03-26 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9186468B2 (en) 2002-04-19 2015-11-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8360992B2 (en) 2002-04-19 2013-01-29 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7708701B2 (en) 2002-04-19 2010-05-04 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device
US8267870B2 (en) 2002-04-19 2012-09-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling with hybrid actuation
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7914465B2 (en) 2002-04-19 2011-03-29 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7713214B2 (en) 2002-04-19 2010-05-11 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device with optical analyte sensing
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US8496601B2 (en) 2002-04-19 2013-07-30 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US7909777B2 (en) 2002-04-19 2011-03-22 Pelikan Technologies, Inc Method and apparatus for penetrating tissue
US8491500B2 (en) 2002-04-19 2013-07-23 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US7909778B2 (en) 2002-04-19 2011-03-22 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US7901365B2 (en) 2002-04-19 2011-03-08 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7717863B2 (en) 2002-04-19 2010-05-18 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7731729B2 (en) 2002-04-19 2010-06-08 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7892185B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US8435190B2 (en) 2002-04-19 2013-05-07 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8430828B2 (en) 2002-04-19 2013-04-30 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a multi-use body fluid sampling device with sterility barrier release
US8690796B2 (en) 2002-04-19 2014-04-08 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
US9072842B2 (en) 2002-04-19 2015-07-07 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9839386B2 (en) 2002-04-19 2017-12-12 Sanofi-Aventis Deustschland Gmbh Body fluid sampling device with capacitive sensor
US9089678B2 (en) 2002-04-19 2015-07-28 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7892183B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US6964871B2 (en) 2002-04-25 2005-11-15 Home Diagnostics, Inc. Systems and methods for blood glucose sensing
US7819161B2 (en) 2002-04-25 2010-10-26 Nipro Diagnostics, Inc. Systems and methods for blood glucose sensing
US20030203498A1 (en) * 2002-04-25 2003-10-30 Home Diagnostics, Inc. System and methods for blood glucose sensing
US20080112852A1 (en) * 2002-04-25 2008-05-15 Neel Gary T Test Strips and System for Measuring Analyte Levels in a Fluid Sample
US20070089987A1 (en) * 2002-04-25 2007-04-26 Home Diagnostics, Inc. Systems and methods for blood glucose sensing
US7160251B2 (en) 2002-04-25 2007-01-09 Home Diagnostics, Inc. Systems and methods for blood glucose sensing
WO2003091717A1 (en) * 2002-04-25 2003-11-06 Home Diagnostics, Inc. Systems and methods for blood glucose sensing
US6959247B2 (en) 2002-04-25 2005-10-25 Home Diagnostics, Inc. Systems and methods for blood glucose sensing
US20040182703A1 (en) * 2002-04-25 2004-09-23 Home Diagnostics, Inc. Systems and methods for blood glucose sensing
US6946299B2 (en) 2002-04-25 2005-09-20 Home Diagnostics, Inc. Systems and methods for blood glucose sensing
US6953693B2 (en) 2002-04-25 2005-10-11 Home Diagnostics, Inc. Systems and methods for blood glucose sensing
US6743635B2 (en) 2002-04-25 2004-06-01 Home Diagnostics, Inc. System and methods for blood glucose sensing
US7678261B2 (en) 2002-09-30 2010-03-16 Infopia Co., Ltd. Apparatus and method for measuring reaction result of samples on biosensor
US20060163086A1 (en) * 2002-09-30 2006-07-27 Infopia Co., Ltd. Apparatus and method for measuring reaction result of samples on biosensor
US8574895B2 (en) 2002-12-30 2013-11-05 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
US9034639B2 (en) 2002-12-30 2015-05-19 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
US10750952B2 (en) 2002-12-31 2020-08-25 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US10039881B2 (en) 2002-12-31 2018-08-07 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US8682598B2 (en) 2003-04-04 2014-03-25 Abbott Laboratories Method and system for transferring analyte test data
US8483974B2 (en) 2003-04-04 2013-07-09 Abbott Diabetes Care Inc. Method and system for transferring analyte test data
US8560250B2 (en) 2003-04-04 2013-10-15 Abbott Laboratories Method and system for transferring analyte test data
US8437966B2 (en) 2003-04-04 2013-05-07 Abbott Diabetes Care Inc. Method and system for transferring analyte test data
US20040214345A1 (en) * 2003-04-23 2004-10-28 Matzinger David P. Ambidextrous capillary-filled test strip
US8262614B2 (en) 2003-05-30 2012-09-11 Pelikan Technologies, Inc. Method and apparatus for fluid injection
US7850621B2 (en) 2003-06-06 2010-12-14 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US8251921B2 (en) 2003-06-06 2012-08-28 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling and analyte sensing
US9730584B2 (en) 2003-06-10 2017-08-15 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US10034628B2 (en) 2003-06-11 2018-07-31 Sanofi-Aventis Deutschland Gmbh Low pain penetrating member
US9144401B2 (en) 2003-06-11 2015-09-29 Sanofi-Aventis Deutschland Gmbh Low pain penetrating member
US8507289B1 (en) 2003-06-20 2013-08-13 Roche Diagnostics Operations, Inc. System and method for coding information on a biosensor test strip
US8586373B2 (en) 2003-06-20 2013-11-19 Roche Diagnostics Operations, Inc. System and method for determining the concentration of an analyte in a sample fluid
US8119414B2 (en) 2003-06-20 2012-02-21 Roche Diagnostics Operations, Inc. Test strip with slot vent opening
US8211379B2 (en) 2003-06-20 2012-07-03 Roche Diagnostics Operations, Inc. Test strip with slot vent opening
US8679853B2 (en) 2003-06-20 2014-03-25 Roche Diagnostics Operations, Inc. Biosensor with laser-sealed capillary space and method of making
US8206565B2 (en) 2003-06-20 2012-06-26 Roche Diagnostics Operation, Inc. System and method for coding information on a biosensor test strip
US7749437B2 (en) 2003-06-20 2010-07-06 Roche Diagnostics Operations, Inc. Method and reagent for producing narrow, homogenous reagent stripes
US20090151864A1 (en) * 2003-06-20 2009-06-18 Burke David W Reagent stripe for test strip
US7727467B2 (en) 2003-06-20 2010-06-01 Roche Diagnostics Operations, Inc. Reagent stripe for test strip
US7829023B2 (en) 2003-06-20 2010-11-09 Roche Diagnostics Operations, Inc. Test strip with vent opening
US8142721B2 (en) 2003-06-20 2012-03-27 Roche Diagnostics Operations, Inc. Test strip with slot vent opening
US7718439B2 (en) 2003-06-20 2010-05-18 Roche Diagnostics Operations, Inc. System and method for coding information on a biosensor test strip
US7645421B2 (en) 2003-06-20 2010-01-12 Roche Diagnostics Operations, Inc. System and method for coding information on a biosensor test strip
US8222044B2 (en) 2003-06-20 2012-07-17 Roche Diagnostics Operations, Inc. Test strip with flared sample receiving chamber
US8298828B2 (en) 2003-06-20 2012-10-30 Roche Diagnostics Operations, Inc. System and method for determining the concentration of an analyte in a sample fluid
US8293538B2 (en) 2003-06-20 2012-10-23 Roche Diagnostics Operations, Inc. System and method for coding information on a biosensor test strip
US8083993B2 (en) 2003-06-20 2011-12-27 Riche Diagnostics Operations, Inc. System and method for coding information on a biosensor test strip
US7645373B2 (en) 2003-06-20 2010-01-12 Roche Diagnostic Operations, Inc. System and method for coding information on a biosensor test strip
US8058077B2 (en) 2003-06-20 2011-11-15 Roche Diagnostics Operations, Inc. Method for coding information on a biosensor test strip
US8148164B2 (en) 2003-06-20 2012-04-03 Roche Diagnostics Operations, Inc. System and method for determining the concentration of an analyte in a sample fluid
US8071030B2 (en) 2003-06-20 2011-12-06 Roche Diagnostics Operations, Inc. Test strip with flared sample receiving chamber
US7879618B2 (en) 2003-06-20 2011-02-01 Roche Diagnostics Operations, Inc. Method and reagent for producing narrow, homogenous reagent strips
US7892849B2 (en) 2003-06-20 2011-02-22 Roche Diagnostics Operations, Inc. Reagent stripe for test strip
US8663442B2 (en) 2003-06-20 2014-03-04 Roche Diagnostics Operations, Inc. System and method for analyte measurement using dose sufficiency electrodes
US7761130B2 (en) 2003-07-25 2010-07-20 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US7896809B2 (en) 2003-07-25 2011-03-01 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
USRE43399E1 (en) 2003-07-25 2012-05-22 Dexcom, Inc. Electrode systems for electrochemical sensors
US8160669B2 (en) 2003-08-01 2012-04-17 Dexcom, Inc. Transcutaneous analyte sensor
US8676287B2 (en) 2003-08-01 2014-03-18 Dexcom, Inc. System and methods for processing analyte sensor data
US8394021B2 (en) 2003-08-01 2013-03-12 Dexcom, Inc. System and methods for processing analyte sensor data
US8442610B2 (en) 2003-08-01 2013-05-14 Dexcom, Inc. System and methods for processing analyte sensor data
US8052601B2 (en) 2003-08-01 2011-11-08 Dexcom, Inc. System and methods for processing analyte sensor data
US8622905B2 (en) 2003-08-01 2014-01-07 Dexcom, Inc. System and methods for processing analyte sensor data
US8000901B2 (en) 2003-08-01 2011-08-16 Dexcom, Inc. Transcutaneous analyte sensor
US8275437B2 (en) 2003-08-01 2012-09-25 Dexcom, Inc. Transcutaneous analyte sensor
US8700117B2 (en) 2003-08-01 2014-04-15 Dexcom, Inc. System and methods for processing analyte sensor data
US8788006B2 (en) 2003-08-01 2014-07-22 Dexcom, Inc. System and methods for processing analyte sensor data
US8788007B2 (en) 2003-08-01 2014-07-22 Dexcom, Inc. Transcutaneous analyte sensor
US8915849B2 (en) 2003-08-01 2014-12-23 Dexcom, Inc. Transcutaneous analyte sensor
US9420968B2 (en) 2003-08-22 2016-08-23 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8777853B2 (en) 2003-08-22 2014-07-15 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US9510782B2 (en) 2003-08-22 2016-12-06 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US9247901B2 (en) 2003-08-22 2016-02-02 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US11589823B2 (en) 2003-08-22 2023-02-28 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US11559260B2 (en) 2003-08-22 2023-01-24 Dexcom, Inc. Systems and methods for processing analyte sensor data
US9585607B2 (en) 2003-08-22 2017-03-07 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8282576B2 (en) 2003-09-29 2012-10-09 Sanofi-Aventis Deutschland Gmbh Method and apparatus for an improved sample capture device
US8945910B2 (en) 2003-09-29 2015-02-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for an improved sample capture device
US9351680B2 (en) 2003-10-14 2016-05-31 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a variable user interface
US7927274B2 (en) 2003-11-19 2011-04-19 Dexcom, Inc. Integrated receiver for continuous analyte sensor
US8282550B2 (en) 2003-11-19 2012-10-09 Dexcom, Inc. Integrated receiver for continuous analyte sensor
US11564602B2 (en) 2003-11-19 2023-01-31 Dexcom, Inc. Integrated receiver for continuous analyte sensor
US8929968B2 (en) 2003-12-05 2015-01-06 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
USRE44695E1 (en) 2003-12-05 2014-01-07 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8428678B2 (en) 2003-12-05 2013-04-23 Dexcom, Inc. Calibration techniques for a continuous analyte sensor
US9579053B2 (en) 2003-12-05 2017-02-28 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US11633133B2 (en) 2003-12-05 2023-04-25 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8249684B2 (en) 2003-12-05 2012-08-21 Dexcom, Inc. Calibration techniques for a continuous analyte sensor
US8911369B2 (en) 2003-12-05 2014-12-16 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8160671B2 (en) 2003-12-05 2012-04-17 Dexcom, Inc. Calibration techniques for a continuous analyte sensor
US11000215B1 (en) 2003-12-05 2021-05-11 Dexcom, Inc. Analyte sensor
US11020031B1 (en) 2003-12-05 2021-06-01 Dexcom, Inc. Analyte sensor
US10188333B2 (en) 2003-12-05 2019-01-29 Dexcom, Inc. Calibration techniques for a continuous analyte sensor
US10299712B2 (en) 2003-12-05 2019-05-28 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8483793B2 (en) 2003-12-05 2013-07-09 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8287453B2 (en) 2003-12-05 2012-10-16 Dexcom, Inc. Analyte sensor
US8668656B2 (en) 2003-12-31 2014-03-11 Sanofi-Aventis Deutschland Gmbh Method and apparatus for improving fluidic flow and sample capture
US8296918B2 (en) 2003-12-31 2012-10-30 Sanofi-Aventis Deutschland Gmbh Method of manufacturing a fluid sampling device with improved analyte detecting member configuration
US9561000B2 (en) 2003-12-31 2017-02-07 Sanofi-Aventis Deutschland Gmbh Method and apparatus for improving fluidic flow and sample capture
WO2005073393A1 (en) * 2004-01-26 2005-08-11 Home Diagnostics, Inc. Systems and methods for blood glucose sensing
US9410917B2 (en) 2004-02-06 2016-08-09 Ascensia Diabetes Care Holdings Ag Method of using a biosensor
US10067082B2 (en) 2004-02-06 2018-09-04 Ascensia Diabetes Care Holdings Ag Biosensor for determining an analyte concentration
US8771183B2 (en) 2004-02-17 2014-07-08 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US8808228B2 (en) 2004-02-26 2014-08-19 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
US7976492B2 (en) 2004-02-26 2011-07-12 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
US10966609B2 (en) 2004-02-26 2021-04-06 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
US10278580B2 (en) 2004-02-26 2019-05-07 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
US10835672B2 (en) 2004-02-26 2020-11-17 Dexcom, Inc. Integrated insulin delivery system with continuous glucose sensor
US9937293B2 (en) 2004-02-26 2018-04-10 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
US8721585B2 (en) 2004-02-26 2014-05-13 Dex Com, Inc. Integrated delivery device for continuous glucose sensor
US8926585B2 (en) 2004-02-26 2015-01-06 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
US11246990B2 (en) 2004-02-26 2022-02-15 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
US10327638B2 (en) 2004-05-03 2019-06-25 Dexcom, Inc. Transcutaneous analyte sensor
US8792955B2 (en) 2004-05-03 2014-07-29 Dexcom, Inc. Transcutaneous analyte sensor
US9833143B2 (en) 2004-05-03 2017-12-05 Dexcom, Inc. Transcutaneous analyte sensor
US8828203B2 (en) 2004-05-20 2014-09-09 Sanofi-Aventis Deutschland Gmbh Printable hydrogels for biosensors
US9261476B2 (en) 2004-05-20 2016-02-16 Sanofi Sa Printable hydrogel for biosensors
US9775553B2 (en) 2004-06-03 2017-10-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
US9820684B2 (en) 2004-06-03 2017-11-21 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
US8092668B2 (en) 2004-06-18 2012-01-10 Roche Diagnostics Operations, Inc. System and method for quality assurance of a biosensor test strip
US9410915B2 (en) 2004-06-18 2016-08-09 Roche Operations Ltd. System and method for quality assurance of a biosensor test strip
US8515516B2 (en) 2004-07-13 2013-08-20 Dexcom, Inc. Transcutaneous analyte sensor
US8475373B2 (en) 2004-07-13 2013-07-02 Dexcom, Inc. Transcutaneous analyte sensor
US8792954B2 (en) 2004-07-13 2014-07-29 Dexcom, Inc. Transcutaneous analyte sensor
US8792953B2 (en) 2004-07-13 2014-07-29 Dexcom, Inc. Transcutaneous analyte sensor
US7885697B2 (en) 2004-07-13 2011-02-08 Dexcom, Inc. Transcutaneous analyte sensor
US8801611B2 (en) 2004-07-13 2014-08-12 Dexcom, Inc. Transcutaneous analyte sensor
US10314525B2 (en) 2004-07-13 2019-06-11 Dexcom, Inc. Analyte sensor
US7899511B2 (en) 2004-07-13 2011-03-01 Dexcom, Inc. Low oxygen in vivo analyte sensor
US8812072B2 (en) 2004-07-13 2014-08-19 Dexcom, Inc. Transcutaneous medical device with variable stiffness
US8825127B2 (en) 2004-07-13 2014-09-02 Dexcom, Inc. Transcutaneous analyte sensor
US7857760B2 (en) 2004-07-13 2010-12-28 Dexcom, Inc. Analyte sensor
US20100228109A1 (en) * 2004-07-13 2010-09-09 Dexcom, Inc. Transcutaneous analyte sensor
US8571625B2 (en) 2004-07-13 2013-10-29 Dexcom, Inc. Transcutaneous analyte sensor
US9833176B2 (en) 2004-07-13 2017-12-05 Dexcom, Inc. Transcutaneous analyte sensor
US8565848B2 (en) 2004-07-13 2013-10-22 Dexcom, Inc. Transcutaneous analyte sensor
US8858434B2 (en) 2004-07-13 2014-10-14 Dexcom, Inc. Transcutaneous analyte sensor
US8750955B2 (en) 2004-07-13 2014-06-10 Dexcom, Inc. Analyte sensor
US8565849B2 (en) 2004-07-13 2013-10-22 Dexcom, Inc. Transcutaneous analyte sensor
US8886272B2 (en) 2004-07-13 2014-11-11 Dexcom, Inc. Analyte sensor
US8615282B2 (en) 2004-07-13 2013-12-24 Dexcom, Inc. Analyte sensor
US9814414B2 (en) 2004-07-13 2017-11-14 Dexcom, Inc. Transcutaneous analyte sensor
US9801572B2 (en) 2004-07-13 2017-10-31 Dexcom, Inc. Transcutaneous analyte sensor
US8548551B2 (en) 2004-07-13 2013-10-01 Dexcom, Inc. Transcutaneous analyte sensor
US7654956B2 (en) 2004-07-13 2010-02-02 Dexcom, Inc. Transcutaneous analyte sensor
US7905833B2 (en) 2004-07-13 2011-03-15 Dexcom, Inc. Transcutaneous analyte sensor
US8515519B2 (en) 2004-07-13 2013-08-20 Dexcom, Inc. Transcutaneous analyte sensor
US10918314B2 (en) 2004-07-13 2021-02-16 Dexcom, Inc. Analyte sensor
US10524703B2 (en) 2004-07-13 2020-01-07 Dexcom, Inc. Transcutaneous analyte sensor
US8313434B2 (en) 2004-07-13 2012-11-20 Dexcom, Inc. Analyte sensor inserter system
US9986942B2 (en) 2004-07-13 2018-06-05 Dexcom, Inc. Analyte sensor
US9775543B2 (en) 2004-07-13 2017-10-03 Dexcom, Inc. Transcutaneous analyte sensor
US7946984B2 (en) 2004-07-13 2011-05-24 Dexcom, Inc. Transcutaneous analyte sensor
US9668677B2 (en) 2004-07-13 2017-06-06 Dexcom, Inc. Analyte sensor
US8989833B2 (en) 2004-07-13 2015-03-24 Dexcom, Inc. Transcutaneous analyte sensor
US9610031B2 (en) 2004-07-13 2017-04-04 Dexcom, Inc. Transcutaneous analyte sensor
US7949381B2 (en) 2004-07-13 2011-05-24 Dexcom, Inc. Transcutaneous analyte sensor
US9603557B2 (en) 2004-07-13 2017-03-28 Dexcom, Inc. Transcutaneous analyte sensor
US8290560B2 (en) 2004-07-13 2012-10-16 Dexcom, Inc. Transcutaneous analyte sensor
US8483791B2 (en) 2004-07-13 2013-07-09 Dexcom, Inc. Transcutaneous analyte sensor
US7783333B2 (en) 2004-07-13 2010-08-24 Dexcom, Inc. Transcutaneous medical device with variable stiffness
US10709363B2 (en) 2004-07-13 2020-07-14 Dexcom, Inc. Analyte sensor
US11883164B2 (en) 2004-07-13 2024-01-30 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US8463350B2 (en) 2004-07-13 2013-06-11 Dexcom, Inc. Transcutaneous analyte sensor
US10709362B2 (en) 2004-07-13 2020-07-14 Dexcom, Inc. Analyte sensor
US10722152B2 (en) 2004-07-13 2020-07-28 Dexcom, Inc. Analyte sensor
US10799159B2 (en) 2004-07-13 2020-10-13 Dexcom, Inc. Analyte sensor
US9044199B2 (en) * 2004-07-13 2015-06-02 Dexcom, Inc. Transcutaneous analyte sensor
US9055901B2 (en) 2004-07-13 2015-06-16 Dexcom, Inc. Transcutaneous analyte sensor
US8731630B2 (en) 2004-07-13 2014-05-20 Dexcom, Inc. Transcutaneous analyte sensor
US9060742B2 (en) 2004-07-13 2015-06-23 Dexcom, Inc. Transcutaneous analyte sensor
US9414777B2 (en) 2004-07-13 2016-08-16 Dexcom, Inc. Transcutaneous analyte sensor
US11064917B2 (en) 2004-07-13 2021-07-20 Dexcom, Inc. Analyte sensor
US8457708B2 (en) 2004-07-13 2013-06-04 Dexcom, Inc. Transcutaneous analyte sensor
US8452368B2 (en) 2004-07-13 2013-05-28 Dexcom, Inc. Transcutaneous analyte sensor
US8663109B2 (en) 2004-07-13 2014-03-04 Dexcom, Inc. Transcutaneous analyte sensor
US10799158B2 (en) 2004-07-13 2020-10-13 Dexcom, Inc. Analyte sensor
US10813576B2 (en) 2004-07-13 2020-10-27 Dexcom, Inc. Analyte sensor
US9078626B2 (en) 2004-07-13 2015-07-14 Dexcom, Inc. Transcutaneous analyte sensor
US10827956B2 (en) 2004-07-13 2020-11-10 Dexcom, Inc. Analyte sensor
US8721545B2 (en) 2004-07-13 2014-05-13 Dexcom, Inc. Transcutaneous analyte sensor
US8229534B2 (en) 2004-07-13 2012-07-24 Dexcom, Inc. Transcutaneous analyte sensor
US11045120B2 (en) 2004-07-13 2021-06-29 Dexcom, Inc. Analyte sensor
US8690775B2 (en) 2004-07-13 2014-04-08 Dexcom, Inc. Transcutaneous analyte sensor
US8231531B2 (en) 2004-07-13 2012-07-31 Dexcom, Inc. Analyte sensor
US11026605B1 (en) 2004-07-13 2021-06-08 Dexcom, Inc. Analyte sensor
US20090036763A1 (en) * 2004-07-13 2009-02-05 Dexcom, Inc. Analyte sensor
US8280475B2 (en) 2004-07-13 2012-10-02 Dexcom, Inc. Transcutaneous analyte sensor
US10918313B2 (en) 2004-07-13 2021-02-16 Dexcom, Inc. Analyte sensor
US10022078B2 (en) 2004-07-13 2018-07-17 Dexcom, Inc. Analyte sensor
US10993641B2 (en) 2004-07-13 2021-05-04 Dexcom, Inc. Analyte sensor
US10993642B2 (en) 2004-07-13 2021-05-04 Dexcom, Inc. Analyte sensor
US10980452B2 (en) 2004-07-13 2021-04-20 Dexcom, Inc. Analyte sensor
US10918315B2 (en) 2004-07-13 2021-02-16 Dexcom, Inc. Analyte sensor
US9247900B2 (en) 2004-07-13 2016-02-02 Dexcom, Inc. Analyte sensor
US10932700B2 (en) 2004-07-13 2021-03-02 Dexcom, Inc. Analyte sensor
WO2006065901A1 (en) * 2004-12-13 2006-06-22 Bayer Healthcare Llc Multi-contact connector assembly for a sensor-dispensing instrument
US8652831B2 (en) 2004-12-30 2014-02-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte measurement test time
US7822454B1 (en) 2005-01-03 2010-10-26 Pelikan Technologies, Inc. Fluid sampling device with improved analyte detecting member configuration
US10624539B2 (en) 2005-03-10 2020-04-21 Dexcom, Inc. Transcutaneous analyte sensor
US11051726B2 (en) 2005-03-10 2021-07-06 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10918318B2 (en) 2005-03-10 2021-02-16 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10925524B2 (en) 2005-03-10 2021-02-23 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US9220449B2 (en) 2005-03-10 2015-12-29 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10918317B2 (en) 2005-03-10 2021-02-16 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10610137B2 (en) 2005-03-10 2020-04-07 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US7920906B2 (en) 2005-03-10 2011-04-05 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10918316B2 (en) 2005-03-10 2021-02-16 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US9314196B2 (en) 2005-03-10 2016-04-19 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US11000213B2 (en) 2005-03-10 2021-05-11 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10610102B2 (en) 2005-03-10 2020-04-07 Dexcom, Inc. Transcutaneous analyte sensor
US10898114B2 (en) 2005-03-10 2021-01-26 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10610135B2 (en) 2005-03-10 2020-04-07 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10617336B2 (en) 2005-03-10 2020-04-14 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10856787B2 (en) 2005-03-10 2020-12-08 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US8611978B2 (en) 2005-03-10 2013-12-17 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10743801B2 (en) 2005-03-10 2020-08-18 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US9078608B2 (en) 2005-03-10 2015-07-14 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10610136B2 (en) 2005-03-10 2020-04-07 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US8560037B2 (en) 2005-03-10 2013-10-15 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10709364B2 (en) 2005-03-10 2020-07-14 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10716498B2 (en) 2005-03-10 2020-07-21 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US8579816B2 (en) 2005-03-10 2013-11-12 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US9918668B2 (en) 2005-03-10 2018-03-20 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US20060231425A1 (en) * 2005-04-15 2006-10-19 Agamatrix, Inc. Method and Apparatus for Detection of Abnormal Traces during Electrochemical Analyte Detection
KR101256133B1 (en) * 2005-04-15 2013-04-23 아가매트릭스, 인코포레이티드 Method and apparatus for detection of abnormal traces during electrochemical analyte detection
US7344626B2 (en) * 2005-04-15 2008-03-18 Agamatrix, Inc. Method and apparatus for detection of abnormal traces during electrochemical analyte detection
US10709332B2 (en) 2005-06-21 2020-07-14 Dexcom, Inc. Transcutaneous analyte sensor
US10813577B2 (en) 2005-06-21 2020-10-27 Dexcom, Inc. Analyte sensor
US10610103B2 (en) 2005-06-21 2020-04-07 Dexcom, Inc. Transcutaneous analyte sensor
US8425757B2 (en) 2005-07-20 2013-04-23 Bayer Healthcare Llc Gated amperometry
US8877035B2 (en) 2005-07-20 2014-11-04 Bayer Healthcare Llc Gated amperometry methods
US9110013B2 (en) 2005-09-30 2015-08-18 Bayer Healthcare Llc Gated voltammetry methods
US8647489B2 (en) 2005-09-30 2014-02-11 Bayer Healthcare Llc Gated voltammetry devices
US10670553B2 (en) 2005-09-30 2020-06-02 Ascensia Diabetes Care Holdings Ag Devices using gated voltammetry methods
US8404100B2 (en) 2005-09-30 2013-03-26 Bayer Healthcare Llc Gated voltammetry
US11435312B2 (en) 2005-09-30 2022-09-06 Ascensia Diabetes Care Holdings Ag Devices using gated voltammetry methods
US9835582B2 (en) 2005-09-30 2017-12-05 Ascensia Diabetes Care Holdings Ag Devices using gated voltammetry methods
US8915850B2 (en) 2005-11-01 2014-12-23 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US10201301B2 (en) 2005-11-01 2019-02-12 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8920319B2 (en) 2005-11-01 2014-12-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9078607B2 (en) 2005-11-01 2015-07-14 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9326716B2 (en) 2005-11-01 2016-05-03 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11363975B2 (en) 2005-11-01 2022-06-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11272867B2 (en) 2005-11-01 2022-03-15 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US10231654B2 (en) 2005-11-01 2019-03-19 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11103165B2 (en) 2005-11-01 2021-08-31 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11911151B1 (en) 2005-11-01 2024-02-27 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US10952652B2 (en) 2005-11-01 2021-03-23 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11399748B2 (en) 2005-11-01 2022-08-02 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11538580B2 (en) 2005-11-04 2022-12-27 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US9323898B2 (en) 2005-11-04 2016-04-26 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US9669162B2 (en) 2005-11-04 2017-06-06 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US8585591B2 (en) 2005-11-04 2013-11-19 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US20100274220A1 (en) * 2005-11-04 2010-10-28 Abbott Diabetes Care Inc. Method and System for Providing Basal Profile Modification in Analyte Monitoring and Management Systems
US20070131549A1 (en) * 2005-12-14 2007-06-14 Nova Biomedical Corporation Glucose biosensor and method
US7955484B2 (en) 2005-12-14 2011-06-07 Nova Biomedical Corporation Glucose biosensor and method
US10265000B2 (en) 2006-01-17 2019-04-23 Dexcom, Inc. Low oxygen in vivo analyte sensor
US9757061B2 (en) 2006-01-17 2017-09-12 Dexcom, Inc. Low oxygen in vivo analyte sensor
US11596332B2 (en) 2006-01-17 2023-03-07 Dexcom, Inc. Low oxygen in vivo analyte sensor
US11191458B2 (en) 2006-01-17 2021-12-07 Dexcom, Inc. Low oxygen in vivo analyte sensor
US8133178B2 (en) 2006-02-22 2012-03-13 Dexcom, Inc. Analyte sensor
US9724028B2 (en) 2006-02-22 2017-08-08 Dexcom, Inc. Analyte sensor
US9625413B2 (en) 2006-03-31 2017-04-18 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US8597575B2 (en) 2006-03-31 2013-12-03 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US9039975B2 (en) 2006-03-31 2015-05-26 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US8933664B2 (en) 2006-03-31 2015-01-13 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US9743863B2 (en) 2006-03-31 2017-08-29 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US9380971B2 (en) 2006-03-31 2016-07-05 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US8593109B2 (en) 2006-03-31 2013-11-26 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US10724985B2 (en) 2006-05-03 2020-07-28 Ascensia Diabetes Care Holdings Ag Biosensor for determining a concentration of a biosensor using an underfill procedure
US9939406B2 (en) 2006-05-03 2018-04-10 Ascensia Diabetes Care Holdings Ag Underfill detection system for a biosensor
US7966859B2 (en) 2006-05-03 2011-06-28 Bayer Healthcare Llc Underfill detection system for a biosensor
US20090095071A1 (en) * 2006-05-03 2009-04-16 Bayer Healthcare Llc Underfill Detection System For A Biosensor
US8973422B2 (en) 2006-05-03 2015-03-10 Bayer Healthcare Llc Underfill detection system for a biosensor
US7920907B2 (en) 2006-06-07 2011-04-05 Abbott Diabetes Care Inc. Analyte monitoring system and method
US11432772B2 (en) 2006-08-02 2022-09-06 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8702624B2 (en) 2006-09-29 2014-04-22 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US11399745B2 (en) 2006-10-04 2022-08-02 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US10349873B2 (en) 2006-10-04 2019-07-16 Dexcom, Inc. Analyte sensor
US10136844B2 (en) 2006-10-04 2018-11-27 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US7831287B2 (en) 2006-10-04 2010-11-09 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US9451908B2 (en) 2006-10-04 2016-09-27 Dexcom, Inc. Analyte sensor
US8423114B2 (en) 2006-10-04 2013-04-16 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US9504413B2 (en) 2006-10-04 2016-11-29 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US11382539B2 (en) 2006-10-04 2022-07-12 Dexcom, Inc. Analyte sensor
US8470604B2 (en) 2006-10-24 2013-06-25 Bayer Healthcare Llc Transient decay amperometry
US8026104B2 (en) 2006-10-24 2011-09-27 Bayer Healthcare Llc Transient decay amperometry
US10190150B2 (en) 2006-10-24 2019-01-29 Ascensia Diabetes Care Holdings Ag Determining analyte concentration from variant concentration distribution in measurable species
US11091790B2 (en) 2006-10-24 2021-08-17 Ascensia Diabetes Care Holdings Ag Determining analyte concentration from variant concentration distribution in measurable species
US9005527B2 (en) 2006-10-24 2015-04-14 Bayer Healthcare Llc Transient decay amperometry biosensors
US20110303539A1 (en) * 2006-10-31 2011-12-15 Abbott Diabetes Care Inc. Analyte Sensors and Methods
US8972198B2 (en) * 2006-10-31 2015-03-03 Abbott Diabetes Care Inc. Analyte sensors and methods
US20150168332A1 (en) * 2006-10-31 2015-06-18 Abbott Diabetes Care Inc. Analyte Sensors and Methods
US10617823B2 (en) 2007-02-15 2020-04-14 Abbott Diabetes Care Inc. Device and method for automatic data acquisition and/or detection
US10022499B2 (en) 2007-02-15 2018-07-17 Abbott Diabetes Care Inc. Device and method for automatic data acquisition and/or detection
US9095290B2 (en) 2007-03-01 2015-08-04 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US9801545B2 (en) 2007-03-01 2017-10-31 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US9035767B2 (en) 2007-05-08 2015-05-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9000929B2 (en) 2007-05-08 2015-04-07 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US10952611B2 (en) 2007-05-08 2021-03-23 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8456301B2 (en) 2007-05-08 2013-06-04 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US10178954B2 (en) 2007-05-08 2019-01-15 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9314198B2 (en) 2007-05-08 2016-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8461985B2 (en) 2007-05-08 2013-06-11 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9949678B2 (en) 2007-05-08 2018-04-24 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US8593287B2 (en) 2007-05-08 2013-11-26 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8362904B2 (en) 2007-05-08 2013-01-29 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US11696684B2 (en) 2007-05-08 2023-07-11 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9574914B2 (en) 2007-05-08 2017-02-21 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US9649057B2 (en) 2007-05-08 2017-05-16 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US10653317B2 (en) 2007-05-08 2020-05-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US20090318792A1 (en) * 2007-05-08 2009-12-24 Fennell Martin J Analyte Monitoring System and Methods
US9177456B2 (en) 2007-05-08 2015-11-03 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US10403012B2 (en) 2007-06-08 2019-09-03 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
US8562558B2 (en) 2007-06-08 2013-10-22 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
US11373347B2 (en) 2007-06-08 2022-06-28 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
US9741139B2 (en) 2007-06-08 2017-08-22 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
US8597188B2 (en) 2007-06-21 2013-12-03 Abbott Diabetes Care Inc. Health management devices and methods
US11264133B2 (en) 2007-06-21 2022-03-01 Abbott Diabetes Care Inc. Health management devices and methods
US11276492B2 (en) 2007-06-21 2022-03-15 Abbott Diabetes Care Inc. Health management devices and methods
US8617069B2 (en) 2007-06-21 2013-12-31 Abbott Diabetes Care Inc. Health monitor
US11672422B2 (en) 2007-09-13 2023-06-13 Dexcom, Inc. Transcutaneous analyte sensor
US9668682B2 (en) 2007-09-13 2017-06-06 Dexcom, Inc. Transcutaneous analyte sensor
US9451910B2 (en) 2007-09-13 2016-09-27 Dexcom, Inc. Transcutaneous analyte sensor
US11744943B2 (en) 2007-10-09 2023-09-05 Dexcom, Inc. Integrated insulin delivery system with continuous glucose sensor
US11160926B1 (en) 2007-10-09 2021-11-02 Dexcom, Inc. Pre-connected analyte sensors
US10653835B2 (en) 2007-10-09 2020-05-19 Dexcom, Inc. Integrated insulin delivery system with continuous glucose sensor
US9717449B2 (en) 2007-10-25 2017-08-01 Dexcom, Inc. Systems and methods for processing sensor data
US11272869B2 (en) 2007-10-25 2022-03-15 Dexcom, Inc. Systems and methods for processing sensor data
US10182751B2 (en) 2007-10-25 2019-01-22 Dexcom, Inc. Systems and methods for processing sensor data
US8417312B2 (en) 2007-10-25 2013-04-09 Dexcom, Inc. Systems and methods for processing sensor data
US9933385B2 (en) 2007-12-10 2018-04-03 Ascensia Diabetes Care Holdings Ag Method of using an electrochemical test sensor
US10690614B2 (en) 2007-12-10 2020-06-23 Ascensia Diabetes Care Holdings Ag Method of using an electrochemical test sensor
US8290559B2 (en) 2007-12-17 2012-10-16 Dexcom, Inc. Systems and methods for processing sensor data
US9135402B2 (en) 2007-12-17 2015-09-15 Dexcom, Inc. Systems and methods for processing sensor data
US9901307B2 (en) 2007-12-17 2018-02-27 Dexcom, Inc. Systems and methods for processing sensor data
US9339238B2 (en) 2007-12-17 2016-05-17 Dexcom, Inc. Systems and methods for processing sensor data
US11342058B2 (en) 2007-12-17 2022-05-24 Dexcom, Inc. Systems and methods for processing sensor data
US9149234B2 (en) 2007-12-17 2015-10-06 Dexcom, Inc. Systems and methods for processing sensor data
US9839395B2 (en) 2007-12-17 2017-12-12 Dexcom, Inc. Systems and methods for processing sensor data
US9149233B2 (en) 2007-12-17 2015-10-06 Dexcom, Inc. Systems and methods for processing sensor data
US10827980B2 (en) 2007-12-17 2020-11-10 Dexcom, Inc. Systems and methods for processing sensor data
US10506982B2 (en) 2007-12-17 2019-12-17 Dexcom, Inc. Systems and methods for processing sensor data
US8229535B2 (en) 2008-02-21 2012-07-24 Dexcom, Inc. Systems and methods for blood glucose monitoring and alert delivery
US9020572B2 (en) 2008-02-21 2015-04-28 Dexcom, Inc. Systems and methods for processing, transmitting and displaying sensor data
US11102306B2 (en) 2008-02-21 2021-08-24 Dexcom, Inc. Systems and methods for processing, transmitting and displaying sensor data
US8591455B2 (en) 2008-02-21 2013-11-26 Dexcom, Inc. Systems and methods for customizing delivery of sensor data
US9143569B2 (en) 2008-02-21 2015-09-22 Dexcom, Inc. Systems and methods for processing, transmitting and displaying sensor data
US8396528B2 (en) 2008-03-25 2013-03-12 Dexcom, Inc. Analyte sensor
US11896374B2 (en) 2008-03-25 2024-02-13 Dexcom, Inc. Analyte sensor
US10602968B2 (en) 2008-03-25 2020-03-31 Dexcom, Inc. Analyte sensor
US9386944B2 (en) 2008-04-11 2016-07-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte detecting device
US9831985B2 (en) 2008-05-30 2017-11-28 Abbott Diabetes Care Inc. Close proximity communication device and methods
US9184875B2 (en) 2008-05-30 2015-11-10 Abbott Diabetes Care, Inc. Close proximity communication device and methods
US8509107B2 (en) 2008-05-30 2013-08-13 Abbott Diabetes Care Inc. Close proximity communication device and methods
US8737259B2 (en) 2008-05-30 2014-05-27 Abbott Diabetes Care Inc. Close proximity communication device and methods
US11770210B2 (en) 2008-05-30 2023-09-26 Abbott Diabetes Care Inc. Close proximity communication device and methods
US9339222B2 (en) 2008-09-19 2016-05-17 Dexcom, Inc. Particle-containing membrane and particulate electrode for analyte sensors
US8560039B2 (en) 2008-09-19 2013-10-15 Dexcom, Inc. Particle-containing membrane and particulate electrode for analyte sensors
US10028683B2 (en) 2008-09-19 2018-07-24 Dexcom, Inc. Particle-containing membrane and particulate electrode for analyte sensors
US10561352B2 (en) 2008-09-19 2020-02-18 Dexcom, Inc. Particle-containing membrane and particulate electrode for analyte sensors
US10028684B2 (en) 2008-09-19 2018-07-24 Dexcom, Inc. Particle-containing membrane and particulate electrode for analyte sensors
CN102227636A (en) * 2008-09-30 2011-10-26 梅纳伊医疗科技有限公司 Sample measurement system
US20110174618A1 (en) * 2008-09-30 2011-07-21 Menai Medical Technologies Limited Sample measurement system
US10980461B2 (en) 2008-11-07 2021-04-20 Dexcom, Inc. Advanced analyte sensor calibration and error detection
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
US11166656B2 (en) 2009-02-03 2021-11-09 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US11006870B2 (en) 2009-02-03 2021-05-18 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US11202591B2 (en) 2009-02-03 2021-12-21 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US11213229B2 (en) 2009-02-03 2022-01-04 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US11006871B2 (en) 2009-02-03 2021-05-18 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US11006872B2 (en) 2009-02-03 2021-05-18 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US9226701B2 (en) 2009-04-28 2016-01-05 Abbott Diabetes Care Inc. Error detection in critical repeating data in a wireless sensor system
US9693688B2 (en) 2009-04-29 2017-07-04 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US9949639B2 (en) 2009-04-29 2018-04-24 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US10172518B2 (en) 2009-04-29 2019-01-08 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US10617296B2 (en) 2009-04-29 2020-04-14 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US9088452B2 (en) 2009-04-29 2015-07-21 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US11872370B2 (en) 2009-05-29 2024-01-16 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
US11793936B2 (en) 2009-05-29 2023-10-24 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
US10470691B2 (en) 2009-07-02 2019-11-12 Dexcom, Inc. Analyte sensor with increased reference capacity
US9237864B2 (en) 2009-07-02 2016-01-19 Dexcom, Inc. Analyte sensors and methods of manufacturing same
US9763608B2 (en) 2009-07-02 2017-09-19 Dexcom, Inc. Analyte sensors and methods of manufacturing same
US9517025B2 (en) 2009-07-02 2016-12-13 Dexcom, Inc. Analyte sensor with increased reference capacity
US9131885B2 (en) 2009-07-02 2015-09-15 Dexcom, Inc. Analyte sensors and methods of manufacturing same
US9351677B2 (en) 2009-07-02 2016-05-31 Dexcom, Inc. Analyte sensor with increased reference capacity
US8828201B2 (en) 2009-07-02 2014-09-09 Dexcom, Inc. Analyte sensors and methods of manufacturing same
US10136816B2 (en) 2009-08-31 2018-11-27 Abbott Diabetes Care Inc. Medical devices and methods
US10429250B2 (en) 2009-08-31 2019-10-01 Abbott Diabetes Care, Inc. Analyte monitoring system and methods for managing power and noise
USD1010133S1 (en) 2009-08-31 2024-01-02 Abbott Diabetes Care Inc. Analyte sensor assembly
US11150145B2 (en) 2009-08-31 2021-10-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
US20110060530A1 (en) * 2009-08-31 2011-03-10 Abbott Diabetes Care Inc. Analyte Signal Processing Device and Methods
US11045147B2 (en) 2009-08-31 2021-06-29 Abbott Diabetes Care Inc. Analyte signal processing device and methods
US9314195B2 (en) * 2009-08-31 2016-04-19 Abbott Diabetes Care Inc. Analyte signal processing device and methods
US9968302B2 (en) 2009-08-31 2018-05-15 Abbott Diabetes Care Inc. Analyte signal processing device and methods
US10492685B2 (en) 2009-08-31 2019-12-03 Abbott Diabetes Care Inc. Medical devices and methods
US8993331B2 (en) 2009-08-31 2015-03-31 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
US11635332B2 (en) 2009-08-31 2023-04-25 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
US9658187B2 (en) 2009-11-10 2017-05-23 Ascensia Diabetes Care Holdings Ag Underfill recognition biosensor
US9234866B2 (en) 2009-11-10 2016-01-12 Bayer Healthcare Llc Underfill recognition biosensor
US20110108440A1 (en) * 2009-11-10 2011-05-12 Bayer Healthcare Llc Underfill Recognition System for a Biosensor
KR101685234B1 (en) 2009-11-10 2016-12-09 바이엘 헬스케어 엘엘씨 Underfill recognition system for a biosensor
KR20120099452A (en) * 2009-11-10 2012-09-10 바이엘 헬스케어 엘엘씨 Underfill recognition system for a biosensor
US8668819B2 (en) 2009-11-10 2014-03-11 Bayer Healthcare Llc Underfill recognition system for a biosensor
US20110231105A1 (en) * 2010-03-22 2011-09-22 Bayer Healthcare Llc Residual Compensation Including Underfill Error
US10591436B2 (en) 2010-03-22 2020-03-17 Ascensia Diabetes Care Holdings Ag Residual compensation including underfill error
US9011658B2 (en) 2010-03-30 2015-04-21 Jabil Circuit (Singapore) Pte, Ltd. Sampling plate
US8894832B2 (en) 2010-03-30 2014-11-25 Jabil Circuit (Singapore) Pte, Ltd. Sampling plate
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US9222910B2 (en) 2010-06-07 2015-12-29 Bayer Healthcare Llc Underfill management system for a biosensor
US10175194B2 (en) 2010-06-07 2019-01-08 Ascensia Diabetes Care Holdings Ag Underfill management system for a biosensor
US9532737B2 (en) 2011-02-28 2017-01-03 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
US9775806B2 (en) 2011-09-21 2017-10-03 Ascensia Diabetes Care Holdings Ag Analysis compensation including segmented signals
US10646445B2 (en) 2011-09-21 2020-05-12 Ascensia Diabetes Care Holdings Ag Analysis compensation including segmented signals converted into signal processing parameters for describing a portion of total error
US9465420B2 (en) 2011-10-31 2016-10-11 Abbott Diabetes Care Inc. Electronic devices having integrated reset systems and methods thereof
US9069536B2 (en) 2011-10-31 2015-06-30 Abbott Diabetes Care Inc. Electronic devices having integrated reset systems and methods thereof
US9980669B2 (en) 2011-11-07 2018-05-29 Abbott Diabetes Care Inc. Analyte monitoring device and methods
US9214753B2 (en) 2012-06-05 2015-12-15 Panasonic Healthcare Holdings Co., Ltd. Connector for biological information measurement, and biological information measurement device using same
US9968306B2 (en) 2012-09-17 2018-05-15 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
US11612363B2 (en) 2012-09-17 2023-03-28 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
US11331022B2 (en) 2017-10-24 2022-05-17 Dexcom, Inc. Pre-connected analyte sensors
US11706876B2 (en) 2017-10-24 2023-07-18 Dexcom, Inc. Pre-connected analyte sensors
US11350862B2 (en) 2017-10-24 2022-06-07 Dexcom, Inc. Pre-connected analyte sensors
US11382540B2 (en) 2017-10-24 2022-07-12 Dexcom, Inc. Pre-connected analyte sensors
US11918354B2 (en) 2019-12-31 2024-03-05 Dexcom, Inc. Particle-containing membrane and particulate electrode for analyte sensors

Also Published As

Publication number Publication date
EP1145000B1 (en) 2005-05-11
EP1145000A1 (en) 2001-10-17
US20020157948A2 (en) 2002-10-31
US6749740B2 (en) 2004-06-15
US20020053523A1 (en) 2002-05-09
CN1201149C (en) 2005-05-11
CN1322299A (en) 2001-11-14
JP4885508B2 (en) 2012-02-29
KR100495935B1 (en) 2005-06-16
WO2001033216A1 (en) 2001-05-10
ATE295538T1 (en) 2005-05-15
KR20010093785A (en) 2001-10-29
EP1145000B8 (en) 2005-09-14
DE60020076T2 (en) 2006-03-16
US20090260985A1 (en) 2009-10-22
AU1234701A (en) 2001-05-14
CA2358993C (en) 2005-08-02
US8066858B2 (en) 2011-11-29
JP2003513279A (en) 2003-04-08
DE60020076D1 (en) 2005-06-16
CA2358993A1 (en) 2001-05-10
US20080283396A1 (en) 2008-11-20
US20040225230A1 (en) 2004-11-11
AU776764B2 (en) 2004-09-23
US20090260986A1 (en) 2009-10-22
JP2006091022A (en) 2006-04-06
US20020148739A2 (en) 2002-10-17
US20100126884A1 (en) 2010-05-27
US6616819B1 (en) 2003-09-09
US6942518B2 (en) 2005-09-13

Similar Documents

Publication Publication Date Title
US6616819B1 (en) Small volume in vitro analyte sensor and methods
US9662057B2 (en) Integrated sample acquisition and analyte measurement method
US20180128767A1 (en) Small Volume In Vitro Analyte Sensor
US20060191787A1 (en) Analyte sensor with insertion monitor, and methods
EP2426485A1 (en) Method of making biosensors
CA2423837C (en) Small volume in vitro analyte sensor and methods

Legal Events

Date Code Title Description
STCF Information on status: patent grant

Free format text: PATENTED CASE

CC Certificate of correction
AS Assignment

Owner name: THERASENSE, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LIAMOS, CHARLES T.;FELDMAN, BENJAMIN J.;FUNDERBURK, JEFFERY V.;AND OTHERS;REEL/FRAME:021085/0641;SIGNING DATES FROM 20000313 TO 20000410

Owner name: THERASENSE, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LIAMOS, CHARLES T.;FELDMAN, BENJAMIN J.;FUNDERBURK, JEFFERY V.;AND OTHERS;SIGNING DATES FROM 20000313 TO 20000410;REEL/FRAME:021085/0641

AS Assignment

Owner name: ABBOTT DIABETES CARE INC., CALIFORNIA

Free format text: CHANGE OF NAME;ASSIGNOR:THERASENSE, INC.;REEL/FRAME:021139/0122

Effective date: 20050801

FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

FPAY Fee payment

Year of fee payment: 12